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Resumen 
 
El reconocimiento de carbohidratos por lectinas (proteínas que selectivamente 
reconocen carbohidratos sin actividad enzimática o inmunológica) es un suceso ubicuo 
en los organismos vivos. De hecho, median variedad de procesos biológicos clave. Por 
esta razón, el interés por estudiar carbohidratos desde esta perspectiva ha aumentado en 
los últimos años. Desde un punto de vista estructural, una gran cantidad de técnicas 
biofísicas han sido empleadas para obtener información detallada acerca de éstos 
procesos de reconocimiento molecular esenciales. En particular, hemos destacado el uso 
combinado de experimentos de RMN con simulaciones de Dinámica Molecular y 
protocolos de modelado molecular como herramientas clave para diseccionar, a escala 
atómica, los elementos de unión clave de ligandos relevantes desde un punto de vista 
biomédico en sus superficies del receptor específico.  
Por consiguiente, en esta tesis, hemos empleado una combinación de RMN-
STD, trNOESY y simulaciones de dinámica molecular como poderosas herramientas 
para obtener información importante acerca del reconocimiento molecular de 
oligosacáridos sintéticos frente a dos anticuerpos específicos IgG C7-37 e IgM G19-2. 
Nuestro estudio ha dado evidencias experimentales de la importancia individual de los 
diferentes residuos, dependiendo de su posición en la secuencia oligosacarídica, también 
para oligosacáridos mas extensos, y su relevancia en el proceso de reconocimiento 
molecular. La información obtenida a partir de los experimentos de RMN-STD 
evidenció la directa implicación del residuo de RhaC seguido por sus residuos vecinos 
(RhapB-RhapC-GlcNAcpD) en todos los oligosacáridos sintéticos en presencia de 
ambos anticuerpos. Experimentos de RMN-trNOESY también dieron información 
estructural de los valores de Φ/Ψ mayoritarios para cada enlace glicosídico, además de 
el equilibrio conformacional existente en el estado unido. Este equilibrio ha sido 
comparado con el existente en el estado libre. Los datos obtenidos han indicado que 
estos procesos de reconocimiento molecular conllevan una selección conformacional. El 
análisis de las superficies moleculares obtenidas para los confórmeros acomplejados 
mostró que las mayoritarias áreas no-polares del ligando están cerca de la superficie del 
anticuerpo.  
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Cuando los N-glicanos interaccionan con lectinas, la naturaleza del epítopo 
objetivo estrictamente depende de la naturaleza de la lectina estudiada, pudiendo 
seleccionar distintos determinantes de la cadena sacarídica del N-glicano con exquisita 
especificidad, dependiendo de la presentación relativa de los diferentes residuos y de la 
arquitectura del sitio de unión. Hemos enfatizado la importancia de la coexistencia de 
sitios de unión de diferentes dominios de lectina para conseguir unión al glicano 
comparando un dominio único de heveina y WGA, un tetrámero. La unidad 
monomérica no reconoce el extenso glicano, con la ramificación en el residuo de βMan 
siendo el elemento clave de descarte de la interacción. Por el contrario, la lectina 
multidominio WGA se une al extremo reductor de ambos N-glicanos sialilado y no 
sialilado admitiendo la posibilidad de obtener interacciones estabilizantes entre-sitios de 
uno de los dominios de heveína vecinos. Mediante estudios con VAA se obtuvo 
información acerca de cómo la α-sialilación 2,6 puede ser acomodada por esta lectina, 
generando un incremento de la unión en N-glicanos naturales cuando lo comparamos 
con el N-glicano no sialilado correspondiente. La unión al extremo terminal LacNAc del 
N-glicano sialilado es detectable, obteniéndose la referencia control para la unión 
positiva.  
También en esta tesis, hemos demostrado la capacidad de cuatro oligosacáridos 
relacionados con antígeno glycotope (relacionado con procesos de respuesta inmune) de 
interaccionar con diferentes fragmentos de anticuerpo scFv que se unen al glycotope. 
Usando experimentos de STD, hemos demostrado que la presencia del residuo 3-O-α-
DGal A’ es decisiva en el proceso de unión.  
Finalmente, también hemos demostrado que una variedad de glicodendrímeros 
funcionalizados con lactosa y con 6’sialil-lactosa pueden ser fácilmente acomodados 
por Viscumina (una lectina modelo tóxica) mejorando la unión. Experimentos de RMN 
asistidos por modelado molecular permitieron la identificación de los rasgos de unión 
clave entre el azúcar y la lectina. El protocolo de modelado ha permitido sugerir un 
modelo estructural de las posibles interacciones multivalentes de estos ligandos con esta 
lectina.   
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Abstract 
 
The recognition of carbohydrates by lectins (proteins that selectively recognize 
carbohydrates without enzymatic or immunological activity) is a ubiquitous event in 
living organisms. Indeed, they mediate a variety of key biological processes. For this 
reason, the interest to study carbohydrates from this perspective has increased in the last 
years. From the structural viewpoint, a number of biophysical techniques have been 
employed to obtain detailed information about these essential molecular recognition 
processes. In particular, we have stressed the combined use of NMR experiments with 
MD simulations and molecular modeling protocols as key tool to dissect, at atomic 
resolution, the key binding elements of biomedical relevant ligands at their specific 
receptor surfaces. 
Thus, in this thesis, we have employed a combination of STD, trNOESY-NMR 
and MD simulations as a powerful tool to provide important information about the 
molecular recognition of synthetic oligosaccharides towards two specific IgG C7-37 
and IgM G19-2 antibodies. Our study has provided experimental evidences on the 
individual importance of the different residues, depending on its position at the 
oligosaccharide sequence, also for longer oligosaccharides, and their relevance for the 
molecular recognition process. The information obtained from STD-NMR experiments 
have evidenced the direct involvement of residue RhaC followed by its neighbor 
residues (RhapB-RhapC-GlcNAcpD) in every synthetic oligosaccharide in the presence 
of both mAbs. trNOESY-NMR experiments have also provided structural information 
on the major Φ/Ψ values for each glycosidic linkage, as well as the existing 
conformational equilibrium in the bound state. This equilibrium has been compared to 
that existing in the free state. The obtained data have indicated that these molecular 
recognition processes involve conformational selection processes. The analysis of the 
obtained molecular surfaces for the bound conformers showed that the major non-polar 
areas of the ligand are close to the antibody surface.  
When large N-glycans interact with lectins, the nature of the target epitope 
strictly depends on the nature of the tested lectin, which can select distinct determinants 
of the complex-type N-glycan saccharide chain with exquisite specificity, depending on 
the relative presentation of the different residues and the architecture of the binding site. 
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We have underscored the importance of the coexistence of binding sites from different 
lectin domains for achieving glycan binding by comparing a single hevein domain and 
WGA, a tetramer. The monomeric unit does not recognize the large glycan, with the 
branching at the βMan residue being the key structural element for precluding the 
interaction. In contrast, the multidomain lectin WGA binds the terminal reducing end of 
either non- or sialylated-N-glycan owing to the possibility of achieving additional inter-
site stabilizing interactions from one of the neighboring hevein domains. Work with 
VAA has yielded insights into how α2,6-sialylation can be accommodated by this lectin, 
providing enhanced binding in natural N-glycans when compared to the non-sialylated 
LacNAc-terminated analogue. The results for the MAL–MAH mixture have permitted 
definition of the role of the α2,6-linked sialic acid residue in blocking binding of the 
corresponding sialylated-N-glycan. The binding to the LacNAc terminus of the non-
sialylated-N-glycan is detectable, providing the control reference for positive binding. 
Also in this thesis, we have demonstrated the capability of four oligosaccharides 
related to the glycotope antigen (related to immunodeficiency processes) to interact with 
different scFv glycotope-binding antibody fragments. Using STD-NMR experiments, 
we have shown that the presence of 3-O-α-DGal A’ moiety is decisive for the binding 
process. 
Finally, we have also shown that a variety of lactose- and 6’sialyllactose-
functionalized glycodendrimers can be easily accommodated by Viscumin, a model 
toxic lectin, providing enhanced binding. NMR experiments assisted by molecular 
modeling permitted the identification of the key sugar-lectin binding features. The 
modeling protocol has permitted to suggest a structural model for the possible 
multivalent interactions of these ligands with this lectin. 
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1.1 Molecular recognition. Carbohydrates and Lectins 
 
1.1.1 Molecular Recognition Processes 
 
Molecular recognition is at the heart of life events. The interaction between 
molecules is of paramount importance for a variety of processes related with life and 
death. Carbohydrate molecules, which mainly exist conjugated in glycoproteins or 
glycolipids, are the key point of molecular recognition processes since they are at the 
periphery of the cell. Indeed, they mediate a variety of intra-, extra-cellular and 
pathological events, as well as cell-cell and cell-matrix interactions. Modifications of 
cell glycosilation also occur during inflammation and cancer1. Therefore, the 
Glycobiology field, somehow between chemistry and biology, with implications in 
biomedicine, is a challenging and active research field. In this context, the study at the 
maximum possible resolution of the role of carbohydrates into key biological 
interactions is of paramount important to completely understand vital processes and to 
open the possibility of their modulation. 
 
1.1.2 Carbohydrates as recognition molecules 
 
Nowadays, it is well described that carbohydrates play an important role in the 
specific molecular recognitions of different entities, of different size and complexity, 
such as lectins, enzymes, virus, and antibodies2. As mentioned above, they mediate 
diverse cellular activities, such as cell recognition, growth, apoptosis and immune 
response3. 
Carbohydrates constitute one of the most abundant and complex types of 
biomolecules in nature, and constitute markers for molecular recognition processes. 
They display a huge potential to encode biological information, given their complex 
spatial structure4 They are composed by simple moieties (monosaccharides), which may 
be connected each other by a great variety of linkage types. They can form linear 
sequences or sophisticated branched structures5. Moreover, the introduction of 
substituents, as phosphate, sulfate groups6 or/and acetyl7 groups at the hydroxyl groups 
highly increases the carbohydrate complexity. This structural diversity allows 
carbohydrates to specific recognize receptors with exquisite efficiency. Therefore, the 
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knowledge of the atomic three dimensional (3D) perspective of the molecular 
recognition process between saccharides and their receptors is a topic of major interest 
for designing carbohydrate-based therapeutic agents. 
 
 
Figure 1.1 Cell surface carbohydrates are recognition molecules used in specific binding and interactions 
among cells, pathogens, and molecules. 
 
1.1.3 Protein-carbohydrate interactions: CH-π, polar interactions, hydrogen 
bonding, and the role of water  
  
 In the last years, different investigations have deeply looked at the fine structural 
details of protein-carbohydrate interactions. Advances in different biophysical and 
spectroscopic techniques, as X-Ray crystallography and NMR spectroscopy, 
complemented by quantitative data obtained through titration microcalorimetry (TMC)8 
have allowed the access to detailed information on the atomic structure of protein-
carbohydrate complexes9 and permitted to speculate on the forces involved in the 
interaction. From the structural perspective, hydrogen bonds (H-bonds) and van der 
Waals forces (often including packing of a hydrophobic sugar face against the aromatic 
amino acid side chains) are the major factors (Figure 1.2) involved in the binding.  
This fact is not unexpected, since from a general molecular recognition 
viewpoint, the typical contributions to the Gibbs’ free energy of ligand binding 
Chapter 1 
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(Equation 0) are originated from hydrogen bonding, van der Waals forces, entropy 
contributions and from the solvent reorganization. In particular, the role of the 
alterations of the geometry and motion dynamics of the receptor, ligand and/or solvent 
molecules should be highlighted10 (Fig. 1.2).  
Eq. 0 
ΔGO = ΔH O – T ΔS O = RT ln Ka    
 
This equation also encodes a fundamental relationship between the enthalpy and 
entropy factors that may be attributed to the participation of weak intermolecular forces. 
It has been well demonstrated that in many cases, when comparing different ligands to a 
given receptor, an increase in the binding enthalpy (ΔH O) is will inherently balanced by 
an entropic (ΔS Oሻ penalty (or vice versa). This phenomenon is noted as the enthalpy-
entropy compensation effect11.  
There are three prevailing models for describing the molecular basis of 
enthalpy/entropy compensation in the binding of oligosaccharides to proteins12. The 
Lemieux’s group first reported compensation in the binding of oligosaccharides to 
proteins13. Initially, the observed compensation was attributed to the loss of protein 
degrees of freedom.  Later, Lemieux14 suggested the existence of differential solvation 
effects to be responsible for the compensation, a hypothesis closer to that of Lumry and 
Rajender11. Carver suggested a third model, where the loss of conformational entropy 
by the ligand on binding provided the major source of the entropic barrier, at least for 
oligosaccharide binding to lectins15. All three mechanisms are undoubtedly operative to 
some extent. The question remains, however, as to which effect is predominant. A 
complete answer could possible derive by only an accurate analysis of the behavior of 
each participant at the molecular recognition process.  
 Because of the amphiphilic character of oligosaccharides, the recognition 
process involves forces of different nature. These types of interactions can be clearly 
seen in the available X-Ray and NMR structures of carbohydrate-protein complexes 
(Figure 2). Polar groups of the sugars are bound by H-bond donors and acceptors in the 
protein backbone and polar side chains. Apolar groups (especially formed by CH groups 
of the pyranose) are complemented by nonpolar surfaces of the proteins. In fact, the CH 
vectors tend to pack against the aromatic residues at the receptor side chains16 (Figure 
1.2). NMR studies have shown the presence of interactions between certain hydrogens 
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belonging to the non-polar faces of the sugar ring and aromatic residues of protein side 
chains. Indeed, these studies have linked the strength of the interaction to the size and 
the electron richness of the arene17.    
Depending on the conformation of the carbohydrates, an arrangement of three C-
H groups with axial orientation on one face of the sugar can effectively interact with the 
surface of a properly positioned aromatic residue. The strength of this interaction is 
relatively weak, since a unique CH-π interaction may worth less than 1 kcal/mol18. 
However, the simultaneous interaction between several CH groups with one aromatic 
system enhances the strength of the interaction19. Clearly, the orientation of the aromatic 
side-chain is determinant for the specificity of the binding. 
 
 
Figure 1.2 General description of the interactions involved in protein-carbohydrate binding. Schematic 
representation of hydrogen-bond and CH-π interactions between aminoacid residues of galectin-1 and 
lactose10. Besides hydrogen bonds between several hydroxyl groups of the saccharide and protein polar 
side chains, stacking interactions between several sugar CH bonds and aromatic rings endow the complex 
with stability. 
Water molecules also play an important role in the molecular recognition 
process. There has been a large debate on this topic and, indeed, Lemieux and co-
workers14b suggested that the reorganization of water molecules upon binding provides 
the driving force for the carbohydrate complex formation. In the receptor, the binding 
pocket is occupied by water molecules that stabilize the orientation of the protein 
residues, later involved in the recognition process, through a network of interactions. 
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When the positions of these waters and aminoacids before and after complex formation 
with the sugar are compared, some of these water molecules in the free state seem to 
occupy the positions of the hydroxyl groups of the sugar in the complex20. Thus, in this 
way, no displacements of aminoacid side chains are necessary. Also, those water 
molecules that are directly involved in the interactions between the protein and the 
sugar display restricted motions, compared to other water entities in bulk solution and, 
therefore they may not be able to adopt the suitable orientation to form hydrogen 
bonding with other vicinal waters. When the complex is going to be formed, the water 
molecules that solvate the polar surface of the protein binding pocket have to be 
displaced to leave the space for the sugar to enter. In the same way, those water 
molecules solvating the polar surface of the carbohydrate are released into the bulk 
solution. All these processes display key enthalpy and entropy requirements. It is 
evident that the reorganization of the solvent implicates many molecules, a multivalency 
process that leads to a strong contribution to the thermodynamics of the system. In fact, 
according to Lemieux14b, the release of the geometry restrains on the receptor-bound 
water molecules may provide a key enthalpy driving force to the binding process 
(“hydrophobic effect”). 
 
1.1.4 The receptors: Lectins and Antibodies 
 
Lectins are proteins that bind carbohydrates with a high selectivity, reversibility 
and efficacy. Lectins are found in many cellular layers of a large number of organisms, 
and their localization reflects their diversity of function. They used to appear in the cell 
surface regulating cellular adhesion and migration processes and, in some cases, helping 
to the cellular metabolism control21. Investigation of lectins and their role in cell 
recognition, as well as the application of these proteins for the study of carbohydrates in 
solution and on cell surfaces, are making marked contributions to the advancement of 
Glycobiology1b. They are not neither antibodies nor enzymes. They are proteins with 
non-immunogenic origin and do not modify the carbohydrate that binds, but can be as 
specific as the interaction between antigens and antibodies or substrates and enzymes21b, 
22. Lectin-monosaccharide interactions, however, are relatively weak with dissociation 
constants often on the order of micromolar to millimolar range21a, 23.  
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Lectins were firstly identified in plants (See Table 1.1). Only later were found in 
microorganisms and animals. It can be safely assumed that only a small fraction of the 
total number of lectins that exist in nature have been now identified. They can be 
identified based on functional assays (for instance, hemagglutination) or by amino acid 
sequence homology (putative lectins) with known lectin sequences. Nowadays, only a 
small fraction of the discovered lectins have been carefully characterized with respect to 
protein structure, binding affinities for extended carbohydrates, and binding 
thermodynamics. This fact is changing, and there is a great interest in the elucidation of 
the function of endogenous lectins, since it might be correlated with a deeper knowledge 
of many diseases and their associated pathogenesis. 
 
1.1.4.1 Plant lectins 
 
The most known members of the diverse group of plant lectins are shown in 
Table 1. The leading position is held by concanavalin A, the classical Man/Glc-binding 
plant lectin from Jack beans. Because of numerous chemical modifications, 
concanavalin A is very useful for chemical, biochemical and biomedical applications4. 
Moreover, this lectin was the first one to be characterized by X-Ray diffraction 
methods. 
In general, they show several functionalities, from plant defence from 
pathogenic attacks to cell wall extension, but also they are involved in mitogenic 
simulation, transport of carbohydrates, mobilization of storage material, and as starting 
points of the symbiosis processes in leguminous plants1c.  
 
- HEVEIN 
 
There are a group of lectins with vegetal origin, with small size, that bind to N-
Acetyl-glucosamine (GlcNAc) oligomers. Indeed, chitin is a polysaccharide 24 that is 
the principal component of insects and crustacean’s exoskeleton and also is present in 
the cellular wall of a large number of microorganisms25. These lectins are characterized 
by a common structural motif, which is referred as the hevein domain26. In fact, because 
of their intrinsic structural properties, joined to their relative easy availability, hevein 
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has been employed as a model to study the mechanism, origin and structural properties 
involved in protein-carbohydrate molecular recognition processes. 
 
 
Table 1.1 Plant Lectins: origin, families, specificities, and some general features. 
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The hevein domain contains around 40-50 aminoacids and is characterized by 
the presence, in conserved positions, of 6 or 8 cystein moieties that form three or four 
disulfide bridges. This name came from hevein itself, a 43 aminoacids polypeptide, 
which is extracted from the latex gum of Hevea brasilensis plant27.  
 
Regardless of its defense properties in the origin plant, hevein as well as other 
homologue proteins present in other plants are directly related with latex allergy28. 
Hevein domains can be founded isolated, as for example in hevein itself or in 
pseudohevein, or being part of bigger proteins, and even covalently grouped in two or 
more domains. For example, the nettle lectin (UDA, Urtica dioica agglutinin) and 
wheat germ agglutinin (WGA), show two and four hevein domains, respectively.  
 
- WGA 
 
Wheat-germ agglutinin is a lectin capable of agglutinating erythrocytes and 
other types of cells29. As mentioned above, WGA is a dimeric lectin, where each 
subunit consists of an assembly of four hevein domains. Therefore, WGA is composed 
of eight hevein domains30. It has been described to be specific for terminal Neu5Ac and 
GlcNAc moieties31, and also longer GlcNAc-containing oligosaccharides as N,N’-
diacetylchitobiose ((GlcNAc)2)29a, 32 by using a variety of techniques, including X-ray 
crystallography30 and NMR spectroscopy33. The deduced structures reveals that the 
primary binding site is constituted by three conserved aromatic residues from one 
hevein domain together with further polar residues (See Fig. 1.3; S114 and E115) from 
the neighbouring hevein domain. All together contribute to the stabilization of the 
complex formed, providing structural evidence for an intra-protein cooperation of lectin 
domains.  
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Figure 1.3 (a) Quaternary structure of WGA (Wheat-Germ Agglutinin). (b) Representation of GlcNAc 
(left) and 6’Sialyllactose (right) recognition by WGA with the key aminoacid residues involved in the 
binding highlighted. 
 
- VAA 
 
The major lectin from mistletoe extract34, viscumin (VAA, Viscum album 
agglutinin, also referred as ML-1), is a heterodimeric lectin composed of a toxic “A” 
chain and a galactose-binding “B” chain. There are many toxic lectins with this 
construction in the plant kingdom, the best studied being ricin (RCA-II), from castor 
beans. A single RCA-II molecule is capable of inactivating at least 50 ribosomes in ten 
minutes. However, more than a citotoxic agent, viscumin is known as an immune 
system activator, with considerable biopharmaceutical interest. Although the structure, 
enzymatic activity, and carbohydrate binding ability is similar to those of type II 
ribosome inactivating proteins (RIPs)34-35, nonetheless viscumin presents some peculiar 
differences that makes it unique.  
Although viscumin is formed by the two A and B chains mentioned above, 
recent electrophoresis studies have revealed that these are not covalently linked by a 
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disulfide bond in all molecules35a. Viscumin forms a dimer in solution over a broad 
range of protein concentrations (0.01-25 mg/ml)36. These VAA solutions exhibit non-
ideality, self-association, and poly-dispersity, as evidenced by sedimentation 
equilibrium and velocity experiments. When diluting the concentration down to 0.01 
mg/ml, the protein behaves like a single ideal component, with the molecular mass of 
the dimer. At very low concentrations, viscumin monomers are also detected 
(concentrations <3μg/ml). However, the possible formation of non-covalent tetramers 
[AB]2 (Figure 1.4) and the existence of a concentration-dependent dimer-tetramer 
equilibrium has also been reported35a, being its coexistence also assessed by electron 
microscopy37. 
 
Figure 1.4 (left) Quaternary structure of the AB dimer of viscumin (PDB 1CE7). The side chain of Trp 
and Tyr key aminoacids are represented in sticks, as a way to indicate the two carbohydrate binding 
domains. (right) Representation of the lactose recognition by Viscumin.  
 
Viscumin’s chain A chain is formed by 254 amino acids, with a molecular 
weight of approximately 29 kDa and a pI of 6.11 (Swiss-Prot P81830). It contains a 
solely Cys (247) residue, which is implicated on the inter-chain disulfide bond with 
chain B. On the other hand, the B chain is formed by 264 amino acids, and also has an 
approximate 29 kDa molecular mass. In the NMR experiments that will be shown 
below, VAA is present in solution as a tetramer (concentration >20μM), formed by non-
covalent interactions between the domains of the adjacent B chains38, as in the ABBA 
tetramer.  
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This geometry causes the Trp CRD in both chain’s (1α subdomains) to be 
located only 15 Å apart from one another, at the tetramer interface, with low 
accessibility. On the other hand, the Tyr binding site at the 2γ subdomain are present at 
the other protein side, separated by 87 Å. ITC and laser photo chemically induced 
nuclear dynamic polarization (CIDNP)39 studies, covering a broad range of 
lactose/VAA ratio have evidenced that, when the lectin is in solution as a dimer (from 
0.01-25 mg/ml concentrations), the Trp site in VAA is only partially occupied. The 
close distance between the Trp sites inevitably imposes steric restrictions on sugar 
binding at these loci.  
Viscumin recognizes galactose specifically40 and, oppositely to ricin, shows very 
low affinity towards GalNAc40b. The binding to galactose-ending oligosaccharides and 
mimetics takes place through key interactions with the galactose residue41. In lactose, 
deoxygenation at C-2 position of the Gal unit results in a considerable affinity loss 
(approximately 8 times), which suggest a local interaction between this hydroxyl group 
and the lectin. The affinity is not regained when analyzing the 2’-O-methyl derivative, 
which could indicate that this hydroxyl acts as an H-bond donor to the protein. 
Alternatively, this lack of affinity could also be due to the existence of steric factors 
precluding the proper docking of a methyl group42. The essential contribution to binding 
arises from the C-3’ and C-4’ positions. In both cases, any substitution causes a great 
decay on the affinity strength42. Nevertheless, only a slight affinity diminishing 
(approximately two times) is observed after dehydrogenation at C-6’. Besides, the 
affinity is regained after the introduction of a fluorine atom or an O-methyl group at that 
position, suggesting that OH-6’ has H-bond acceptor properties40a, 42 and that there is 
room for further extension at this region. Although the binding force of the association 
of viscumin with a Gal-containing ligand is generated by the non-reducing end, the 
residue attached to the Gal moiety as well as the anomeric configuration of that 
glycosidic linkage displays a decisive influence on the observed affinity 40b, 43.  
Previous studies showed no significant affinity variations when large 
substituents were introduced at position Glc C-3 of lactose. Hydrogenation at C-6 also 
revealed a minor diminishing of the affinity, suggesting a weak contact of the OH-6 
with the protein. Furthermore, in addition to β-linked disaccharides, such as Galβ(1-
2)Galβ(1-R) and Galβ(1-3)Galβ(1-R), the lectin appears to bind well to terminal non-
reducing Galα(1-3)Gal sequences of complex-type oligosaccharides and to the P1-
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characteristic Galα(1-4)Gal40, 44. The binding domain has also been postulated to be 
fairly extended, capable of accommodating additional residues. In fact, VAA presents 
high affinity for those oligosaccharides in which the terminal Gal moiety is further 
sialylated at O-6, giving rise to a α(2-6)-linked saccharide. In fact, it has been suggested 
that VAA’s “true receptors” are complex sialoglycoproteins and gangliosides holding 
the terminal Neu5Acα(2-6)Galβ(1-4)GlcNAc sequence45.  
The biological responses in animals and humans to viscumin action include, 
among others, the modulation of genetic expression, induction of cytokine secretions, 
release of immune-competent cells from the bone marrow, modulations of leukocytes 
phagocytic activity46, protein synthesis inactivation and cellular apoptosis. Thus, 
viscumin acts both as a cytotoxic agent and a biologic response modulator47.  
In all cases, these processes are set in motion as a consequence of the toxin 
binding to specific cellular receptors. The access inside the cell may occur by several 
endocytic means that internalize the viscumin-receptor complex. In the initial 
recognition and internalization process by 3T3 cells, viscumin interacts with receptors 
located at the cell periphery, being then enclosed in small endocyclic vesicles present all 
over the cell surface, with tendency to accommodate them in cellular interior48.  
RIPs have relevant biomedical interest due to their potential use for treatment of 
several human diseases. To date, its most noteworthy use lies on the production of 
immunotoxins ant other conjugates for AIDS and cancer experimental therapy49. 
Regrettably, their use still presents clinical problems related to its toxicity. Thus, there 
is a significant need of insightful studies focused on the structure and ligand recognition 
mechanism of these proteins. This knowledge could allow the design of new 
alternatives, which could display a high selectivity for the therapeutic goal, raising the 
minimum possible side effects.  
 
- MAL 
 
Maackia amurensis hemagglutitin, the lectin from the seeds of Maackia 
amurensis leguminous plant, is a 26 kDa protein that is known as a strong mitogenic 
activator against human peripheral lymphocytes50. The first interaction studies showed 
that MAL-bound glycans with α2-3-Gal-linked sialic acid residues were efficiently 
recognized, as in the Sialα(2-3)Galβ(1-4)GlcNAc of N-linked glycans51. However, it 
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has been recently found that MAL can also bind to the corresponding non-sialylated 
glycan52. In our interaction studies, we have used the mixture of the two lectin species 
present in the seed of M. amurensis, MAL and MAH.  
 
1.1.4.2 Carbohydrate-recognizing antibodies 
Antibodies are γ-globulin proteins that can be found in blood and serum of 
vertebrates. These molecules are used by the immune system to recognize and 
neutralize foreign systems, such as virus and bacteria. In fact, as mentioned above, 
bacteria and viruses contain unique carbohydrates on their surfaces, which are then 
recognized by the key antibodies thus activating the human immune system53.  
The basic structure of an antibody consists of two identical large heavy chains 
(H chains) accompanied by two identical small light chains (L chains), which are 
covalently attached by a disulfide bond to each other (see Fig 5). They can be grouped 
into different isotypes based on the type of heavy chain. For mammals, there are five 
different antibody isotypes (IgG, IgA, IgM, IgD, and IgE). They display different 
functionality, thus allowing the recognition of different foreign objects (Fig 1.5). 
 
Figure 1.5 (a) Schematic structure representations of a typical IgG antibody with the different parts 
detailed. (b) Structure representation of IgG and IgM antibodies.   
Chapter 1 
16 
 
All antibody molecules share the same basic structural characteristics but display 
remarkable variability in the regions that bind their antigens. The part of the antigen that 
is highly specifically recognized by the specific antibody is called the epitope. The 
variability of the antigen-binding regions (or variable regions, VH and VL) accounts for 
the capacity of the different antibodies to bind a tremendous number of structurally 
diverse antigens. There are more than 107, perhaps as many as 109 different antibody 
molecules in every individual, each with unique amino acid sequences in their antigen-
combining sites. The effector functions and common physicochemical properties of the 
antibodies are associated with the non-antigen-binding portions (or constant regions, 
CH and CL), which exhibit relatively few variations in their aminoacid sequences. 
The antigen-binding sites of most antibodies are surfaces that can accommodate 
the conformational epitopes of different molecules. As in any molecular recognition 
event, the recognition of antigen by the antibody involves non-covalent reversible 
binding (electrostatic forces, hydrogen bonds, van der Waals forces, and hydrophobic 
interactions)53. The specific characteristics of the corresponding interaction process 
leads to the specific recognition of a given antigen, which may take place with varying 
affinities. In fact, the key recognition features of one particular antigen reflect the 
structural and dynamic properties of the associated antibody V regions.  
 
1.2 Conformational analysis of carbohydrates: NMR and Molecular 
Dynamics   
 
 
1.2.1 Anomeric and exo-anomeric effects 
 
Carbohydrates in aqueous solution exist in equilibrium between their open chain 
and cyclic forms. The carbonyl carbon in the open chain becomes the anomeric carbon 
in the cyclized structure, which is the most oxidized carbon of the ring. Cyclized aldose 
and ketose carbohydrates can adopt either the α or β anomeric configuration, depending 
on the orientation of the group attached to the so-called anomeric carbon54. The 
assignment of the configuration is determined by the relationship between the group 
attached to the anomeric carbon (hydroxyl) and the group attached to the highest 
numbered chiral carbon in the ring (Carbon at position 6). When the groups are trans, 
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the α configuration is noted and when they are in cis-type orientation, the β 
configuration is used55 (Fig 1.6). 
α-D-Galactose β-D-Galactose
 
Figure 1.6 2D representation of the α and β configuration of a D-Galactose residue.  
 
The anomeric effect was initially defined as the preference for an electronegative 
substituent, at the anomeric carbon in a carbohydrate, to be in an axial rather than 
equatorial orientation56. In cyclohexane, it is well known that substituents attached to 
the ring tend to prefer the equatorial position over the axial one, due to unfavourable 
steric interactions for the axial conformer. However, contrary to steric predictions, 
electronegative substituents at the anomeric position of carbohydrates and other 
heterocycles were observed to exist predominantly as the axial conformer. This 
phenomenon was named as the anomeric effect.  
Two rationales exist that explain the origin of the anomeric effect, the 
electrostatic model (also known as the rabbit ear and dipole-dipole model) and the 
molecular orbital model (also known as the double-bond/no-bond model and 
hyperconjugative model)57.  
Originally, the anomeric effect was defined in terms of electrostatic interactions. 
In this electrostatic model,57 it was speculated that the increased preference for the 
electronegative group to be axial is due to the existing repulsive dipole-dipole 
interactions for the equatorial orientation. However, this model was discussed by the 
compelling equilibrium effects that were observed when the polarity of the solvent was 
modified. In principle, for the electrostatic model, one would predict that a polar solvent 
would stabilize the more polar, equatorial, conformation to a greater extent than a non-
polar solvent. Interestingly, that was not the case, evidencing that the electrostatic 
model is not sufficient for explaining the anomeric effect. The molecular orbital model 
presented an alternative explanation for the anomeric effect56a. The preference for the 
axial conformation was attributed to the stabilization provided by donation of electron 
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density from the anti-periplanar orbital (σ*) on the ring oxygen (sp3 or p) to the anti-
bonding orbital of the C-X bond58. This stabilizing interaction can only occur in the 
axial conformation due to the requirement for the donating oxygen orbital and the C-X 
bond to be anti-periplanar. The origin of the anomeric effect continues being a matter of 
discussion59. 
a.
b.
 
Figure 1.7 Schematic representation of the anomeric (a) and exo-anomeric (b) effect. {Figure Adapted 
from 60}. 
Similarly, the exo-anomeric effect describes the preference of the exocyclic 
glycosidic torsion angle (Φ) to adopt a gauche (or synclinal) orientation. In this spatial 
disposition, the lone pair electronic density at O1 can be delocalized with respect to the 
σ* from the C1-O5 bond. This fact affects the dihedral angle defined by the glycosidic 
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torsion and determines a favourable interaction between the glycosidic O1 electronic 
pair with the σ* orbital of the endocyclic bond C1-O5. This phenomenon is known as 
the exo-anomeric effect (out of the ring), similarly to the endo-anomeric effect (within 
the ring, also simply referred as the anomeric effect)59. In fact, the combination of steric 
and electrostatic interactions generates the preference for two orientations of the 
glycosidic torsion Φ (H1-C1-O1-Cx): -60º and +60º for the α and β forms in a 4C1 chair, 
and +60º and -60º for the α and β forms in a 1C4 chair (Fig 1.7). The magnitude of the 
steric and stereoelectronic contributions has been deduced in solution60. 
 
1.2.2 Nuclear Magnetic Resonance and Carbohydrates: Basic concepts 
 
Nuclear Magnetic Resonance (NMR)61 is a spectroscopic technique related with 
the intrinsic property of atomic nuclei that have a spin quantum number different to 0. 
Every nucleus have an associated magnetic moment, μ, by the relationship μ = γxS, 
being γ the magnetogyric ratio, which is characteristic of each nucleus. The magnitude 
and the orientation of the associated magnetic moment with the nuclear spin can only 
adopt a limited number of values. For a given nuclear spin n, 2n+1 possible angular 
moments exist, with values from –n to +n. For example, for nuclei with spin number of 
n=½, like 1H, 15N or 13C, there are two possible spin states; m=+½ and -½.  
In the absence of an external magnetic field, these levels are degenerated; that is, 
both states have the same energy, and the number of nuclei in both states will be about 
equal. On the other hand, when placed within an external, static magnetic field (denoted 
B0), this degeneration disappears, producing a population difference between both 
states, as shown in Eq. 1. 
Eq. 1  
 
ΔE = γhB0    (1)    Nlow / Napp = e -ΔE / k t    (2)      ω0 = γ (B0 – Bi)       δ = (ω – ωref) / ωref). 106    (3) 
 
Thus, there will be a minor fraction of nuclei populating the lower energy spin 
state, related with the Boltzmann distribution (Eq. 1 (2); K= Bolztmann constant). 
The Nuclear Magnetic Resonance (NMR) signal results from the difference 
between the energy absorbed for the nuclear spins in the presence of a radiofrequency. 
This generates a transition from the low energy state to the high-energy state. When the 
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system returns to the equilibrium, the energy emitted follows the inverse step: there are 
transitions from the high-energy state to the low-energy state. Therefore, the NMR 
signal is proportional to the population difference in both states.  
The magnetic moment of every nucleus precesses around the external magnetic 
field (B0). The frequency of this precession is named Larmor resonance frequency (ω0). 
This is different for each particular nucleus and is related to the energy difference 
between both levels. The Larmor frequency of a given nucleus depends on its 
magnetogyric constant γ and on the magnetic field intensity, B0 (Eq. 1 (3)). However, 
there are local perturbances in the magnetic field associated with every nucleus, mainly 
due to the protection applied by the closer electrons.  
As a result, we can use NMR as a spectroscopic technique, since the nuclei with 
different chemical environment precess with different frequencies. To reduce 
complexity in providing data, NMR prefers the use of chemical shifts (δ, expressed in 
ppm), to the use of actual Larmor frequencies. The corresponding relationship is shown 
in Eq. 1(3). Here, ω is the Larmor frequency for an observed nucleus and ωref is the 
Larmor frequency for a reference nucleus, which normally corresponds with TMS or 
TSP in 1H NMR.   
There has been a spectacular progress in the NMR field with advances in distinct 
areas to generate an improvement in the resolution (decreasing the field homogeneity), 
an increase in the sensibility (using the Fourier Transformation), or the development of 
structure determination, conformation and dynamics techniques of complex 
molecules.61 
 
1.2.3 Conformation and NOE effect 
 
The shape of a given oligosaccharide is determined by the conformation of the 
furanose/pyranose rings and the relative positioning of the rings in the chain. Based on 
X-Ray crystallography, neutron diffraction, and NMR data, the 4C1 chair conformer is 
energetically preferred for D-pyranose ring structures (1C4 for L-sugars)62. In rare cases, 
for example, for L-iduronic acid pyranoses, constituents of heparan and dermatan 
sulfates, this is not the case. L-iduronic acid displays a major skew boat form 2SO6, 63. 
However, the main contribution to defining the shape of a glycan generally does not 
originate from this source, but rather from changes of the two dihedral angles Φ, Ψ of 
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each glycosidic bond (Fig. 1.8). For linkages involving the hydroxymethyl C6 carbons, 
a third angle, ω, should be also considered. Since the pyranose rings linked by the 
glycosidic bonds and their exocyclic substituents may be rather bulky, their sizes 
imposes topological restraints on the intramolecular movements of the oligomer. 
The orientations of the glycosidic bonds are specified by the corresponding 
torsion angles Φ/Ψ (H1-C1-O1-Cx and C1-O1-Cx-Hx, respectively, with x being the 
aglyconic linkage position, as in Fig. 1.8). For 1-6 linkages, ω is defined as O5-C5-C6-
O6. 
φ ψ
ω
 
Figure 1.8 Torsion angles φ, ψ and ω.  
 
Compared to oligopeptides with small side chains, the conformational space 
accessible to the molecule at room temperature is thus relatively restricted. This spatial 
factor limits the range of interchangeable conformations. The accessible space has been 
inferred by using computer-assisted molecular mechanics and dynamics calculations 
and convincingly documented by experimental evidence, primarily from NMR63a, b. 
Exploring the actual positions of each oligosaccharide on the scale between high 
flexibility with an ensemble of conformers and almost complete rigidity definitely has 
salient implications for predicting its role as a coding unit. In this respect, it is also 
worth pointing out that the existing notable level of intramolecular flexibility is not a 
favourable factor for crystallization. Indeed, such an extent of unrestrained 
conformational entropy can contribute to explaining the frequently frustrating 
experience in crystallization attempts in carbohydrate chemistry. If, on the other hand, 
the level of conformational entropy is confined to only very few stable conformers, the 
presented shape distribution is a function not only of the sequence, but also of external 
factors affecting the current status of the equilibrium. Sugar receptors as probes for 
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distinguishing bioactive or bioinert glycan presentation modes on proteins have already 
provided the hypothesis experimental support64. 
Emil Fischer already introduced the classical projection formulae for sugars, 
with a standard orientation (carbon chain vertical, carbonyl group at the top; Fig. 
1.9).The use of models with flexible bonds between the atoms, easily permitted to 
'stretch' the sugar models into a position suitable for projection. He assigned to 
dextrorotatory glucose (via the derived glucaric acid) the projection with the OH group 
at C-5 pointing to the right, well knowing that there was a 50% chance that this was 
wrong. 
HC
OHH
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Figure 1.9 Classical representation of pyranose by Fisher. 
 
Towards the end of the nineteenth century, it was realized that free sugars (not 
only the glycosides) existed as cyclic hemiacetals or hemiketals. Mutarotation, 
discovered in 1846 by Dubrunfaut, was now interpreted as being due to a change in the 
configuration of the glycosidic (anomeric) carbon atom. Fischer assumed the cyclic 
form to be either five-membered or six-membered rings. In the 1920s, Haworth 
proposed the terms 'furanose' and 'pyranose' for the two forms. He also introduced the 
'Haworth depiction' for writing structural formulae, a convention that was soon widely 
followed. Cyclic forms with a three-membered ring are called oxiroses, those with a 
four-membered ring oxetoses, those with a five-membered ring furanoses, with a six-
membered ring pyranoses, with a seven-membered ring septanoses, with an eight-
membered ring octanoses, and so on. If a cyclic form of a sugar is to be represented in 
the Fischer projection, a long bond can be drawn between the oxygen involved in ring 
formation and the (anomeric) carbon atom to which it is linked. 
In the Haworth representation of the cyclic form (Fig. 1.10), the ring is 
orientated almost perpendicular to the plane of the paper, but viewed from slightly 
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above so that the edge closer to the viewer is drawn below the more distant edge, with 
the oxygen behind and C-1 at the right-hand end. To define the perspective, the ring 
bonds closer to the viewer are often thickened. Figure 10 shows the schematic 
representation of pyranose ring closure in D-glucose with the reorientation at C-5 
necessary to allow ring formation. 
 
Figure 1.10 Classical representation of pyranose by Fisher and Haworth. 
 
The orientation of the model described above results in a clockwise numbering 
of the ring atoms. Groups that appear to the right of the modified Fischer projection 
appear below the plane of the ring; those on the left appear above. In the common 
Haworth representation of the pyranose form of D-aldohexoses, C-6 is above the plane. 
The Haworth representation implies a planar ring. However, as mentioned 
above, due to the tetrahedral geometric of carbon backbone, monosaccharides assume 
conformations that are not planar. The conformation and the spatial arrangements of the 
ring atoms of a monosaccharide in the cyclic form is well described by the IUPAC-IUB 
Joint Commission on Biochemical Nomenclature (E2, 3E, 3T2, 4C1, 1C4, 2,5B, 1S3, 2S0, 
etc). 
 
The NOE effect 
 
The nuclear Overhauser enhancement (NOE) is the key parameter to determine 
internuclear (proton-proton) distances and therefore, it contains key conformational 
information. It is based on the existence of dipole-dipole interactions between two 
moving NMR-active nuclei, which must be close enough in the space. 
If we consider two spins, I and S, the intensity of I changes when the equilibrium 
state of the closest spin S is perturbed by a radio-frequency pulse. Then, the 
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magnetization is transferred from one spin to the other one through space. This change 
is intensity is commonly known as the NOE and it is governed by three possible 
transitions: the zero-, single- and double quantum transitions61, 65, which describe the 
cross-relaxation pathway (Fig. 1.11) and the variation of intensities, as defined by the 
Solomon equation given below: 
 
W1S and W1I : single quantum transitions
W2 : double quantum transitions
W0 : zero quantum transitions
W2 and W0 are cross relaxation probabilities  
 
Figure 1.11 Diagram illustrating the population levels, intensity changes and transition probabilities in a 
two-spin ½ system, which gives rise to the NOE.  
 
Eq. 2 
dIZ/ dt = - ( IZ – I0Z)(W0 + 2W1I + W2) – (SZ - S0Z)(W2 – W0)  
 
SZ and IZ are the longitudinal components of the magnetization. S0Z and I0Z are 
these values at zero time. The zero-, one and double quantum transitions depend on the 
tumbling rate of the molecule and determine if the variation of the intensity is negative 
or positive. 
The cross relaxation rate constant σIS is defined as the difference between the 
double and zero-quantum transition probabilities (W2-W0) and is a measure of how fast 
the magnetization is transferred between the S and I spins. Finally, the dipolar 
longitudinal relaxation rate constant, ρIS, is defined by the term W0+2W1I+W2, and 
describes the part of the relaxation process that restore the equilibrium state of spin I. 
In this way, after saturating spin S, at the steady state: dIZ/dt=SZ=0, and the 
equation can be rewritten as: 
 
Eq. 3 
(IZ – I0Z) / S0Z = σIS / ρIS  
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and the enhancement of the intensity (η) of the signal of I after saturation of spin S can 
be determined by: 
 
Eq. 4 
 
ηI {S} = γS / γI [ W2 – W0 / W0 + 2W1I + W2 ] = γS / γI [ δIS / ρIS ] 
 
the gyromagnetic ratios (γS / γI ) are important when the two spins are different. In the 
case of homonuclear NOE, the σIS and ρIS are related to the precession frequency (ω) and 
the correlation time (τC): 
 
Eq. 5 
 
η = (5+ ω2τC2- 4ω4τC4)/ (10+23ω2τC2+4ω4τC4)  
 
According to these equations, NOEs depend on the spatial proximity (for the 
transfer to be efficient), on the spectrometer frequency and on the tumbling rate61, 65. For 
small molecules, with fast tumbling in solution, dipolar relaxation is long and the NOE 
signals are positive, with a maximum enhancement of 50% (Figure 1.12). In contrast, 
large molecules, slowly tumbling in solution, provide efficient NOE negative signals, 
and the enhancements can reach 100%. This change of sign can be explained looking at 
the possible transitions. In fact, for short τC the best possible transition is the double 
quantum transition W2, which corresponds to fast frequencies. When W2 dominates, the 
intensity of I increases, corresponding to a NOE positive signal. The opposite behaviour 
is found for large molecules with large τC. In this case, W0 dominates, and the intensity 
of I decreases, corresponding to a NOE negative signal61, 65. 
Also, for intermediate motions, the curve in Fig. 1.12 (NOE curve) passes 
through zero, in a region in which the enhancement of NOE is negligible. Depending on 
the temperature and spectrometer frequency, this zero-crossing point is found from 500 
to 1500Da, (from tri- to penta-saccharides). 
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Figure 1.12 Dependence of NOE and ROE with molecular motion.  
 
It is possible try to avoid the zero-crossing point, by modifying the experimental 
conditions that can affect τC. Spectra at lower temperatures can be recorded, or taken 
after modifying the solution conditions (viscosity). Also, a different spectrometer 
frequency can be used. In fact, it has been described that ultra-high field spectrometers 
(800, 900 MHz, and beyond) permit to reach a better resolution, since the spin-spin 
relaxation mechanism is affected. In fact, for molecules with fast τC, the constant rate 
1/T2 depends on B0 (the static external magnetic field). Therefore, at high magnetic 
fields, T2 is more favorable leading to narrow signals (better resolution) and better 
enhancement in NOE signals66. 
In a real situation, the NOE (η) also depends on the proton-proton distances. 
Thus, the NOE is inversely proportional to the inverse of the sixth power of the distance 
between the interacting nuclei. In this case, knowing the NOE value between two nuclei 
(A-B) and the distance between them, it is possible to calculate other distances 
corresponding to observed NOEs (X and Y) in the same molecule through this simple 
equation (isolated spin pair approximation): 
 
Eq. 6 
 
ηA {B} / ηX {Y} = rAB -6 / rXY -6 
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This distance dependence reflects the necessity for dipolar interactions (short 
range) to give rise to NOEs. In fact, at large distances the NOE effect is minimum, with 
an exponential decay in the NOE with increasing distances65. Depending on the 
molecular motion and the spectrometer frequency, the maximum distance that can be 
monitored in oligosaccharides is aprox. 4 Å, whereas for large molecules can reach even 
6 Å. 
A variety of NMR sequences have been employed to measure NOEs, both in 1D 
and 2D versions (Fig. 1.13). Nowadays, the so-called transient experiments are 
employed, instead of the saturation experiments that were commonly employed years 
ago (and in the Solomon equations). In this method (either 1D or 2D), the perturbation 
of the system is obtained by inverting the target resonance/s. Just one resonance is 
usually selected in the 1D version, or all the spins in the 2D-protocol. Thus, the 
inversion of the population differences across the corresponding transitions allows NOE 
development in the absence of external interference. During the mixing time, the NOE 
grows up for a selected period of time and then, the changes in intensities are monitored 
by the employment of a read pulse and acquisition65, 67. 
 
In all these cases, the key points are the calibration of the 90° pulse and the 
determination of the associated delays to obtain the best results. As mentioned above, 
one additional problem for oligosaccharides could be the zero crossing region around 
ωτC~1.1, were the observed NOEs are basically absent. If the experimental conditions 
of the sample cannot be modified or the access to a different spectrometer is not 
possible, there is one additional way to NOEs, through the use rotating-frame NOE 
spectroscopy or ROESY experiment65. Under spin-lock conditions, the nuclei are still 
able to experience dipolar relaxation, now in the transverse plane, leading to ROE 
effects, which are always positive for all values of τC (Fig. 1.12, ROE curve). A frequent 
problem is the occurrence of scalar-coupling-mediated cross peaks, due to TOCSY-like 
effect during the spin-lock period. Some modification shave been employed to 
overcome this problems65. 
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1D NOE
2D NOESY
2D ROESY
τm
τmt1
τm
1H
1H
1H
 
Figure 1.13 Different experimental pulse sequences to measure NOEs. 1D-NOE: A single resonance is 
selectively inverted. Then, NOEs grow up during mixing time (τm). 2D-NOESY: All resonances are 
frequency labeled after the 90 degree pulse and inverted after the evolution period. 1D-ROESY: NOEs in 
the rotating frame. All resonances are frequency labeled after the 90 degree pulse and “spin locked” after 
the evolution period. Rotating frame NOEs grow up during τm.  
 
 
1.2.4 Computational Methods: Molecular Dynamics 
 
Molecular modeling methods try to help to describe a living system through the 
chemical and physical points of view. It is today well known and assumed that 
biomolecules are dynamic entities that display their functionality by adopting distinct 
conformations in solution. 
MD may give details on the different time-dependent properties of the system. In 
principle, different information may be extracted from a MD simulation: 
- From the exploration of the conformational space to the refinement of a given 
structure. 
- From the characterization of equilibrium averages to the description of the 
structural, motional and thermodynamic properties of the system. 
For these purposes, empirical energy functions have been developed. They are 
mathematical equations constituted by simple terms that allow the description of 
physical interactions closely related to the structure and dynamic properties of 
biomolecules. These empirical “force fields” use atomistic models instead of electrons 
and nuclei to simplify the mathematical treatment and enhance the speed of 
calculations. 
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The potential energy function permits to calculate the potential energy (V) as a 
function of the three-dimensional structure (R), and it is divided in two main terms: 
 
Eq. 7 
 
The internal term gathers all the parameters related to covalently-bonded atoms, 
while the external one represents the non-bonding interactions between atoms68. 
The parameters characterizing a three-dimensional covalently-bonded structure 
(internal term) are bond lengths (b), valence angles (θ), dihedral angles (χ), and 
distances (rij). 
In any modern force-field, bond-stretching and angle-bending are treated as 
harmonic functions, which oscillate around an equilibrium value (b0, θ0). Kb and Kθ 
are the force constants associated with the bond and angle terms. 
When MDs are performed, in absence of bond-breaking or bond-making events, 
motions are strongly related to the stretching, bending and torsions of the connected 
atoms. The torsional term is treated as an oscillatory function. In fact, in addition to the 
force constant Kχ, it also includes periodicity (n) and phase (δ) terms. The magnitude of 
Kχ is the height of the energy barrier to rotation, n indicates the number of cycles per 
360° rotation, while δ is the location of the maxima in the dihedral energy surface, 
generally 0º or 180º. Each torsion angle in a molecule is treated as a sum of dihedral 
terms that have different periodicity, constant forces and phases68. 
The external terms are of paramount importance to characterize biological 
systems. There is also a strong influence of the environment on the properties of 
biomacromolecules. The key parameters of the external terms are the well depth εij 
between the atoms i and j, the minimum interaction radius, Rminij; and the partial atomic 
charge, q. The term in square brackets is associated to the van der Waals (VDW) 
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interactions. In many cases, a Lennard-Jones potential (or 6-12 potential) is used to 
define these interactions (Fig 1.14). The (1/r)12 represents the repulsion energy between 
atoms, very important at short-range distances. The attraction force energy is defined by 
the (1/r)6 term and is related to instantaneous dipole-induced dipole interactions 
(London’s dispersion forces). This term works at longer distances. The negative sign 
denotes the favourable nature of this phenomenon68. The minimum interaction radius 
Rminij and the well depth, εij (Fig. 1.14)69 are related to the minimum of the curve. They 
are not determined for every possible interaction pair, but calculated for the individual 
atom types and are combined to obtain the ij cross terms. 
 
Eq. 8 
Rminij = (Rmini+ Rmin j ) / 2  
 
Eq. 9 
εij = √(εiεj )  
 
 
 
Figure 1.14 Variation of the van der Waals energy versus distance.  
 
The last term of the external contribution to the total potential energy is the 
electrostatic or Coulomb term. It defines the distance-dependent interactions between 
the “partial” charges qi and qj related to atoms i and j. 
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The non-bonded terms (VDW and electrostatic) are essential to describe the 
conformation of molecules and their interactions with the environment. They strongly 
influence the calculation, since there are many non-bonded contacts, many more than 
bond, angle and torsion interactions68. 
 
The non-bonded dispersion and repulsion terms rapidly decay with the distance. 
Therefore, the calculations can be restricted to the estimations between neighbouring 
nuclei. Generally, a cut-off is defined, around 8-10 Å65, 68. 
 
There are several force fields (FFs) for biomolecules70. Some are well 
parametrized for proteins, peptides, carbohydrates, and small organic molecules, or 
combinations thereof. Some may include explicit solvent representations, or implicit 
solvent models, using a dielectric constant to simulate the medium71. Others may 
estimate free energies. It is important to select the proper set of parameters (FFs) related 
to the particular application, especially if the calculated results are to be compared with 
experimental data. From this perspective, it is also essential to define the required 
experimental information. We have used the TIP3P rigid water model, which considers 
the three atoms of water, each atom with a point charge, and Lennard-Jones parameters 
applied on the oxygen atom65. Due to its simplicity and efficiency, this is the most 
widely used in MDs. When calculations with explicit solvent are performed, the solute 
is placed in a box under so-called “periodic boundary conditions”. The solute and the 
solvent are arranged in a regular lattice structure, and a unit cell is generated, so that the 
atoms (and their associated properties) are infinitely replicated in three dimensions. In 
this way, it is possible to avoid edge effects. In fact, when a molecule goes out from one 
side of the box, it re-enters from the other side. This method permits to maintain a 
constant density and, depending on the protocol, also the internal pressure can be 
constant. The shape of the box can be cubic (See Fig. 1.15), a truncated octahedron, or a 
rhombic dodecahedron.  
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Figure 1.15 Approach for solvated MD calculation; a cubic box.  
 
In this Thesis, AMBER11 has been used for all the MD simulations. The 
AMBER software package is an ensemble of programs72 that allow different type of 
calculations, including MDs, free energy calculations, QM/MM simulations, MDs with 
time-average restrains from experimental data, etc. Several force fields are implemented 
for the different biomolecules, Parm9973 and its variations for proteins and nucleic 
acids74, Glycam06 for carbohydrates75, and GAFF, which is the general AMBER force 
field76, for organic molecules. 
The following programs, presented in Fig. 1.16, are used to prepare the input 
files, to perform the simulations, and to analyze the data: 
 
Figure 1.16 Basic information flow in AMBER77 
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1.3 NMR and Molecular Recognition  
 
NMR spectroscopy is one of the most widely used techniques to characterize 
molecular recognition events at the atomic level. NMR techniques can be employed for 
studying protein-ligand interaction process. These methods, usually assisted by 
computational protocols, permit to elucidate the structural features of the binding 
entities, as well as to characterize the kinetic and thermodynamic characteristics of the 
free-bound equilibrium. NMR techniques provide the possibility to study interaction 
events directly in solution, close to the physiological medium. Since the binding process 
strongly modifies the physicochemical properties of both partners, especially rotational 
and diffusion motion timescales, there are several NMR parameters that are influenced 
by the interaction process, as chemical shift, relaxation times and NOEs, diffusion 
constants, etc.  
The binding of small ligands to large receptors follows a bimolecular association 
reaction with second-order kinetics:   
 
Eq. 10 
 
The equation represents a dynamic equilibrium involving three species: the free 
receptor E, the free ligand L, and the receptor-ligand complex, EL. The unimolecular 
rate constant koff is inversely proportional to the mean lifetime τB of the receptor-ligand 
complex. The bimolecular rate constant, kon, measures the probability of a productive 
encounter between the free receptor and the ligand and is often assumed to be controlled 
by diffusion. Thus, kon can vary between 107 and 109 M- 1 s- 1. The binding affinity can 
be described by the temperature-dependent equilibrium dissociation constant or KD: 
 
Eq. 11 
 
The bound receptor fraction is defined by 
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Eq. 12 
 
Last equations can be combined yielding the following equation: 
 
Eq. 13 
 
where PBE is the fractional occupation of the receptor binding site by ligand L. 
When [L]«KD, PBE is proportional to [L]. When [L]=KD, the receptor is half 
saturated; that is, half of the receptor molecules exist in a one-to one complex with the 
ligand. When [L]»KD, the receptor is completely saturated and PBE= 1; in this limit, 
every receptor binding site is occupied by one ligand, which on average exchanges with 
a second distinct ligand every ≈ 1/koff seconds. According to these points, ligands with 
weak affinity have large KD and thus require the addition of more ligand to saturate the 
receptor binding site. 
In the two-state equilibrium, ligand and receptor molecules will exist in either a 
free (L, E) or complexed (EL) state. In the free state, both receptor and ligand retain 
their intrinsic NMR parameters (e.g. chemical shifts, relaxation rates, translational 
diffusion coefficients). In each other’s presence, the mutual binding affinity of ligand 
and receptor drives an exchange process that toggles both sets of molecules between the 
free and complexed states. At equilibrium, they adopt free and bound state populations 
([E], [L], [EL]). Under these conditions, the ligand transiently adopts NMR parameters 
characteristic of the typically much larger receptor. Alternatively, from the receptor’s 
perspective, the ligand transiently perturbs the binding site microenvironment(s), which 
may alter the distribution of conformations sampled by the ensemble of receptor 
molecules. In either case, the exchange modulates the NMR parameters of both 
molecules. It is the ability to experimentally distinguish these exchange-modulated 
parameters from those of the free state what enables NMR detection of the receptor-
ligand interaction and hence the employment of NMR-based screening protocols. 
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A complete discussion of how chemical exchange modifies the NMR parameters 
(dynamic NMR) should include a description of the modified Bloch equation formalism 
of Hahn, Maxwell, and McConnell78. This formalism (HMM) provides an excellent 
theoretical framework to describe the majority of the exchange phenomena that occur in 
NMR screening experiments, under all exchange regimes. For most applications 
described here, it is sufficient to consider only the case of fast exchange. 
 
1.3.1 The thermodynamics and kinetic aspects  
 
The solutions to the HMM equations78 describe the behaviour of the system 
magnetization on arbitrary exchange time-scales. In NMR-based screening, however, 
these equations are almost never solved, and fast exchange is simply assumed. This 
assumption is made for two reasons. First, the experimental conditions for ligand-based 
NMR studies are often well suited to fast exchange. These experiments are typically 
carried out with LT/ET> 10 (where LT and ET are total ligand and total receptor 
concentration respectively) and the binding compounds have a KD ≥ 100μM. If kon is 
well approximated by a diffusion-limited value (107-109 M-1 s-1), then the slowest 
exchange rate kex value will lie in the range 1000 <kex< 100 000 s-1. Ligand-based NMR 
methods are primarily 1H-based and consequently, kex exceeds most differences in 
intrinsic 1H relaxation rates and rotating frame precession frequencies. This fact thus 
ensures that the fast exchange assumption is valid. A second motivation for assuming 
fast exchange is the resulting algebraic simplicity. Generally, the NMR parameters Q 
become the simple averages. 
 
Eq. 14 
Qavg= PB QB + PF QF  
 
Here, Qavg is the observed exchange-averaged parameter for the ligand (or 
receptor) in the presence of the receptor (or ligand). Observed differences between Qavg 
and QF provide a signature of receptor binding and indicate a hit in a NMR screening 
based on that parameter. In the case of Eq.14, Qavg is a simple population-weighted 
average and it applies to those parameters Q for which chemical shift modulations are 
not relevant. These parameters include longitudinal auto-relaxation and cross-relaxation 
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rates, rotating-frame spin-locking autorelaxation and cross-relaxation rates, as well as 
translational diffusion coefficients. The bound state contribution in Eq.14 is PBQB. The 
ability to detect binding with adequate sensitivity depends critically on PBQB, being 
significant relative to PFQF. However, typical screening conditions where LT » ET make 
PB « PF. For this reason, it is much preferred to measure NMR parameters Q that 
become amplified in the bound state (i.e. QB » QF). 
 
1.3.2 The receptor point of view  
 
Screening by NMR may proceed by using ligand- or receptor-based methods. 
Receptor-based methods observe and compare the NMR parameters of the receptor 
molecule resonances in the presence and absence of compound mixtures. Thus far, the 
receptor-based methods have focused mostly on proteins. Such methods incorporate 
site-specific characterization afforded by assigned protein NMR spectra along with a 
priori knowledge of the protein’s three-dimensional structure (either from X-ray, NMR, 
or modeling procedures) to drive lead generation. By identifying perturbations of 
assigned protein resonances, not only are ligands identified, but also their binding sites 
are localized. Localization of binding sites also enables one to immediately distinguish 
specific from nonspecific binding. Finally, unlike ligand-based methods, receptor-based 
methods do not rely on fast exchange to retrieve bound state information. Observation 
of receptor resonances permits the characterization of both higher and lower affinity 
hits. 
NMR methods demand physicochemical properties of the protein target that 
present progressively more difficult challenges. First, milligram quantities of soluble, 
non-aggregated protein must be over-expressed and purified. Then, suitable expression 
hosts must be found that permit isotope enrichment (e.g. 13C, 15N, 2H) critical for the 
resonance assignment of typically large (>30000Da) therapeutic targets. After sufficient 
quantities of labelled protein are available, it must be ensured that the sample is stable 
for the time required for sequential resonance assignment. Although new data 
acquisition approaches promise to accelerate resonance assignment, it can still be a 
relatively lengthy process (weeks) for the large monomeric proteins (>30000Da) 
routinely encountered in pharmaceutical research. Unfortunately, the time required for 
NMR assignment of such targets inevitably favours other approaches, such as X-ray 
crystallography, that can provide high-resolution structural information to medicinal 
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chemistry on a faster time scale (if crystals are available). The main research 
summarized in this Thesis refers to ligand-based NMR methods and in particular to 
trNOE and STD techniques. Next sections will explain, in detail, the fundamental of 
these methodologies. 
 
1.3.3 The ligand point of view: trNOE and STD 
 
Alternatively, the typical implementation of ligand-based methods compares the 
NMR parameters of a mixture of compounds in the presence and absence of the receptor 
molecules. This approach renders the molecular weight of the receptor molecule 
irrelevant. In fact, the most powerful ligand-based approaches become more sensitive 
when dealing with larger receptors. Additionally, ligand observation bypasses the need 
to produce milligram quantities of isotope labeled receptor. Depending on the approach, 
less than a milligram of unlabeled protein is required for these experiments (receptor 
concentration is often ≤1μM, and no assignments are necessary). Both receptor- and 
ligand-based approaches have distinct advantages and disadvantages. An obvious 
disadvantage of ligand-based approaches is the inability to localize the binding site of 
the small molecule hits on the receptor. Also, ligand-based approaches rely on the 
exchange-mediated transfer of bound state information to the free state. This 
requirement biases ligand-based methods towards the identification of weakly binding 
ligands (rapid exchange) and the use of large ligand molar excesses (LT/ET»1). The 
consequent risk is that, under these conditions, ligand may start to occupy, weaker 
affinity, non specific binding sites. 
STD79, transferred NOE (TR-NOESY), and DOSY80 are very useful techniques 
detecting binding based on changes in the rotational and translational motional 
properties of the oligosaccharides upon binding to large macromolecular receptors81.  
 
- TrNOESY  
 
The exchange-transferred (trNOESY) experiment is an useful technique to study 
the carbohydrate conformation in the presence of a specific protein. The reasons for its 
success probably involve various factors: sugar interactions in solution are not strong, 
there is fast exchange between the free and bound states of the saccharide, and the 
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possible changes in the conformational equilibrium of the oligosaccharide ligand upon 
binding to the receptor are accessible to TR-NOESY analysis. 
These experiments are specifically useful in the medium–low-affinity range and 
they have therefore been adopted to detect carbohydrate interactions in different 
systems81c. Moreover, when a protein cannot be completely analyzed in solution, due to 
its large size or to the unavailability of isotopically labelled material, information on the 
conformation of the bound oligosaccharide can still be obtained from transferred NOE 
(TR-NOE) experiments. Indeed, it is well established that NOE effects (NOEs) are 
extremely useful in determining the 3D structure of molecules in solution79. When 
ligand molecules bind to receptor proteins, their associated NOEs undergo drastic 
changes in sign and magnitude due to the change in the effective global motion 
rotational correlation time (see below). These changes are the basis for a variety of 
experimental schemes that are designed to detect and characterize binding activity. 
The principles of trNOEs were originally observed and described long ago and 
have found widespread use in the determination of the 3D structures of ligands bound to 
receptor proteins. The observation of trNOEs relies on the existence of different 
tumbling times τc of free and bound molecules. Low- or medium-molecular-weight 
molecules (MW<2000) have a short correlation time τc (picoseconds) and, as a 
consequence, such molecules exhibit positive NOEs (or no NOEs), depending on their 
molecular weight, shape, and the field strength. Large molecules, however, exhibit 
strong and negative NOEs. When a small molecule or ligand is bound to a large 
molecular weight protein, it behaves as a part of the large molecule and adopts the 
corresponding NOE behaviour, that is, it shows strong negative NOEs (called trNOEs). 
These trNOEs contain information on the bound conformation of the ligand (Fig. 1.17).  
Therefore, the existence of binding of a given ligand to a receptor protein can 
easily be distinguished by merely observing the sign and size of the observed NOEs. As 
for regular NOEs, various experimental implementations have been explored in the last 
two decades, ranging from 1D to 2D transient NOE experiments. Also, several schemes 
have been developed that allow a quantitative interpretation of trNOEs, thus, yielding 
more reliable information on the conformation of the bound ligands. 
In general, it is possible to observe inter- and intramolecular trNOEs. Whereas 
intramolecular trNOEs are the key to define bound-ligand conformations, 
intermolecular trNOEs occur between a ligand and a receptor protein, and therefore, in 
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principle, may allow the determination of the orientation of bound ligands in protein 
binding pockets. From a technical perspective, it is essential to systematically employ 
different mixing times and protein/ligand molar ratios (usually from 5:1 to 50:1, 
depending on the affinity and kinetic parameters) in order to deduce quantitative 
conclusions, which can be further assessed by employing available computer 
programs81c. 
 
 
Figure 1.17 Left. Schematic representation of a NOESY spectrum for a free sugar. Cross peaks and 
diagonal peaks have different signs. Right. Schematic representation of a TR-NOESY spectrum recorded 
for an exchanging ligand–protein system. Cross peaks and diagonal peaks have the same signs, as 
expected for a large molecule, thus indicating binding to the protein. The relative sizes of the peaks and 
the appearance of new ones may be used to detect conformational variations81c.  
 
- STD 
 
Saturation-transfer NMR spectroscopy has been used for many years to 
characterize binding features of ligands and receptors82. More recently, Meyer and 
Peters have developed a method based on the transfer of saturation from the protein to 
the bound ligands79. By utilizing difference spectroscopy, especially 1H-based NMR 
experiments, it is possible to obtain well-resolved spectra of the ligand with the 
corresponding information. By subtracting one spectrum in which the protein 
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resonances are saturated from a second one, without protein saturation, a difference 
spectrum (see below for further details) is produced in which only the signals of the 
ligand(s) that have felt the transfer of saturation from the protein do appear (Fig. 1.18). 
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Figure 1.18 Schematic representation of the STD process82.  
 
The irradiation frequency is set at a position where only resonances from the 
protein nuclei and no resonances from the ligand nuclei are located. Therefore, in the 
on-resonance experiment, selective saturation of the signals of the protein nuclei is 
achieved. For the on-resonance irradiation, frequency values around -1 ppm are 
practical, because no ligand nuclei resonances are found in this spectral region, whereas 
the significant line width of protein signals still allows selective saturation. If the 
ligands show no resonance signals in the aromatic proton spectral region, the saturation 
frequency may also be placed there (ca. 7 ppm) or even further downfield (δ=10–12 
ppm). In order to achieve the desired selectivity and to avoid side-band irradiation, 
shaped pulses are employed for the saturation of the protein signals79. 
The degree of ligand saturation depends on the residence time of the ligand in 
the protein-binding pocket. The dissociation of the ligand will then transfer the saturated 
ligand into solution, where the free ligand gives rise to resonance signals with narrow 
line widths. For those ligand protons that interact with protein protons through an 
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intermolecular NOE, a decrease in intensity is observed. However, in the presence of 
other molecules such as impurities and other non-binding components it is not usually 
possible to identify such attenuated signals. Therefore, in a second experiment, the 
irradiation frequency is set at a value that is far from any signal, ligand or protein, for 
example, δ40 ppm (off-resonance spectrum). The spectrum is recorded and yields the 
regular NMR spectrum of the mixture. Subtraction of the on-resonance from the off-
resonance spectra leads to a difference spectrum, in which only the signals of the 
protons that were attenuated by saturation transfer are visible. All molecules without 
binding activity are cancelled out. 
Saturation of the protein and the bound ligand is very fast (about 100 ms). 
Therefore, a fast off-rate of the ligand transfers the information about saturation quickly 
into solution. If a large excess of the ligand is present, one binding site can be used to 
saturate many ligand molecules in a few seconds. Ligands in solution lose their 
information by normal T1/T2 relaxation, which is in the order of seconds for small 
molecules. Thus, the proportion of saturated ligands in solution increases during the 
saturation time, and so the information about the bound state resulting from the 
saturated protein is amplified, which means that only a relatively small amount of 
protein is required. On the other hand, if binding is very tight, and consequentially off 
rates are in the range of 0.1–0.01 Hz, the saturation transfer to ligand molecules is not 
efficient. This is usually the case for KD values less than 1 nM. If the KD values are 100 
nM or larger, fast exchange of free and bound ligands leads to an efficient buildup of 
saturation of the ligand molecules in solution. 
The observed intensities of the signals arising from the ligand in the STD NMR 
spectrum are not directly proportional to the binding strength. STD NMR effects largely 
depend on the off-rate. As outlined above, larger off-rates should result in larger STD 
signals. However, when binding becomes very weak, the probability of the ligand being 
in the receptor site becomes very low, which results in weak STD signals. 
The intensity of the STD signals depends, among other things, on the irradiation 
time/saturation time and on the excess of ligand molecules used79. The more ligand that 
is used and the longer the irradiation time, the stronger the STD signal is. In general, the 
irradiation time is 2s and a 100-fold excess of ligand is used to give good results. Before 
ligands in solution have lost their saturation, the process of association (followed by 
dissociation) can occur many times and thus put many more saturated ligands into 
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solution. The maximum net effect of saturation on ligand protons occurs if a large 
excess of ligand is used, because it is very unlikely that a ligand with saturation re-
enters the binding site. From the high ligand:protein ratios, it is clear that the amount of 
protein required for the measurements is very small. At 500 MHz, an amount of 
approximately 1.2 nmol of protein is sufficient to record good STD spectra. At a 
molecular weight of 50 kDa, this translates into about 60 μg of protein.  
It has been already shown that STD-NMR is an excellent technique for 
determining the binding epitope of the ligand, information that is of primarily 
importance for a rational drug design process83. As consequence of the intermolecular 
saturation transfer process described above, the ligand saturation is higher for those 
protons that are in closer contact with the receptor. This kind of information can be 
accurately analyzed84 and the STD effect can be quantitatively analyzed in a similar 
way to that mentioned above for quantitative estimation of trNOEs79. 
The STD principle can be combined with any NMR pulse sequence, and one 
rather powerful experiment is the STD TOCSY experiment. Especially in cases where 
the library or ligand is more complex (for example, large oligosaccharides) the 
additional deconvolution of signals brought about by the second dimension is very 
helpful. The STD TOCSY experiment was also shown to be ideally suited for mapping 
the binding epitope of ligands79. By using the STD TOCSY method it was possible to 
screen a library of like carbohydrates to identify functional groups involved in 
binding85. 
STD NMR spectroscopy is well-suited to study the interactions of ligands with 
macromolecular receptors. As STD is a preparatory pulse sequence all types of NMR 
spectra can be recorded, for example, 1D NMR spectra, TOCSY, COSY, and HSQC. 
STD NMR spectroscopy can be used to identify from large complex mixtures of 
compounds those with bioactivity. Other experiments have combined the STD sequence 
with editing/filtering schemes based on the existence of 19F, 13C or 15N in the interacting 
molecules86. 
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2.1 Introduction 
Shigellosis or bacillary dysentery is an invasive and highly contagious disease of 
the human colon. In fact, it is one among the many forms of enteric infections that to a 
large extent affects worldwide1. It causes 2 billion cases in humans per year2, being 
severe and even fatal in children between one and five years.  
Shigella flexneri is the most frequently isolated Shigellosis causative agent, 
especially in developing countries. The protective host immune response to S. flexneri is 
against the O-Antigen part of the lipopolysaccharide of the outer membrane of the 
bacterium. 
 
Figure 2.1 Schematic representation of the structure of the Lipopolysacchairde of a GRAM-negative 
bacterial endotoxin. 
The lipopolysaccharide (LPS, See Figure 2.1), which is produced by Gram-
negative bacteria, is a powerful activator of innate immune responses. They are the 
major components of the outer membrane of GRAM-Negative bacteria and exert, in 
isolated form, a variety of biological activities in animals and plants. LPS is a powerful 
activator of innate immune responses and is responsible for endotoxic shock, which is 
the often fatal complication of sepsis. It is only in the past few years that the molecular 
mechanisms by which LPS initiates signaling responses in immune system have been 
elucidated 3. 
The general structure of bacterial LPS consists of a hydrophobic lipid A domain, 
an oligosaccharide ‘core’ and a distal polysaccharide (or O-Antigen)3-4. 
The lipid A moiety alone is sufficient to activate the innate immune response; 
adaptive (antibody) responses are generated to the O-antigen polysaccharide later in the 
course of an infection. Lipid A consists of a diglucosamine diphosphate head group that 
is substituted with a variable number of acyl chains, ranging from four to eight3. 
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The outer core region provides an attachment site for the O-polysaccharide (O-
Antigen)4. In bacteria the core oligosaccharides are conceptually divided into two 
regions: inner core (lipid A proximal) and outer core. Bacteria produce 
lipooligosaccharides (LOSs) that contain a recognizable inner core from which extend 
one or more mono- oligosaccharide branches (equivalent to the outer core). Within a 
genus or family, the structure of the inner core tends to be well conserved, and the fact 
that the core oligosaccharides from distantly related bacteria share structural features in 
the inner core is a reflection of the importance of the core in outer-membrane integrity. 
The inner core typically contains residues of Kdo and L-glycerol-D-Mannoheptose 
(L,D-Hhep). The last Kdo linked is often modified with a phosphate or ethanolamine 
group. The outer core is made of hexose residues that are attached to the last heptose 
residue in the inner core4. Hexoses often found in the outer core include D-Glc, D-Man, 
D-Gal, etc. There is usually at least three hexoses linked β1→3, with the O-Antigen 
being attached to the third hexose. 
A repetitive glycan polymer contained is referred to as the O-Antigen, O-
Polysaccharide, or O-Side-chain of the bacteria. The location of O-polysaccharide at the 
cell surface places it at the interface between the bacterium and its environment. The O-
Antigen is attached to the core oligosaccharide, and comprises the outermost domain of 
the LPS molecule. The composition of the O-chain varies from strain to strain. For 
example, there are over 160 different O-antigen structures produced by different E. coli 
strains4. The O-Antigen is exposed on the outer surface of the bacterial cell, and, as a 
consequence, is a target for recognition by host antibodies. The O-Antigen is composed 
by repeated units (RUs) that can differ in the monomer glycoses, the position and 
stereochemistry of the O-glycosidic linkages, and the presence or absence of non-
carbohydrate substituents. O-RUs from different structures may comprise varying 
numbers of monosaccharides, they may be linear or branched. In some cases, non 
stoichiometric modifications (e.g.,O-Acetylation or glycosylation)5 have been 
identified. 
Early interest in the chemistry, biosynthesis, and genetics of O-Antigens was 
stimulated by their roles as essential virulence determinants and their potential 
application in vaccine development, but information is now available for a wide range 
of species with different lifestyles. The primary role(s) of the O-polysaccharides appears 
to be protective. In animal pathogens, O-polysaccharides may contribute with their 
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chemistry (chain length and sugars composition) to bacterial evasion of host immune 
responses, particularly the alternative complement cascade6.  
In the case of Shigella flexneri, depending on the structure of the O-Antigen, 
there are 14 different serotypes. Every serotype contains repeated units of the same 
tetrasaccharide backbone2, 7 (See Fig. 2.2). The differences between the serotypes are 
conferred by phage modifications, including addition to the basic structure of α-D-
glucose or/and O-Acetyl groups. These modifications are immune determinants within 
S. flexneri serotypes7. These substitutions result from the action of α-D-glucopyranosyl 
and/or O-acetyltransferases coded by serotype-converting bacteriophages inserted in the 
bacterium chromosome.  
 
Figure 2.2 (A) SF3a synthetic oligosaccharide backbone used in the study. (B) Shematic representation of 
the oligosaccharides used in the study.  
This serotype diversity and virulence supposes a top priority of WHO (World 
Health organization) implying the development of a potent vaccine that can protect 
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against all bacterium serotypes. From inspection of the chemical features of the 
different group types and after type factor characterization, it was assumed that 
immunizing with O-antigens from only serotypes 3a, 2a and 6 could protect against 
almost every S. flexneri serotypes8. Indeed, it can be envisaged that acquiring detailed 
knowledge of the fine chemical details of the three-dimensional shapes of these O-
antigens is essential for a definitive substantiation of the sero-specificity of strains at the 
molecular level, as well as for a better understanding of the role of the O-antigens in the 
final vaccine formulation7. 
Understanding at the maximum possible resolution the interactions of these 
antigens with specific monoclonal antibodies (mAb) should be a key step for designing 
more effective O-antigen based vaccines9. Moreover, it could permit to exquisitely 
define the specificity of the isolated polysaccharides and the possibility of being 
replaced by well-defined synthetic carbohydrates.  
On this basis, it has been shown that modifications of the O-antigen structure by 
either glucosylation or O-Acetylation enhance the survival of S. flexneri5. According to 
the existing data, it has been deduced that glucosylation modulates the polysaccharide 
conformation to acquire a more compact structure, then increasing its exposition at the 
host cell surface. On the other hand, the fine structural-activity details of the role of the 
O-Acetylation in pathogenesis caused by S. flexneri remains still unknown.     
Nevertheless, it has been postulated that the exceptionally high serological 
impact 5, 10 of the 2-O-Acetyl group at Rhamnose C in SF3a serotype (See Fig. 2.2) may 
be accounted for by its axial orientation. In fact, a striking difference was observed 
when the immunochemical specificities of native O-Acetylated versus de-O-Acetylated 
SF3a LPS were tested against SF3a antisera10. None of them were bound to de-O-
Acetylated LPS. This result permitted to propose that the 2-O-axially oriented 
presentation is essential for the recognition with receptors and antibodies as compared 
with those presented by O-Acetylation at the other positions. 
Evidences on the molecular recognition features of other S. flexneri serotypes 
have been presented. For instance, for SF2a serotype,9 the binding epitope of differently 
modified oligosaccharides (AB(E)CD, B(E)CDA and ECDA’B’), towards the 
protective monoclonal antibody F22-4 has been elucidated. It was shown that 
trisaccharide ECD (E, C and D are αDGlcp, αLRhap and βDGlcNAcp respectively) is 
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the key moiety that specifically interacts with the mAb. NMR experiments assisted by 
Molecular Dynamics simulations showed the existence of certain glycosidic 
conformational restriction at the ECD motif upon binding, although the terminal 
residues remained rather flexible. Additionally, mimics of the S. flexneri 5a O-specific 
polysaccharide 11 have been employed to improve their specificity towards anti O-
antigen antibodies. For instance, the presence of a branched Glucose (residue E) taking 
part of the DA(E)BC pentasaccharide essential for its recognition by the protective 
mIgA C5 and I3 antibodies, while for S. flexneri type 3a, the key structure is composed 
by one α-D-Glc residue linked to a 3-O-Rha A residue, while O-2 of Rha C is O-
acetylated (Fig. 2.2A).  
 
2.2 Objectives 
Herein, we have dissected the fine conformational and molecular details of the 
interaction between a series of oligosaccharides related to the original O-Antigen and 
specific monoclonal antibodies. In particular, a combination of experimental (STD-
NMR12 and trNOESY-NMR) and computational methods (MD simulations) has been 
employed to gain the key structural insights into their specificity. The main object of the 
project is to study the ability of synthetically available SF3a serotype oligosaccharides 
to mimic the original O-antigen and deduced their molecular recognition and 
conformational behavior upon binding to specific mAb IgG C7-37 and IgM G19-2 
antibodies. The strategy may facilitate the design of either ligands or carbohydrate 
recognition domains important in the design of vaccines against S. flexneri serotype 3a 
(SF3a).  
The synthetic oligosaccharides employed in this study are based on the natural 
RU structure of the SF3a serotype (EABCD, dubbed as SF3aM, see Fig 2.2A). The 
employed oligosaccharides (See Fig. 2.2B) display different substitutions of the same 
natural SF3a RU sequence (EABC, EABCD, D(E)ABC, BCDAE, B’CD(E)AB, 
E’A’BCD(E)A, D’(E’)A’BCD(E)A, B’C’D’(E’)A’BCD(E)A for the SF3aG, M, K, O, 
R, S, V, and AA synthetic oligosaccharides respectively). The synthetic 
oligosaccharides and specific antibodies IgG C7-37 and IgM G19-2 were provided by 
Dr. Laurence Mulard’s group at Institute Pasteur (Paris).  
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2.3 The conformation of the oligosaccharides in the free state; NMR 
and MD simulations 
 
The MD simulation data provided ensemble-averaged geometries that were 
employed to measure the key interprotonic interglycosidic distances that could give rise 
to NOE/ROE correlations. Then, they were compared to the NOESY/ROESY 
experimental data. On this side, the analysis of the cross peaks in these NOE-based 
spectra allowed establishing the experimental average interprotonic distances along the 
glycosidic linkages.  
From now on, the behavior of the different linkages will be presented:  
The E-A linkage.-This glycosidic linkage (See Fig. 2.2) is present in all ligands. 
According to the MD simulations, there are populations of two conformers, which differ 
in the orientation of Ψ angle (synΨ- and synΨ+), while Φ is always dictated by the exo-
anomeric effect. Fittingly, according the MD simulations, their relative populations 
depended on the chemical substitution at the vicinity of the linkage. In particular, for the 
non-reducing end of ligands SF3aG, SF3aM and SF3aS, the MD simulations predicted a 
major synΨ- geometry (ca. 60% of the population) and a minor synΨ+ conformation. 
The key NOEs are H1E-H2A and H1E-H3A. Their intensities may be translated in the 
relative populations of both conformers. In contrast, for the reducing end of SF3aK, 
SF3aO, SF3aR SF3aV SF3aAA, and SF3aS, the presence of a D residue attached at O2 
of Rhap A affected the conformational behavior around E-A glycosidic linkage. Now, 
the presence of the synΨ- conformation is further increased, while the alternative synΨ+ 
conformation showed the concomitant decrease in population. Inspection of molecular 
models suggested that this geometry is now more sterically-hindered8. The presence of 
residue D also provides one additional NOE constrain. Only when the conformation 
around the glycosidic torsion angles of the E-A fragment is exoΦ/synΨ- (and also at the 
D-A disaccharide moiety, see later), there is a short H1D-H1E distance. Therefore, this 
H1D-H1E is exclusive for the exoΦ/synΨ- geometry around the E-A glycosidic linkage 
(See Fig. 2.3).  
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Figure 2.3 Detail of E-A-D fragment of SF3aK oligosaccharide showing the relevant distances for every 
possible conformation around E-A and D-A glycosidic torsions. 
 Indeed, the experimental NMR distances (Tables 2.1 A-H) derived from the 
ROESY spectra were, in cases, in very satisfactory agreement with the MD-based data. 
Thus, in the free state for all SF3a ligands, there are two conformational families in 
solution around the A-E linkage, exoΦ/synΨ+ and exoΦ/synΨ-, with a preference for 
the last one, which is further increased when residues D-like are present. The H1D-H1E 
NOE was always present for SF3aK, SF3aO, SF3aR, SF3aS, SF3aV, and SF3aAA. In 
any case, the presence of certain conformational mobility around E-A (and E’-A’) 
torsions is granted from the combined MD/NMR approach. For example, in the case of 
ROESY spectrum of SF3aM oligosaccharide (See Figure 2.5), the strong interresidual 
H1E-H2A and H1E-H3A cross peaks observed are both stronger than the intraresidual 
H1E-H2E cross peak. Therefore, the presence of a conformational equilibrium is 
granted. 
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Figure 2.4 (A) Plots of the available conformational space for the Φ/Ψ glycosidic linkages corresponding 
to the E/A linkage. The presence of a major syn-Ψ- conformation may be expected, especially for the D-
substituted molecules. (B) Φ/Ψ (showed in Black/Red lines respectively) values of E/A glycosidic torsion 
of each SF3a oligosaccharides during the MD simulation.  
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Figure 2.5 The key NOEs from relevant zones in the spectra found in the F2 (A, C) and F1 (B) dimension 
for SF3aM ligand. The ROESY spectra in the free state are shown always at the top (in blue) and the 
trNOESY in the presence of IgG (center) or IgM (below) in the trNOESY spectra are also shown. 
ROESY SF3aM
1E‐2A 1A‐2A
1B‐2B 1A‐2B
2C‐3C
1E‐3A
1B‐5A 1E‐2E
2C‐5B 1C‐3D
1D‐3D
1D‐5D
2C‐1C
1E‐2A 1A‐2A
1B‐2B
1A‐2B
1E‐3A
1E‐2E 1D‐5D
1E‐2A
1A‐2A1B‐2B
1A‐2B
1E‐3A
1E‐2E 1D‐5D2C‐5B 1C‐3D
1B‐3C
NOESY SF3aM + IgG
1B‐3C
1B‐5A
NOESY SF3aM + IgM
1B‐3C
1B‐5A
ROESY SF3aM
NOESY SF3aM + IgG
NOESY SF3aM + IgM
1E‐2A
1A‐2A
1B‐2B
1A‐2B
1B‐3C
2C‐3C
1E‐3A 1B‐5A
1E‐2E
2C‐5B
1D‐3D
1C‐3D
1E‐2A
1A‐2A
1B‐2B
1A‐2B
1B‐3C
2C‐3C
1E‐3A 1B‐5A
1E‐2E
2C‐5B
1D‐3D
1C‐3D
1E‐2A
1A‐2A
1B‐2B
1A‐2B
1B‐3C
2C‐3C
1E‐3A 1B‐5A
1E‐2E
2C‐5B
1D‐3D
6A‐1B
6B‐2C
1B‐
6A
Syn‐
6A‐1B
ROESY SF3aM
NOESY SF3aM + IgG
NOESY SF3aM + IgM
A B
C
Chapter 2 
62 
 
 
The D-A linkage.-According to the MD data, this torsion angle could sample two 
conformational regions (exoΦ/synΨ+ and exoΦ/synΨ-), with a major population of the 
exoΦ/synΨ+ geometry. In the studied ligands, the D-A linkage is always associated 
with the presence of one E residue attached to the A moiety, which influences the 
conformational behavior. Indeed, there is a correlation between the E-A and D-A 
glycosidic torsions, since a simultaneous exoΦ/synΨ+ orientation for both E-A and D-A 
linkages is satirically hindered. In fact, the MD simulations for the different 
oligosaccharides showed that the D-A(E) fragment may adopt three different 
geometries. The exoΦ form is always present, while the two Ψ angles may be present 
both as synΨ- or a combination of synΨ- and synΨ+ for the D-A and E-A linkages, as 
outlined in Figure 2.3. However, as mentioned above, the presence of the H1D-H1E 
NOE strongly suggests that the exoΦ/synΨ- conformer around E-A is present. The 
actual presence of the different conformers was assessed from the comparison of the 
expected distances for the three conformations, estimated form MD simulations with 
those estimated from the NOE measurements (Table 2.1 A-H). While the H1D-H2A 
interglycosidic distance is related to the conformation around this particular glycosidic 
linkage (2.3-2.4Å for the synΨ- and longer, around 2.9Å for the synΨ+ forms), the 
presence or absence of the remote H1D-H1E and NHAcD-H3E/H4A long-range 
distances is related to the combination of particular values for both glycosidic torsions. 
For instance, for a double synΨ- conformation or synΨ- and synΨ+ around D-A and E-
A, respectively, a value of 2.8 Å for H1D-H1E would be expected (with an observable 
NOE). The other synΨ+/synΨ- combination for D-A and A-E, respectively would 
provide much longer distances (Fig 2.3). The global comparison between the MD-based 
distance values and those deduced from the NMR data are gathered in Tables 2.1 A-H. 
For example, in the case of ROESY spectrum of SF3aO oligosaccharide (See Figure 
2.7), the interresidual H1D-H2A and H1E-H1D cross peaks are observed, weaker than 
the intra-residual H1D-H3D one. Therefore, according to the obtained data, the NOE 
data strongly suggest the presence of a conformational equilibrium around Ψ of this D-
A (or D’-A’) glycosidic linkage. 
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Figure 2.6 (A) Plots of the available conformational space for the Φ/Ψ glycosidic linkages corresponding 
to the D/A linkage. The presence of a conformational equilibrium may be expected. (B) Φ/Ψ (showed in 
Black/Red lines respectively) values of D/A glycosidic torsion of each SF3a oligosaccharides during the 
MD simulation. 
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Figure 2.7 The key NOEs from relevant zones in the spectra found in the F2 (A, C) and F1 (B) dimension 
for SF3aO ligand. The ROESY spectra in the free state are shown always at the top (in blue) and the 
trNOESY in the presence of IgG (center) or IgM (below) in the trNOESY spectra are also shown. 
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The B-C linkage.-The B-C glycosidic linkage is present in all ligands. The MD 
simulations suggest that two conformations around the glycosidic linkage (exoΦ/synΨ+ 
and exoΦ/synΨ-) are present with similar populations. However, the distances derived 
from ROESY spectra strongly indicated that all these SF3a ligands show a strong 
preference for the exoΦ/synΨ- geometry (See Tables 2.1 A-H). For example, in the case 
of ROESY spectrum of SF3aS oligosaccharide (See Figure 2.9), the interresidual H1B-
H3C cross peak is observed, stronger than the intraresidual H1B-H2B one. Therefore, 
the presence of a major exoΦ/synΨ- geometry can be deduced. In particular, the 
presence of a CH36B-H2C NOE is exclusive of this conformation (associated to a 
distance of ~3.3Å), together with the occurrence of a very strong H1B-H3C NOE 
(distance of 2.1-2.2Å) stronger than that between H5B and H2C (2.5 Å) supports this 
conclusion. 
 
 The C-D linkage.-The C-D glycosidic torsion is present in ligands SF3aM, 
SF3aO, SF3aR, SF3aS, SF3aV and SF3aAA. According to the MD simulations, the 
conformational behavior of C-D strongly depends on the particular environment. For 
non-substituted D GlcNAc residues, as in SF3aM, the conformational space around the 
C-D linkage is fairly wide, with similar populations of the two possible exoΦ/synΨ+ 
and exoΦ/synΨ- geometries. However, according to the MD, the presence of one Rhap 
A linked to D in the rest of the ligands affects its conformational behavior and the 
exoΦ/synΨ+ conformation is now somehow more populated8. These MD-based 
predictions were in close agreement with the analysis of the key inter-proton distances 
estimated from the ROESY experiments. For both exoΦ/synΨ+ and exoΦ/synΨ- 
geometries, it is expected a short H1C/H3D distance (2.3 Å). In principle, there is also 
an exclusive H5C/H4D NOE only for the exoΦ/synΨ- conformation (2.7 Å), but it was 
not found. For example, in the case of ROESY spectrum of SF3aR oligosaccharide (See 
Figure 2.11), the interresidual H1C-H3D cross peak is observed. The obtained data 
suggest the presence of a conformational equilibrium around Ψ. 
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Figure 2.8 (A) Plots of the available conformational space for the Φ/Ψ glycosidic linkages corresponding 
to the B/C linkage. The presence of a conformational equilibrium may be expected. (B) Φ/Ψ (showed in 
Black/Red lines respectively) values of B/C glycosidic torsion of each SF3a oligosaccharides during the 
MD simulation. 
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Figure 2.7 The key NOEs from relevant zones in the spectra found in the F2 (A, C) and F1 (B) dimension 
for SF3aS ligand. The ROESY spectra in the free state are shown always at the top (in blue) and the 
trNOESY in the presence of IgG (center) or IgM (below) in the trNOESY spectra are also shown. 
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Figure 2.10 (A) Plots of the available conformational space for the Φ/Ψ glycosidic linkages 
corresponding to the C/D linkage. The presence of a conformational equilibrium may be expected. (B) 
Φ/Ψ (showed in Black/Red lines respectively) values of C/D glycosidic torsion of each SF3a 
oligosaccharides during the MD simulation. 
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Figure 2.11 The key NOEs from relevant zones in the spectra found in the F2 (A, C) and F1 (B) 
dimension for SF3aR ligand. The ROESY spectra in the free state are shown always at the top (in blue) 
and the trNOESY in the presence of IgG (center) or IgM (below) in the trNOESY spectra are also shown. 
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 The A-B linkage.-The A-B glycosidic torsion is present in most of the ligands 
(except SF3aO). The MD simulations predicted that the exoΦ/synΨ- geometry is 
predominant, although the alternative exoΦ/synΨ+ form is also present, independently 
of the single (with E) or double (with D and E) substitution at Rhap A. For the 
exoΦ/synΨ- geometry, a very strong H1A/H2B NOE (associated to a 2.2 Å distance) 
should be expected, much stronger than the H5A/H1B alternative (2.8 Å). Fittingly, the 
distances derived from ROESY spectra were in agreement with the presence of 
conformational equilibria, with a predominance of the exoΦ/synΨ- conformer in most 
cases. For example, in the case of ROESY spectrum of SF3aAA oligosaccharide (See 
Figure 2.13), the strong interresidual H1A’-H2B cross peak is observed, much stronger 
than the intra-residual H1A’-H2A’. The obtained data suggest the presence of a major 
Ψ- conformer. 
 
Figure 2.12 Plots of the available conformational space for the Φ/Ψ glycosidic linkages corresponding to 
the A/B linkage. The presence of a conformational equilibrium may be expected.  
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Figure 2.13 The key NOEs from relevant zones in the spectra found in the F2 (A, C) and F1 (B) 
dimension for SF3aAA ligand. The ROESY spectra in the free state are shown always at the top (in blue) 
and the trNOESY in the presence of IgG (center) or IgM (below) in the trNOESY spectra are also shown. 
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2.4 The bound state 
2.4.1 The recognition of the designed oligosaccharides by IgG and IgM; STD 
experiments 
 
The decoration of the linear E-A-B-C polysaccharide backbone with E and OAc 
residues provide different possibilities of epitope presentation. Moreover, the 
oligosaccharides studied herein were designed to provide evidences of the individual 
importance of the different residues, depending on its position (reducing, non reducing 
or internal) at the oligosaccharide sequence and of their relative relevance for the 
molecular recognition process. Moreover, for the longer oligosaccharides, the 
possibility of presenting an extended epitope could also be explored.  
The simpler SF3aG oligosaccharide is a tetrasaccharide with residue E at the non 
reducing end and the acetylated C residue at the reducing end, further decorated with a 
n-propyl chain. The STD experiments provided clear evidences of the direct 
involvement of residue C, followed by the neighbor B residue (See Fig. 2.14). The 
acetylated residue is the key point for the interaction with both antibodies. 
 
Thus, STD experiments were performed to study the relevance of residue 
GlcNAc D in the molecular recognition of the different oligosaccharides by IgG and 
IgM. While residue D is absent in SF3aG (EABC), there are two possible minimum 
“natural” repeating units of S. flexneri 3a serotype, either SF3aM (EABCD), with D at 
the reducing end, or SF3aK, with D at the non-reducing end (Fig. 2.2B). As mentioned 
above, even in the absence of residue D (SF3aG, EABC), the inspection of the STD 
spectra either in the presence of IgG or IgM evidenced the existence of interaction. 
Interestingly, the STD signal for RhapA methyl group was clearly smaller than those of 
B and C in the presence of IgG (Fig. 2.15A). In the presence of IgM, the STD signals of 
H1 and H2 protons of RhapC (Fig. 2.15B) were significantly stronger than those of the 
other residues.  
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Thus, the analysis of the STD intensities permitted to suggest that the BC 
fragment is the major epitope for IgG, while IgM especially recognizes residue C. When 
GlcNAcpD is located at the reducing end, as in SF3aM (EABCD), the strongest STD 
effects are those from the RhapC, followed by the GlcNAcpD residues. Nevertheless, 
the inspection of the STD signals for the methyl moieties of the OAc and NAc groups 
suggested the existence of a better interaction of C than D (See Fig. 2.15) with IgG, 
while was fairly similar for IgM. The interaction of the E-A segment is less important. 
 
 
 
Figure 2.14 The interaction of SF3aG with IgG (A,a) and IgM (B,b) antibodies, as deduced from the STD 
experiments. The ligand: antibody molar ratio was 200:1 key. The observed STDs indicate the major 
involvement of the acetylated residue C, followed by its neighbors towards the non-reducing moiety. 
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Figure 2.15 The interaction of SF3aM with IgG (A, a, c) and IgM (B, b) antibodies, as deduced from the 
STD experiments. The ligand: antibody molar ratio was 200:1 key. The observed STDs indicate the major 
involvement of the acetylated residue C, followed by residue D. 
However, when the GlcNAcpD moiety is at the non reducing end, as in SF3aK 
(D(E)ABC), the interaction of D with the antibodies was significantly weaker, 
especially with IgG (Fig. 2.16). These results strongly suggest that the relative position 
of GlcNAc D in the oligosaccharide sequence is essential for making contacts with the 
antibody. The inspection of the STD intensities of the methyl groups of the A, B, and C 
Rhap units also implied a different involvement of these residues with the antibody. 
Clearly, residue A is less involved in the interaction than B and C, which is heavily 
involved.  
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Figure 2.16 The interaction of SF3aK with IgG (A, a, C(blue)) and IgM (B, b, C(green)) antibodies, as 
deduced from the STD experiments. The ligand: antibody molar ratio was 200:1 key. The observed STDs 
indicate the major involvement of the acetylated residue C, followed by residue B. D is now not directly 
involved in binding 
The E-A branch (GlcpEα(1-3)RhapA)is commonly detected in all S. flexneri 
serotypes13. However, its relevance in S. flexneri serotype 3 for the immune recognition 
process by selective antibodies is already unknown. To prove the influence of the 
relative position of this substitution in the recognition of these oligosaccharides by IgG 
and IgM, STD-NMR experiments of penta and heptasaccharides displaying the E-A 
substitution at the reducing end, at the non-reducing end, and at both ends in the 
presence of IgG and IgM were performed (SF3aM, SF3aO, and SF3aS, respectively). 
The analysis of the STD experiments (Fig. 2.17) permitted to demonstrate that the three 
oligosaccharides were indeed recognized by both antibodies. In particular, in the 
Reference
STD +IgG
STD +IgM
H6C
H6B
H6A
25%
57%
Reference
STD +IgG
STD +IgM
100%
13%
NHAcDOAcC
100%
67%
D
C
B
E
A 90%
100%
100%
Pr
E
OAc
D A B CA
a
Pr
E
OAc
D A B C
D
C
B
E
A
84% 100%
97%
100%
B
b
C
Chapter 2 
76 
 
presence of IgG, (Fig. 2.17) RhapC and surrounding B and D residues always displayed 
the strongest STD intensities, implying that is the key point of the interaction. Further 
analysis of the STD spectra of SF3aM and SF3aO systematically showed lower 
intensities of protons from E and A residues, indicating that the relative position of E-A 
fragment at either end of the pentasaccharide sequence is not important for making 
contacts with the antibodies. However, if the E-A branch is at both ends (SF3aS), the 
NMR experiments showed that the E’-A’ branch at the non-reducing end provided 
significantly larger STD intensities than its E-A counterpart at the reducing end (Fig. 
2.17), although always smaller than those for the B-C-D triad. Similar results were 
obtained in the presence of IgM (See Fig 2.18).  
 
 
Figure 2.17 The interaction of SF3aO (left, A, a) and SF3aS (right, B, b) with IgG antibody, as deduced 
from the STD experiments. The ligand: antibody molar ratio was 200:1 key. The observed STDs indicate 
the major involvement of the acetylated residue C, followed by residue B. The reducing moieties are less 
involved in the binding event. 
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Figure 2.18 The interaction of SF3aO (left) and SF3aS (right) with IgM antibody, as deduced from the 
STD experiments. 
 
The roles of a RhapB substitution of SF3aO at the reducing end to provide 
hexasaccharide SF3aR (B’CD(E)AB) and that of a GlcNAcpD substitution of SF3aS at 
the non reducing end to produce octasaccharide SF3aV (D’(E)ABCD(E)A) were also 
tested in the presence of IgG and IgM. STD experiments evidenced the existence of the 
molecular recognition process with both antibodies, and permitted to define the epitope 
(See Fig. 2.19 and 2.20). For SF3aR in the presence of IgG, RhapC and RhapB residues 
are the key recognized epitope, followed by residue D (Fig. 2.19). Indeed, the observed 
STD intensities monotonically decrease from the B-C non-reducing end disaccharide 
moiety towards the reducing end. Similar results were detected for octasaccharide 
SF3aV in the presence of IgG (Fig. 2.20). Again, especially RhapB and RhapC, 
followed by GlcNAcp D, obtained the highest STD intensities. Interestingly, the STD 
effect at GlcNAcp D’ was smaller than that at GlcNAcp D. 
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Figure 2.19 The interaction of SF3aR with IgG (A, a) and with IgM (b) antibodies, as deduced from the 
STD experiments. The ligand: antibody molar ratio was 200:1 key. The observed STDs indicate the major 
involvement of the acetylated residue C, followed by its flanking B and D residues. The reducing 
moieties are less involved in the binding event. The role of A is very minor. A similar behavior was 
observed for IgM binding. 
 
Figure 2.20 The interaction of SF3aV with IgG (A, a) and IgM (b) antibodies, as deduced from the STD 
experiments. The ligand: antibody molar ratio was 200:1 key. The observed STDs indicate the major 
involvement of the acetylated residue C, followed by its flanking B and D residues. The reducing 
moieties are less involved in the binding event. D is more involved than D’ at the non-reducing end. A 
similar behavior was observed for IgM binding. 
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Finally, a long octasaccharide constituted by two repeating units of the S. 
flexneri serotype 3 (SF3aAA) was also employed. The STD results in the presence of 
IgG clearly indicated that the residues directly implicated in the recognition were 
RhapC’ at the “non-reducing” side of the octasaccharide, followed by GlcNAcpD’ and 
RhapA’. Again, the STD intensities decreased from the non-reducing towards the 
reducing end. Fittingly (Fig. 2.21A and a), STD signals for the methyl moieties of 
OAcC’, OAcC and NAcD’ demonstrate this. Similar results were obtained in the 
presence of IgM (See Fig. 2.21b). 
 
Figure 2.21 The interaction of SF3aAA with IgG (A(blue),a) and IgM (A(green),b) antibodies, as 
deduced from the STD experiments. The ligand: antibody molar ratio was 200:1 key. The observed STDs 
indicate the major involvement of the acetylated residue C’, followed by its neighbor D’ residue. The 
reducing moieties are less involved in the binding event. C’ is more involved than C at the reducing end. 
A similar behavior was observed for IgM binding. 
Thus, the STD results indicate that the acetylated residue C, flanked by B and D 
moieties, constitutes the major binding epitope for both antibodies, independently of its 
position at the oligosaccharide sequence. Nevertheless, for a double B-C-D substitution 
(as in SF3aAA), the major interaction takes place at the “non reducing” end. Residue A, 
as well as the reducing end propel moiety provide minor contacts with the antibodies, 
while the role of E, being minor, depends on its position in the sequence, becoming 
somehow more relevant for longer oligosaccharides. 
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2.4.2 The conformation in the bound state; trNOESY experiments 
 
trNOESY experiments were also performed to gain additional structural 
information on the binding mode of the different oligosaccharides, to deduce the 
possible presence of a conformational selection process and to support the STD-based 
results. Fittingly, NOESY experiments (200ms mixing time) for the different 
oligosaccharides in their free state in water solution acquired at 600MHz and 298K did 
not give any NOE cross peaks for the sugar protons, thus indicating that the rotational 
global motion correlation time is around 200-300 microseconds timescale and the zero-
NOE condition is fulfilled. In contrast, in the presence of either IgG or IgM, clear 
trNOESY negative cross peaks for all the oligosaccharides were observed, indicating 
the presence of a molecular recognition process. As already described, the existence of 
negative cross peaks is an unequivocal indication of the existence of increased effective 
rotational motion correlation times of the saccharide, accounting for the existence of an 
antibody-bound state. Thus, the analysis of these cross peaks permitted to deduce 
distance information that, in principle, could be related to the bound conformation of the 
saccharine. Therefore, the experimental key proton-proton distances across the 
glycosidic linkages were deduced and compared to those previously obtained in the free 
state in solution using ROESY measurements. Interestingly, for several molecules, the 
analysis of the cross peaks (Tables 2.1 A-H), suggested the existence of a particular 
conformational distribution around different glycosidic linkages, in some cases different 
to that existing in the free state. These facts indicate that the interaction of certain 
oligosaccharides with IgG and IgM antibodies modifies the oligosaccharide 
conformational behavior.  
All the obtained data are gathered and summarized in Tables 2.1 A-H, although 
some comments may be added here to assess the goodness of the data and its agreement 
with the STD results. For instance, for the SF3aM/IgG complex (Fig. 2.22), the 
hydrogens at the propyl group clearly showed positive NOEs (i.e., H2-H1a and H2-
H1b), while the rest of the sugar molecule showed negative NOES (i.e., H6B-H4B). 
This fact unequivocally indicates that the propel group does not directly interact with 
the IgG antibody and that, therefore, it does not take part in the interacting epitope. In 
fact, this fact was also evidenced by the STD data described above. In other cases, no 
clear negative cross peaks were observed for some of the monosaccharide, also 
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suggesting that these moieties did not maintain important contacts with the antibody. 
Similar data were extracted from the analysis of the complexes with IgM. 
 
Figure 2.22 Region of propyl protons of SF3aM free ROESY spectrum and trNOESY of SF3aM /IgG 
complex. 
The E-A linkage.-As described above, the conformational behavior of this 
glycosidic linkage maybe described by a conformational equilibrium, in which the 
exoΦ/synΨ- conformation is predominant in free solution. For SF3aG, weak or very 
weak interresidual H1E-H3A and H1E-H2A were obtained, suggesting that this region 
of the saccharide is not deeply involved in the binding (as also observed in the STD 
experiments). For SF3aM, a similar behavior was observed in the presence of IgG, 
while for IgM, the data suggested the recognition of the exoΦ/synΨ- geometry. This 
was also the case for SF3aK, SF3aO, and SF3aR when bound to the two different 
antibodies. For SF3aS (See Fig. 2.9) and SF3aV (Figure 2.24), which bears two 
different E-A linkages, negative NOE cross peaks were much stronger for the internal 
moiety than for the non-reducing terminal end. This fact strongly supports that the 
terminal and internal units are differently involved in the recognition process, with 
special interaction for the internal ones. The NOE pattern suggested that the internal 
units are recognized in with a major exoΦ/synΨ- geometry. For SF3aAA, the two E-A 
fragments are internal. The NOE patterns suggest a major recognition of the 
exoΦ/synΨ- conformation. 
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Figure 2.23 The key NOEs found for the SF3aG oligosaccharide found in the F2 (A, C) and F1 (B) 
dimension. The ROESY spectra in the free state are shown always at the top (in blue) and the trNOESY 
in the presence of IgG (center) or IgM (below) in the trNOESY spectra are also shown. Weak and very 
weak interresidual H1E-H2A and H1E-H3A cross peaks are observed. The obtained data suggest that the 
E-A fragment is not involved in the binding process. 
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Figure 2.24 The key NOEs found for the SF3aV oligosaccharide in the F2 (A, C) and F1 (B) dimension. 
The ROESY spectra in the free state are shown always at the top (in blue) and the trNOESY in the 
presence of IgG (center) or IgM (below) in the trNOESY spectra are also shown. 
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The D-A linkage.-Regarding the D-A(E) glycosidic linkage, the proximity of 
H1D to the water signal precluded the proper quantification of the interesidual H1D-
H2A cross peak with respect to the intraresidual H1D-H3D. However, the strong 
intensity of the H1D-H2A cross peak was correlated with the existence of a major 
exoΦ/synΨ- geometry for the D-A linkage of SF3aK, SF3aO, SF3aR, and SF3aS. For 
SF3aK, the H1D-H2A cross peak was significantly smaller than the H1B-H3C 
analogue, indicating the different involvement of the two glycosidic linkages in the 
binding event (See Fig 2.25). The D-A linkage has less importance for the recognition, 
especially for IgG, as also observed in the STD experiments. For the two D-A 
glycosidic linkages of SF3aAA (See Fig. 2.13) and especially of SF3aV (Fig. 2.24), the 
cross peak pattern intensities suggested the major involvement of the internal linkages 
than the reducing end analogues, in close agreement with the STD results. In all cases, 
the exoΦ/synΨ- was the major bound conformer.  
The B-C linkage.-For the B-C linkage, which could be defined as a major 
exoΦ/synΨ- geometry in the free state for all the oligosaccharides, the analysis of the 
trNOESY data pointed out to the same behavior when the different oligosaccharides 
were bound to either IgG or IgM. The bound state conformation to the two antibodies 
corresponds to the major one existing in solution. For example, in the case of SF3aR, 
The cross peak intensity of the interresidual H1B’-H3C is much stronger than the 
intraresidual one, indicating that the exoΦ/synΨ- geometry is the major one recognized 
by both antibodies (See Fig 2.11). 
The C-D linkage.- For the C-D glycosidic torsion, the key H1C-H3D cross peaks 
was fairly intense in the bound state to IgG and IgM. These facts probably indicate that 
the exoΦ/synΨ+ region is the bound conformer to these antibodies. Again, this region 
also corresponds to the binding epitope of most of these molecules for the studied 
antibodies, as deduced from the STD experiments. For example, in the case of SF3aM 
(See Figure 2.5B) and SF3aV (See Figure 2.24B), the cross peak intensity of the 
interresidual H1C-H3D is fairly strong, indicating that the exoΦ/synΨ+ geometry is the 
major one recognized by both antibodies in both cases. 
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Figure 2.25 The key NOEs found for the SF3aK oligosaccharide in the F2 (A, C) and F1 (B) dimension. 
The ROESY spectra in the free state are shown always at the top (in blue) and the trNOESY in the 
presence of IgG (center) or IgM (below) in the trNOESY spectra are also shown 
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The A-B linkage. -The A-B linkage showed basically identical behavior in the 
free and bound states to both antibodies, with a clear predominance of the exoΦ/synΨ- 
geometry, as deduced from the intensity of the interresidual H1A’-H2B cross peak, 
much stronger than the corresponding intraresidual one. For example, in the case of 
SF3aM (See Figure 2.5 B) and SF3aR (See Figure 2.11B), the cross peak intensities of 
the interresidual H1A-H2B is fairly strong, significantly stronger than the intraresidual 
H1A-H2A, indicating that the exoΦ/synΨ+ geometry is the major one recognized by 
both antibodies. Also in the case of SF3aAA (See Fig. 2.13B), the cross peak intensities 
of the interresidual H1A’-H2B is fairly strong, significantly stronger than the 
intraresidual H1A’-H2A’, indicating that the exoΦ/synΨ+ geometry is the major one 
recognized by both antibodies.  
 
2.5 Conclusions 
The NMR analysis has shown that there is major recognition epitope in the 
studied oligosaccharides and they display a major conformation in their bound states to 
the antibodies, through a conformational selection process. In the absence of a three-
dimensional model of the antibodies, no clear-cut conclusions may be extracted on the 
driving forces for the interaction to take place. In any case, we decided to explore the 
occurrence of different polar/non-polar surfaces of the different ligands using the 
previously calculated bound conformation. The corresponding data are given in Figures 
2.26A-C. In the case of Fig 2.26A, the polar regions for each oligosaccharide were 
highlighted in red. The analysis of the computed molecular surfaces showed that the 
major polar zones correspond to the non interacting zone of the ligand, thus supporting 
the STD-NMR results. On the other hand, the non-polar regions for the same 
oligosaccharides were highlighted in grey in Figs. 2.26B and C. Analysis of molecular 
surfaces showed that the major non-polar zones correspond to the closest zone of the 
ligand to the antibody surface according to the STD-NMR results previously described.  
As example, for SF3aM, upon inspection of the polar/non-polar molecular 
surfaces, it can be deduced that the E and A residues display a polar surface. This region 
should be solvent exposed (See SF3aM ligand, Fig 2.26A). In fact, for this SF3aM 
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ligand (Figs 2.26B and C), the non-polar region, in grey, contains C and D residues. 
These moieties are making the key contacts with the antibody according to the NMR 
experiments. This fact implies that this region of the structure is making non-polar 
interactions with the protein surface. Similar observations can be derived for the rest of 
the oligosaccharide/mAb systems. 
 In summary, we have demonstrated that the combination of STD and trNOESY 
NMR and MD simulations could provide important information about the molecular 
recognition of synthetic oligosaccharides towards two specific antibodies IgG C7-37 
and IgM G19-2. Firstly, ROESY-NMR experiments gave us structural information 
about the major Φ/Ψ values of each glycosidic linkage and therefore, the existing 
conformational equilibrium. 
 Secondly, our study has provided experimental evidences on the individual 
importance of the different residues, depending on its position at the oligosaccharide 
sequence, also for longer oligosaccharides, and their relative relevance for the molecular 
recognition process. The information derived from STD-NMR experiments clearly 
showed evidences of the direct involvement of residue C followed by its neighbor 
residues (RhapB-RhapC-GlcNAcpD) in every synthetic oligosaccharide in the presence 
of both mAbs. The detailed analysis of trNOESY-NMR experiments in the presence of 
protective antibodies IgG and IgM, gave insights into the presence of a conformational 
selection process, always supported by the STD-based results. The polar/non-polar 
surface generation of all ligand-bound conformers supported the results obtained from 
the NMR experiments (See Fig 2.26A-C). In all instances case, the region directly 
involved in the interaction according to STD experiments (Residue C and surroundings; 
RhapB-RhapC-GlcNAcpD) always coincided with a clear non-polar area in the bound 
oligosaccharide three-dimensional structure (See arrows in Fig 2.26B and Fig 2.26C).   
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Figure 2.26 A-C Polar/Non polar surfaces generated from all ligand-bound conformers emphasizing in A 
polar zones in red and non-polar zones in grey in B and C. In Figure B the black arrows detail the epitope 
of each ligand observed in the STD experiments. 
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TABLE 2.1 A
SF3aG
CONFORMATION 1 
(syn-)
CONFORMATION 2 
(syn+) Experimental FREE STATE Experimental IgG Experimental IgM
E-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcE H1-RhaA H2 2.1 4 2.4 very weak very weak
GlcE H1-RhaA H3 2.7 2.3 2.5 very weak very weak
A-B
Distance Calculated (Angs.) Calculated (Angs.)
RhaA H1-RhaB H2 2.2 2.5 2.2 2.1 2.4
RhaA H5-RhaB H1 2.7 2.3 2.6 >2.7 >2.7
RhaA CH36-RhaB H1 3.2 4 3.6 3.4 >3.5
B-C
Distance Calculated (Angs.) Calculated (Angs.)
RhaB H1-RhaC H3 2.1 2.6 2.1 2.1 2.1
RhaB H5-RhaC H2 2.5 2.4 2.7 2.4 2.5
RhaB CH36-RhaC H2 3.3 4 3.5 3.3 nd
TABLE 2.1 B
SF3aM
CONFORMATION 1 
(syn-)
CONFORMATION 2 
(syn+) Experimental FREE STATE Experimental IgG Experimental IgM
E-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcE H1-RhaA H2 2.1 4 2.4 2.8 2.4
GlcE H1-RhaA H3 2.7 2.3 2.5 >3.0 2.7
A-B
Distance Calculated (Angs.) Calculated (Angs.)
RhaA H1-RhaB H2 2.2 2.5 2.3 2.1 2.2
RhaA H5-RhaB H1 2.7 2.3 2.6 2.6 2.6
RhaA CH36-RhaB H1 3.3 4 3.3 nd 3.3
B-C
Distance Calculated (Angs.) Calculated (Angs.)
RhaB H1-RhaC H3 2.1 2.6 2.2 2.1 2.1
RhaB H5-RhaC H2 2.5 2.4 2.6 2.4 2.5
RhaB CH36-RhaC H2 3.8 4 3.8 nd nd
C-D
Distance Calculated (Angs.) Calculated (Angs.)
RhaC H1-GlcNAcD H3 2.3 2.5 2.5 2.5 2.5
RhaC H5-GlcNAcD H4 2.7 3.5 >3.3 nd nd
Chapter 2 
92 
 
 
 
 
TABLE 2.1 C
SF3aK
CONFORMATION 1 
(syn-)
CONFORMATION 2 
(syn+) Experimental FREE STATE Experimental IgG Experimental IgM
E-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcE H1-RhaA H2 2.2 4 2.6 2.5 2.5
GlcE H1-RhaA H3 2.8 2.2 2.6 2.7 2.8
D-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-RhaA H2 2.3 2.9 2.4 2.6 2.5
GlcNAcD NHAc-RhaA H4 5.2 3.5 >4 >4 >4
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-GlcE H1 2.8 5.3 3.2 3 2.9
GlcNAcD NHAc-GlcE H3 5.8 3.9 >4 >4 >4
A-B
Distance Calculated (Angs.) Calculated (Angs.)
RhaA H1-RhaB H2 2.2 2.6 2.3 2.2 2.2
RhaA CH36-RhaB H1 3.3 4.1 3.4 3.5 3.8
B-C
Distance Calculated (Angs.) Calculated (Angs.)
RhaB H1-RhaC H3 2.2 2.6 2.2 2.2 2.2
RhaB CH36-RhaC H2 3.3 4.2 nd 3.3 3.6
TABLE 2.1 D
SF3aO
CONFORMATION 1 
(syn-)
CONFORMATION 2 
(syn+) Experimental FREE STATE Experimental IgG Experimental IgM
E-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcE H1-RhaA H2 2.2 4 2.4 2.3 2.4
GlcE H1-RhaA H3 2.8 2.2 2.5 2.9 2.7
D-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-RhaA H2 2.2 2.6 2.5 2.2 2.2
GlcNAcD NHAc-RhaA H4 5.2 3.5 >3.5 >4 >4
D-E (Long range)
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-GlcE H1 2.4 6.1 2.6 NOE 2.4
GlcNAcD NHAc-GlcE H3 5.8 3.6 >4 >4 >4
B-C
Distance Calculated (Angs.) Calculated (Angs.)
RhaB H1-RhaC H3 2.2 2.6 2.2 2.2 2.2
RhaB H5-RhaC H2 2.5 2.4 2.6 2.6 2.7
RhaB CH36-RhaC H2 3.2 4 3.8 nd nd
C-D
Distance Calculated (Angs.) Calculated (Angs.)
RhaC H1-GlcNAcD H3 2.3 2.5 2.5 2.5 2.5
RhaC H5-GlcNAcD H4 2.7 3.5 nd nd nd
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TABLE 2.1 E
SF3aR
CONFORMATION 1 
(syn-)
CONFORMATION 2 
(syn+) Experimental FREE STATE Experimental IgG Experimental IgM
E-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcE H1-RhaA H2 2.2 4.1 2.5 2.5 2.4
GlcE H1-RhaA H3 2.8 2.25 2.7 2.7 2.6
D-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-RhaA H2 2.2 2.7 2.7 2.2 2.2
GlcNAcD NHAc-RhaA 
H4 4.6 3.5 >3.5 >4 >4
D-E (Long range)
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-GlcE H1 2.4 6 2.7 3 2.7
GlcNAcD NHAc-GlcE H3 6 3.7 4 >4 >4
A-B
Distance Calculated (Angs.) Calculated (Angs.)
RhaA H1-RhaB H2 2.2 2.5 2.2 2.2 2.2
RhaA H5-RhaB H1 2.6 2.5 2.5 2.5 2.7
RhaA CH36-RhaB H1 3.3 4.1 3.5 NOE nd
B'-C
Distance Calculated (Angs.) Calculated (Angs.)
RhaB' H1-RhaC H3 2.2 2.7 2.2 2.2 2.3
RhaB' H5-RhaC H2 2.5 2.6 2.7 2.5 nd
RhaB' CH36-RhaC H2 3.2 4.4 3.6 nd nd
C-D
Distance Calculated (Angs.) Calculated (Angs.)
RhaC H1-GlcNAcD H3 2.3 2.5 2.5 2.6 2.6
RhaC H5-GlcNAcD H4 2.6 3.5 nd nd nd
TABLE 2.1 F
SF3aS
CONFORMATION 1
(syn-)
CONFORMATION 2
(syn+)Experimental FREE STATE Experimental IgG Experimental IgM
E'-A'
Distance Calculated (Angs.) Calculated (Angs.)
GlcE' H1-RhaA' H2 2.2 4.1 2.5 >3 3
GlcE' H1-RhaA' H3 2.8 2.3 2.5 2.8 2.8
A'-B
Distance Calculated (Angs.) Calculated (Angs.)
RhaA' H1-RhaB H2 2.2 2.5 2.2 2.2 2.2
RhaA' CH36-RhaB H1 3.3 4.1 3.5 3.5 3.5
B-C
Distance Calculated (Angs.) Calculated (Angs.)
RhaB H1-RhaC H3 2.1 2.5 2.1 2.1 2.1
RhaB CH36-RhaC H2 3.4 3.9 3.7 nd nd
C-D
Distance Calculated (Angs.) Calculated (Angs.)
RhaC H1-GlcNAcD H3 2.3 2.5 2.5 2.5 2.5
RhaC H5-GlcNAcD H4 2.5 3.5 nd nd nd
D-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-RhaA H2 2.2 2.7 2.5 2.5 2.5
GlcNAcD NHAc-RhaA H4 4.6 3.7 3.9 >4 >4
E-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcE H1-RhaA H2 2.2 4.1 2.5 2.6 2.6
GlcE H1-RhaA H3 2.8 2.3 2.5 2.8 2.7
D-E (Long range)
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-GlcE H1 2.4 5 2.8 2.9 2.9
GlcNAcD NHAc-GlcE H3 5 3.6 4 >4 >4
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TABLE 2.1 G
SF3aV
CONFORMATION 1 
(syn-)
CONFORMATION 2 
(syn+)Experimental FREE STATE Experimental IgG Experimental IgM
E'-A'
Distance Calculated (Angs.) Calculated (Angs.)
GlcE' H1-RhaA' H2 2.1 4.1 2.7 >2.7 >2.7
GlcE' H1-RhaA' H3 2.8 2.3 2.6 >2.8 >2.8
D'-A'
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD' H1-RhaA' H2 2.2 2.7 2.6 2.2 2.2
D'-E' (Long range)
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD' H1-GlcE' H1 2.4 4.5 >3.2 >3 >3
GlcNAcD' NHAc-GlcE' H3 5.7 3.7 >4 nd nd
A'-B
Distance Calculated (Angs.) Calculated (Angs.)
RhaA' H1-RhaB H2 2.2 2.5 2.2 2.2 2.2
RhaA' CH36-RhaB H1 3.4 4 3.5 3.5 3.5
B-C
Distance Calculated (Angs.) Calculated (Angs.)
RhaB H1-RhaC H3 2.2 2.5 2.2 2.2 2.2
RhaB CH36-RhaC H2 3.3 4 3.3 nd nd
C-D
Distance Calculated (Angs.) Calculated (Angs.)
RhaC H1-GlcNAcD H3 2.3 2.5 2.5 2.6 2.6
RhaC H5-GlcNAcD H4 2.7 3.5 nd nd nd
D-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-RhaA H2 2.2 2.5 2.6 2.4 2.4
E-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcE H1-RhaA H2 2.1 4.1 2.5 2.6 2.6
GlcE H1-RhaA H3 2.8 2.2 2.5 2.8 2.8
D-E (Long range)
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-GlcE H1 2.4 4.7 2.9 2.9 2.9
GlcNAcD NHAc-GlcE H3 5.1 3.7 4 >4 >4
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Tables 2.1 A-H Inter-glycosidic distances of every SF3a oligosaccharide derived from MD simulations 
(first and second columns), derived from ROESY spectra (third column) and in the presence of the 
Immunoglobulins; derived from NOESY spectra in the presence of IgG (fourth column) and IgM (fifth 
column). 
 
TABLE 2.1 H
SF3aAA
CONFORMATION 1
(syn-)
CONFORMATION 2 
(syn+) Experimental FREE STATE Experimental IgG Experimental IgM
B'-C'
Distance Calculated (Angs.) Calculated (Angs.)
RhaB' H1-RhaC' H3 2.2 2.5 2.2 nd nd
RhaB' H5-RhaC' H2 2.5 2.4 2.5 nd nd
RhaB' CH36-RhaC' H2 3.2 4 3.7 nd nd
C'-D'
Distance Calculated (Angs.) Calculated (Angs.)
RhaC' H1-GlcNAcD' H3 2.3 2.5 2.5 2.6 2.6
RhaC' H5-GlcNAcD' H4 2.7 3.5 nd nd nd
D'-A'
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD'H1-RhaA' H2 2.2 2.5 2.5 2.2 2.2
GlcNAcD' NHAc-RhaA' 
H4 4.8 3.7 >4 >4 >4
E'-A'
Distance Calculated (Angs.) Calculated (Angs.)
GlcE' H1-RhaA' H2 2.2 4.1 2.6 2.4 2.4
GlcE' H1-RhaA' H3 2.8 2.3 2.6 2.6 2.6
D'-E' (Long range)
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD' H1-GlcE' H1 2.4 4.7 >3 2.7 2.7
GlcNAcD' NHAc-GlcE' H3 3.6 5.2 >4 >4 3.5
A'-B
Distance Calculated (Angs.) Calculated (Angs.)
RhaA' H1-RhaB H2 2.3 2.4 2.2 2.2 2.2
RhaA' CH36-RhaB H1 3.4 3.9 3.5 3.5 3.5
B-C
Distance Calculated (Angs.) Calculated (Angs.)
RhaB H1-RhaC H3 2.2 2.5 2.2 2.2 2.2
RhaB H5-RhaC H2 2.5 2.4 2.5 nd nd
RhaB CH36-RhaC H2 3.3 3.9 3.7 nd nd
C-D
Distance Calculated (Angs.) Calculated (Angs.)
RhaC H1-GlcNAcD H3 2.3 2.5 2.5 2.6 2.6
RhaC H5-GlcNAcD H4 2.7 3.5 nd nd nd
D-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-RhaA H2 2.2 2.5 nd nd nd
E-A
Distance Calculated (Angs.) Calculated (Angs.)
GlcE H1-RhaA H2 2.2 4 2.5 2.4 2.4
GlcE H1-RhaA H3 2.8 2.3 2.6 2.5 2.6
D-E (Long range)
Distance Calculated (Angs.) Calculated (Angs.)
GlcNAcD H1-GlcE H1 2.4 4.6 3 2.7 2.7
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2.6 Materials and Methods 
 
Nomenclature 
The glycosidic torsion angles were defined employing the NMR-based 
convention, referred to the glycosidic and aglyconic hydrogens. In particular, φ was 
defined as H1’-C1’-O1-CX and ψ as HX-CX-O1-C1’. X refers to either position 2 or 3 
for the (1→2) and (1→3) linkages, respectively. 
Methods 
MD simulations of SF3a oligosaccharides 
The initial geometries of the SF3a ligands were generated by using the LEAP 
module of AMBER1014. Structures were first minimized and then the solute was placed 
in a rectangular TIP3P box with water molecules, occupying up to 11Å from the sugar 
center of mass. The MD simulations were run for 4ns using GLYCAM06 force field15, 
started after four initial minimization steps with the solute restrained in its initial 
position. A final minimization step without solute restriction was also carried out. 
Snapshots were collected every 20μs. Post processing of the trajectories (torsion, 
distances, RMSD) for further analysis was performed using the PTRAJ module of 
AMBER1014.  
For the polar/non-polar surface generations there have used the major 
conformers of the synthetic oligosaccharides in the presence of the mAbs using 
MAESTRO module of Schrödinger16.  
Sample preparation 
The NMR study of the SF3a oligosaccharides in water solution was performed 
using 1mM samples in D2O. Standard 2D-methods, such as TOCSY (with mixing times 
of 30 and 80ms), ROESY (300 ms), NOESY (400 and 600 ms), and HSQC experiments 
were employed, using Bruker Avance 500 and 600 MHz (equipped with a triple channel 
cryoprobe) NMR spectrometers. 
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Samples of the monoclonal antibodies IgG and IgM were lyophilized, and re-
dissolved in deuterated phosphate-buffered saline (PBS, pH= 7.3) for the ligand binding 
experiments. The synthetic oligosaccharides and specific antibodies IgG C7-37 and IgM 
G19-2 were prepared at Institute Pasteur (Paris) and the synthesis has been reported 
elsewhere. 
NMR studies (STD and trNOESY experiments) 
Saturation transfer difference (STD)12 experiments were performed on both 500 
MHz and 600 MHz NMR spectrometers, at 298K or 313K. The experiments were 
carried out using samples with an antibody/ligand molar ratio of 1/200. In particular, the 
employed concentrations were 10uM/2mM for experiments with IgG, and 5uM/1mM 
for those with IgM). Different experiments (8000 scans each) were performed in which 
the saturation time of the protein was varied from 0.5 to 2s. Selective “on-resonance” 
irradiation of antibody resonances was performed at either δ7 or -1.5 ppm, while the 
“off-resonance” frequency was always set at 100 ppm. Similar results were obtained. 
STD experiments on free SF3a ligands at 1mM in D2O were also acquired in order to 
obtain “blank” experiments. 
All ligands displayed similar STD growth for all signals upon increasing of the 
saturation time. Therefore, the obtained results after 2 seconds of saturation time are 
discussed, since they displayed the best signal/noise ratio.  
trNOESY experiments17 were carried out on the 600MHz spectrometer, 
equipped with a triple-channel cryoprobe. The employed samples used a 1/30 
antibody/ligand molar ratio, with a 33uM/1mM ratio for IgG and 20uM/600uM for 
IgM. The mixing time was 200 ms. trNOESY experiments were also performed to 
detect possible spin diffusion transfers. The obtained results were compared to those 
ROESY experiments recorded for the free ligand. Then, for both free (ROESY) and 
bound (trNOESY) states, the cross peak volumes were used to estimate the key 
interproton distances, using the isolated spin approximation. In all cases, an 
intraresidual proton pair that contained one of the protons involved in the distance to be 
determined was used as internal reference. 
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3.1 Introduction 
Molecular recognition is at the heart of essential biological events. The 
recognition of saccharides presented as part of natural scaffolds (protein, sphingolipids) 
by protein receptors (lectins) mediates key processes underlying many aspects of life as 
reflected by the term “sugar code”1. Matching the wide spectrum of glycan structures 
(glycome complexity2), lectins are found in all branches of the phylogenetic tree and 
have proven to be versatile tools for glycan detection and structural characterization3.  
Indeed, there is nowadays particular interest in the identification of glycoprotein 
glycan structures as a result of altered glycoprotein expression occurring in diseases, 
hereby defining functional glycobiomarkers of diagnostic value4. Recent technological 
advances have led to the development of lectin and glycan microarrrays, which offer a 
comparative view of the lectin–glycan interactions and provide a high-throughput 
approach to screen a wide range of glycan profiles and to determine glycan binding 
specificity of the lectin5.  
With the growing realization that the presentation of a glycan epitope can affect 
its recognition by lectins3b, it is timely to study these interactions with natural glycans of 
the proper size and then rigorously define the contact sites, especially in cases with 
more than one possible interaction mode. 
NMR and X-ray crystallography provide key information at atomic resolution on 
biomolecules, including complexes. However, in the protein–carbohydrate interaction 
field, these techniques have mainly focused on acquiring information of complexes 
formed by lectins with small/medium-sized fragments of natural glycan chains. Often, it 
is an open question how affinity/specificity is regulated on the level of complex 
glycans. 
 
3.2 Objectives 
N-Glycans6 are common modifications of membrane/secreted proteins. They 
confer specific properties to the associated protein that will ultimately determine its fate. 
The structures of N-glycans are widely diverse, although share common structural 
motifs. They always contain a core pentasaccharide unit, which is composed of a 
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chitobiose unit linked to a trimannoside moiety that introducesa branching point with 
two antennae. Both antennae can be extended by N-acetyllactosamine (LacNAc) units, 
terminated by α2,6- or α2,3-linked sialic acid. As abundant species among N-glycans, 
we have herein studied the biantennary complex-type nonasaccharide–Asn (with 
LacNAc termini) (Figure 3.1 compound 2) and its α2,6-sialylated undecasaccharide–
Asn derivative (Figure 3.1 compound 4), which were isolated from egg yolk by the 
group of Prof. C. Unverzagt in Bayreuth (Figure 3.1). These structures represent the 
common motifs of N-glycans on glycoproteins, with α2,6-sialylation acting as the 
salient signal for masking/docking1b, 7. In fact, these structures contain several binding 
epitopes in their primary structures and therefore are very good tools to understand how 
lectins select a given epitope among all those present in the carbohydrate ligand. From 
the receptor side, different lectins have been selected. According to published data, they 
should be able to bind different epitopes of the natural N-glycans. In particular, two 
agglutinins described with binding affinity to the N,N′-diacetylchitobiose ((GlcNAc)2) 
part of the core have been chosen, namely, wheat germ agglutinin (WGA)8 and the 
WGA-derived single domain similar to hevein9. Hevein, one of the smallest plant 
lectins with 43 amino acids, was the first lectin whose structure in complex with its 
sugar ligand was solved in solution10 by using NMR techniques8. As mentioned in the 
introduction, WGA harbors eight hevein domains and displays a dual specificity for 
both GlcNAc and Neu5Ac,8 which are monosaccharides found at opposing ends of 
natural N-glycans. Whether both sugars are binding targets in an N-glycan or whether 
the lectin exhibits selectivity was not known, prompting us to perform this study. 
 
Figure 3.1 Glycan structures used in this study. 
Sialylated N‐glycan
Core trisaccharide
Non‐Sialylated‐N‐glycan
6’‐SialylLacNAc
Glycopeptide
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The used approach can likewise be used to obtain structural view on target–site 
interaction. To illustrate this application, the Viscum album agglutinin (viscumin, VAA) 
was selected. It binds LacNAc termini on N-glycans, and also in the case of α2,6-
sialylated N-glycans11. As a negative control, a mixture of lectins, for whom α2,6-
sialylgalactose terminus blocks recognition, was chosen. In this context, the two 
agglutinins from the seeds of Maackia amurensis (the leukoagglutinin MAL and the 
hemeagglutinin MAH) have been selected8, 12. 
We show that the mode of epitope presentation is crucial for glycan recognition 
and that the selectivity observed in assays with free sugars can change after subtle 
alterations of the N-glycan structure. The same can hold true for lectins differing in 
quaternary structure. 
 
3.3 Results 
3.3.1 The single hevein Domain vs WGA 
 
WGA constitutes the classical model for chitooligosaccharide binding. 
Additionally, WGA is often included among the sialic acid binding lectins. Therefore, 
two potential epitopes are presented in sialylated glycopeptides for this lectin. In fact, 
the recognition features of chitooligosaccharides by hevein domains have been well 
established through NMR9-10. More recently, we have demonstrated that the 
trisaccharide N-glycan core (Figure 3.1 compound 1) is also recognized by hevein, with 
GlcNAc1 (linked to Asn) on subsite +2 (on top of W21), GlcNAc2 on subsite +1 (on 
top of W23), and βMan at subsite −1, leaving the Asn residue outside of the binding 
site, without establishing interactions with the lectin13. This structural model was used 
as a template for analyzing the recognition of complex-type N-glycans. However, when 
we titrated a 0.3 mM solution of a single hevein domain (the B domain of WGA14) with 
increasing amounts of the sialylated N-glycan–Asn (Figure 3.1 compound 4), no 
changes were observed for the 1H NMR resonances of the lectin. Similarly, attempts to 
dock the undecasaccharide–Asn (Figure 3.1 compound 4) using the binding mode of the 
core trisaccharide–Asn (Figure 3.1 compound 1 and Figure 3.2) wereunsuccessful. In 
fact, branching at position 6 of the central βMan residue causes a steric clash of the 
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sugar extension with different protein residues, independent of the presence of either gg 
or gt rotamers at the C5–C6 linkage. In contrast, WGA is known to bind N-glycans8. 
 
Figure 3.2 (A) Complex of hevein with the trisaccharide core (Figure 3.1 compound 1) as deduced from 
NMR13. (B) Attempted docking of the extended N-glycan structure (Figure 3.1 compound 4) obtained by 
superimposition of the sialylated N-glycan in the trisaccharide core template (see panel A). The extension 
at position O6 of the central Man moiety in the core causes steric clashes with the protein. The gg 
orientation is shown at Man C5–C6. The gt rotamer is sterically also forbidden. Subsites are indicated on 
top, and the key amino acids, i.e., Trp21 and Trp23, are annotated. 
WGA is a dimeric lectin where each subunit consists of an assembly of four 
hevein domains15. It has been described to be specific for terminal Neu5Ac and GlcNAc 
moieties by inhibition studies8, X-ray crystallography15, and NMR spectroscopy16. The 
structure of complexes, also with a small sialoglycopeptide15c, reveals that the primary 
binding site is constituted by three conserved aromatic residues from one hevein 
domain. Nevertheless, further polar residues (S114 and E115) from the neighboring 
hevein domain contribute to the stabilization of the complex, providing structural 
evidence for the intra-protein cooperation of lectin domains. 
Strikingly, and in contrast to the observations for the single hevein domain, the 
STD experiments performed with the sialylated N-glycan–Asn (Figure 3.1) in the 
presence of the multidomain lectin showed STD signals, evidencing the existence of 
interaction. Analysis of the STD spectra (Figure 3.3) clearly showed that the terminal 
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Neu5Ac residue was not the key point for the recognition process. Only a very weak 
effect was observed for the methyl group of the 5-acetamide, while the ring hydrogens 
were not present in the STD spectrum (Figures 3.3 and 3.4). 
 
Figure 3.3 (A) STD (below) and off-resonance spectrum (on top) of the sample containing WGA and the 
sialylated N-glycan (Figure 1). The region of the methyl protons of the Ac groups is enlarged on the right. 
(B) left, TOCSY of ligand 4; right, STD-TOCSY of the mixture of WGA and sialylated N-glycan 4. The 
sialyl residue does not contribute to the binding event. In contrast, the Asn residue provided clear STD 
signals indicating its direct involvement in the recognition process. 
In fact, the residues in closer contact with the protein are at the opposite end of 
the molecule, namely, the GlcNAc1 and Asn moieties. Thus, the binding mode is 
different from that occurring between a single hevein domain (Figure 3.2A) and the 
trisaccharide core (Figure 3.1), in which the Asn moiety was far from the lectin 
(positive NOEs in the NOESY spectrum of the complex)13. For hevein itself, GlcNAc1 
and GlcNAc2 are located at subsites +2 and +1, respectively. However, for WGA, the 
docking/minimization procedure based on the experimental observations showed that 
the binding mode is shifted by one subsite: the Asn residue now occupies subsite +2 (on 
top of W21); GlcNAc1 is on subsite +1 (on top of W23), and GlcNAc2 sits on subsite 
−1. In this situation, the βMan residue is shifted one subsite away from the center of 
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binding to the protein, and therefore, the typical branching at O6 does not cause steric 
clashes with the protein (Figure 3.5). Obviously, the following question arises: why 
does the single hevein domain not use this binding mode for recognizing the large 
sialylatedN-glycan? Detailed comparisons pointed to the presence of the additional 
polar residues in the neighboring hevein domain in WGA; that is, S114 and E115 
appear as key factors stabilizing the complex. They form hydrogen bonds with the N-
glycan (Figure 3.5), which are absent in the single hevein domain. Probably, this 
binding mode (GlcNAc1–Asn on subsites +1 and +2, respectively) is energetically not 
favorable in the case of just a single hevein domain13, where these new interactions 
cannot contribute to the binding enthalpy. 
 
 
Figure 3.4 HSQC (edited) spectrum of compound in Fig. 3.1, and superimposed STD (in red) and off 
resonance spectrum (in black) in presence of WGA. Hydrogens of the sialyl residue do not appear in the 
STD, implying that they are not directly involved in WGA binding.  
H2 GlcNAc 1
H5 Neu5Ac
H6 Neu5Ac
H7 Neu5Ac
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 Figure 3.5 Deduced complex of the sialylated N-glycan (in orange) in the primary binding site of WGA, 
as deduced from the docking, minimization, and MD process. Amino acids Y66, Y64, and S62 
(equivalents to W21, W23, and S19 in hevein) from one hevein domain are represented in gray CPK, 
while S114 and E115 from the neighboring hevein domain are represented in balls and sticks, in purple. 
The sialyl residues are exposed to the solvent and not directly involved in WGA binding. 
Analogous STD experiments were carried out with the non-sialylated N-glycan–
Asn (Figure 3.1 compound 2 and Figure 3.6). They were employedas control to 
ascertain the binding mode deduced above. The results were very similar to those 
obtained with the sialylated N-glycan: Asn and GlcNAc1 displayed the strongest STD 
intensities, with much lower intensities for the branches. 
Figure 3.6 (left) TOCSY spectrum of non-sialylated N-glycan. (right) STD-TOCSY of WGA/non-
sialylated N-glycan. As for sialylated N-glycan, the Asn and GlcNAc1 residues provided clear STD 
signals indicating their direct involvement in the recognition process. 
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As already mentioned, WGA is often included among the sialic acid binding 
lectins. However, our experimental STD data have shown that, although sialylated N-
glycan is indeed recognized by WGA, the terminal sialic acid of the undecasaccharide 
does not establish primary interactions with the lectin. Instead, the interactions occur via 
the GlcNAc1 and Asn moieties at the stem region of the glycan. 
To prove binding to a sialylated, but GlcNAc-free compound, one additional 
STD experiment with 6′-sialylLacNAc (Figure 3.1 compound 5) was acquired. The 
STD spectrum (Figure 3.7) clearly showed that only the protons from the sialyl 
(Neu5Ac) residue showed STD intensity, especially those from the acetyl group, in 
agreement with the published X-ray crystallographic data15. The other STD signals 
corresponded to H5, H6, H7, and H4 of Neu5Ac. Thus, although WGA recognizes 
simple sialyl-containing oligosaccharides, when presented in the context of a complex 
N-glycan, the sialic acid is therefore not its primary contact site, as it is for the isolated 
branch-end trisaccharide. Explicitly, in the sialylated N-glycan–WGA complex, only the 
acetyl group of Neu5Ac showed weak STD, and protons H5, H6, and H7 did not show 
STD signals (See Figure 3.4). 
This result underscores the inherent value of the given approach to team up 
binding-site identification by STD NMR spectroscopy with N-glycan preparation. When 
more than one possible contact site is presented, the given strategy can determine the 
preferred epitope in the context of the N-glycan. 
 
Figure 3.7 STD spectrum (below) of 6’-sialylLacNac with WGA. On top, off resonance reference 
spectrum. Hydrogens of the sialyl residue clearly appear in the STD, implying the direct involvement in 
WGA binding. 
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Since the recognition of the sialylated and non-sialylated-N-glycan by WGA 
mainly involves GlcNAc1 and the Asn residue, it remained to be clarified whether there 
is an influence of a peptidic moiety, as occurring in glycoproteins. Thus, an STD 
experiment was carried out under the same experimental conditions for a mixture of the 
glycopeptide (Figure 3.1 compound 3) and WGA. The spectrum showed STD 
intensities similar to those obtained for the non-sialylated-N-glycan (Figure 3.8). In 
particular, the protons of the additional peptide residues did not show up in the 
spectrum, indicating exclusive recognition of the glycopeptide by WGA through the 
GlcNAc–Asn region. We next proceeded to a case study of actual branch-end 
recognition. 
 
Figure 3.8 STD (below) and off-resonance (on top) of glycopeptides 1 and 3 and WGA. As for 2 and 4, 
the Asn and GlcNAc1 residues provided clear STD signals indicating their direct involvement in the 
recognition process.  
3.3.2 Viscumin 
 
As mentioned in the introduction section, this lectin is a toxic AB-type protein. 
The B chain harbors two carbohydrate-binding sites, characterized by W38 and Y249. 
In solution, the lectin activity of VAA can be attributed primarily to the Tyr site17. The 
recognition mode of lactose by VAA has been characterized by X-ray crystallography, 
chemical mapping, and modeling18. It has been reported that VAA strongly binds 
Neu5Acα2–6Galβ1–4GlcNAc on gangliosides and glycoproteins, while gangliosides 
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with terminal galactoses are poorly recognized19. α2,6-Sialylation can improve 
inhibitory capacity of lactose11b. Nevertheless, a structural rationalization to those facts 
has not yet been given. 
Figure 3.9 shows the STD spectra, along with their corresponding reference 
spectra, for VAA in the presence of the sialylated N-glycan (on top) and of the non-
sialylated analogue (below). Both compounds are bound by VAA, but the STD 
intensities were significantly stronger for the sialylated than for the non-sialylated. 
Since strictly the same experimental conditions were kept, the results suggest respective 
grading of interaction for VAA. Furthermore, the distinct protons of the Neu5Ac 
residue (H3ax, H3eq, and Ac) clearly revealed that this residue is in close contact with 
VAA. This fact was confirmed by the STD-TOCSY spectrum (Figure 3.10). Thus, in 
this case, the terminal Neu5Ac moiety is clearly involved in the recognition process, 
and its absence weakens but does not prevent glycan–ligand interaction. 
 
Figure 3.9 STD spectra of the mixtures of VAA with (A) 4 and (B) 2. The methyl groups regions are 
enlarged at the right-hand side, and the resonances are annotated for each case. The STD spectra are 
shown below, while the corresponding off-resonance spectra are on top. In all cases, VAA binds both 
molecules. 
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Figure 3.10 (A) TOCSY spectrum of sialylated N-glycan. (B) STD-TOCSY with Viscumin. The sialyl 
residue is in contact to the lectin surface.  
 
Three-dimensional (3D) structures of the corresponding complexes were 
generated by using molecular modeling techniques, taking the available experimental 
X-ray coordinates for the VAA–lactose complex as a starting geometry. In the resulting 
3D structure, the galactose-binding site is formed by amino acids D335, N256, and 
Q238 that establish hydrogen bonding with the Gal residue and by Y249, which 
establishes stacking interaction with the α-face of the Gal moiety, explicitly with H3, 
H4, and H5 (Figure 3.11A). Inspection of this experimental geometry detects space for 
a sugar extension at Gal O6. This location is surrounded by polar amino acids that may 
efficiently interact with sialic acid residues; they are S200, R245, and Q238. Docking of 
sialylated N-glycan at this locus, using the lactose-binding model as a template, 
provided a stable pose, which was further optimized through an energy minimization 
and MD protocol. Of note, further interactions can then take place between Neu5Ac and 
the above-mentioned polar residues (Figure 3.11B): R245 establishes a bidentate 
hydrogen bond with the glycerol chain of the sialic acid residue, S200 is hydrogen 
bonded to the carboxylic acid, and Q238 establishes a cooperative hydrogen bond with 
OH7 of Neu5Ac and OH3 of the branching GlcNAc. Evidently, these interactions 
appear to underlie the preferential affinity reported above. Terminal LacNAc units are 
recognized, but further sialylation to Neu5Acα2–6LacNAc enhances binding. 
H3ax Neu5Ac
H3eq Neu5Ac
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Figure 3.11 (A) X-ray structure (pdb code 1PUU) of VAA complexed with lactose. The amino acids 
implicated in interactions with the ligand are highlighted. (B) Docking pose of the sialylated N-glycan on 
the Tyr site in subdomain 2γ. The amino acids providing new further interactions (hydrogen bonds 
depicted in green) with the Neu5Ac residues are highlighted. 
 
3.3.3 Maackia amurensis lectins 
 
The mixture of the two lectin species from the seeds of Maackia amurensis, 
MAL and MAH, was employed12. Both isolectins are known to be able to bind to α2,3-
sialylgalactose, although with different preferences: the leukoagglutinin (MAL) is 
known to preferentially react with Neu5Acα2,3Galβ1,4βGlcNAc moieties present in N-
glycans16c, while the hemagglutinin (MAH) has higher affinity for the disialylated 
tetrasaccharide Neu5Acα2,3Galβ1,3[Neu5Ac(2,6)]αGalNAc present in O-glycans4e, 12, 
20. The binding sites of both isolectins are very similar, with the only differences being 
the amino acids Y221 and E222 of MAL, which are replaced by Ala residues in MAH. 
The X-ray crystal structure of MAL complexed with 3′-sialyllactose has been 
reported21. 
1D STD and two-dimensional STD-TOCSY experiments were acquired for the 
sialylated and non-Sialylated-N-glycan, using samples with a protein/ligand 1:20 (50 
μM/1 mM) ratio. The corresponding spectra are shown in Figure 3.12. The comparison 
of the spectra on the left (sialylated N-glycan-Asn) and on the right (non-sialylated) 
enabled the assessment that the MAL–MAH mixture indeed does not recognize the 
Neu5Acα(2,6)Gal-containing molecule (Figure 3.1 compound 4), providing a negative 
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control for specificity, while it does efficiently bind to the non-sialylated species. The 
documented lack of reactivity in lectin-affinity chromatography or in glycan arrays 
serves as further control4e, 12. 
 
Figure 3.12 (left) STD and STD-TOCSY spectra corresponding to MAA–sialylated N-glycan (Compound 
4). No STD is detected. (right) Spectra corresponding to MAA–non-sialylated N-glycan (Compound 2). 
The terminal N-acetyllactosamine residues provided clear STD signals indicating their direct involvement 
in the recognition process. 
 From the analysis of this STD spectrum, it was deduced that the residues 
interacting with the lectin are the non-reducing end terminal galactose and GlcNAc 
residues (LacNAc unit), while in this case, the GlcNAc1 and Asn stem at the other end 
is not in contact with the protein. This observation is in agreement with the previously 
reported specificity data and with the published crystallographic structure (pdb code 
1DBN). Indeed, the binding site of MAL is unusually narrow for a lectin. Both the 
terminal galactose and GlcNAc residues are sandwiched between Y136 and Y221, 
leaving Gal O6 deep inside the binding site and establishing hydrogen bonding with 
D137, clearly precluding the extension through Gal O6, as it is the case of the 2,6-
sialylated N-glycan. Now, the absence of the sialic acid moiety allows the terminal 
LacNAc unit of non-sialylated-N-glycan to perfectly fit inside the binding pocket, 
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following the typical feature for lectin binding3b by establishing a combination of CH−π 
stacking interactions with Y136 and Y221 and hydrogen bonds with Y131, D87, D137, 
and E22421. Further interactions are established with GlcNAc2 and ManB through Y136 
and Y221 (Figure 3.13A). Terminal elongation of the non-sialylated-N-glycan with 
Neu5Ac but with an α2–3 linkage was then explored by modeling procedures (Figure 
3.13B), yielding a complex in which Neu5Ac not only fits in the narrow lectin binding 
site but further contributes to the binding by hydrogen bonding to amino acids K107, 
S104, and Y136, as also observed in the X-ray structure for sialylα2,3-lactose21. Thus, 
in this particular example, the presence of the α2,6-linked Neu5Ac moiety impairs the 
N-glycan ligand binding to the lectin. Interestingly, in the absence of Neu5Ac, 
recognition of the underlying LacNAc unit occurs. 
 
Figure 3.13 (A) Modeled structure (using a docking and MD protocol) for the complex formed between 
MAL and the non-sialylated-N-glycan, using the deposited X-ray structure (pdb code 1DBN) as the 
template structure. The N-acetyllactosamine at the 1→6 branch has been docked at the binding site. (B) 
3D model for the recognition of an analogous undecasacharide as the sialylated-N-glycan but with 
terminal Neu5Ac in α2-3 linkages instead of the trisaccharide Neu5Acα2-3Galβ1-3GlcNAcβ with the 
1DBN X Ray structure and further energy minimization. 
 
3.4 Conclusions 
The preparation of N-glycans facilitates definition of the docking sites of lectins 
on complex glycans. Shown herein, the nature of the target epitope strictly depends on 
the nature of the tested lectin, which can select distinct determinants of the complex-
type saccharide chain with exquisite specificity, depending on the relative presentation 
of the different residues and the architecture of the binding site. 
A B
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We have underscored the importance of the coexistence of binding sites from 
different lectin domains for achieving glycan binding by comparing a single hevein 
domain and WGA. The monomeric unit does not recognize the large glycan, with the 
branching at the βMan residue being the key structural element for precluding the 
interaction. In contrast, the multidomain lectin WGA binds the terminal reducing end of 
either non- or sialylated-N-glycan, namely, the GlcNAc–Asn epitope, owing to the 
possibility of achieving additional inter-site stabilizing interactions from one of the 
neighboring hevein domains. In this context, it is worth emphasizing that WGA does 
not bind to non- or sialylated-N-glycan through the (GlcNAc)2 moiety, as it would be 
expected. The chemical nature of the branched N-glycans excludes the possibility of 
efficient interactions of the chitobiose stem with the two consecutive aromatic residues 
typical for hevein domains, and thus, the recognized epitope is shifted by one position 
to the GlcNAc–Asn fragment. Despite being considered as a sialic acid binding lectin, 
our data have clearly shown that the sialyl residue of the sialylated-N-glycan is not a 
key player in the binding process. Thus, in naturally occurring N-glycopeptides, 
although presented at the spatially less readily accessible non-reducing end, binding 
occurs via the N-glycan–Asn stem region, a result of conspicuous importance for the 
interpretation of data using WGA in array platforms or in cyto- or histochemical 
glycophenotyping. Given the assumed significance of sialylation, for example, in tumor 
suppressor activities in response to environmental effectors or in immunity22, caution 
should thus be exercised regarding WGA as a tool to detect alterations in this parameter. 
As demonstrated, on the level of small glycans, WGA can accommodate sialic acid 
residues. Indeed, using α2,6-sialyllactose, we clearly demonstrate that this small 
trisaccharide is recognized by WGA, but the situation is different on the level of N-
glycans. Considering the importance of terminal sialylation, we have extended our study 
by analyzing the respective recognition structurally. 
Work with VAA has yielded insights into how α2,6-sialylation can be 
accommodated by this lectin, providing enhanced binding in natural N-glycans when 
compared to the non-sialylated LacNAc-terminated analogue. Our methodology has 
permitted identification of the direct involvement of the sialic acid, as well as a network 
of interactions. 
Conversely, the results for the MAL–MAH mixture have permitted definition of 
the role of the α2,6-linked sialic acid residue in blocking binding of the corresponding 
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sialylated-N-glycan. The binding to the LacNAc terminus of the non-sialylated-N- 
glycan is detectable, providing the control reference for positive binding. 
In conclusion, the wide variety found both within the glycome and lectin 
architectures is a challenge for analyzing carbohydrate–lectin interactions. Advances in 
the macroscopic analysis of oligosaccharide binding using array-based and other 
technologies1b can strategically be complemented by the given approach, to rigorously 
define the contact sites also of complex glycans. Thus, the combination of N-glycan 
preparation, STD NMR spectroscopy, and modeling protocols gives new insights and 
proves its potency to detect and characterize epitope selection and interaction. They are 
of particular relevance for lectins used for biomedical applications. 
 
3.5 Materials and Methods 
 
Methods 
NMR experiments  
The 1H NMR resonances of the ligands were completely assigned through 
standard TOCSY (60 ms mixing time), NOESY (300 and 500 ms mixing time), and 
HSQC experiments on 800 MHz (cryo) and 600 MHz spectrometers. Typical 
concentrations were 1 mM for the homonuclear experiments and 2 mM for the 
heteronuclear experiments. 
The samples for saturation-transfer difference (STD) experiments as adapted to 
the individual lectins23 were prepared in phosphate-buffered saline (pH = 5.7 for MAA 
and WGA, and pH = 7.3 for Viscumin) using ligand/lectin ratios varying from 1:20 to 
1:100. The applied temperatures varied between 283 and 303 K. Molar ratio and 
temperature were optimized in each case. Representative experiments with significant 
STD responses are presented in the figures. 
Data from one-dimensional (1D) STD experiments were acquired at 600 and 500 
MHz using a Gaussian pulse (49 ms) cascade separated by 1 ms delays. STD-TOCSY 
experiments were acquired at 500 MHz, using 256 increments and a isotropic mixing 
time of 60 ms. In all cases, the on-resonance frequency was set at the aromatic or 
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aliphatic regions (6.9 or 0.5 ppm, respectively), and a series of experiments were 
recorded, where the saturation time was varied between 200 ms and 2 s. The off-
resonance frequency was always set at 100 ppm. Under these conditions, the free ligand 
in solution showed residual STD intensities in the 1D STD spectra that were taken into 
account when analyzing the STD spectra. 
Molecular Modeling  
The templates for the modeling procedures were built based on X-ray structures 
of WGA complexed with small oligosaccharides (pdb codes: 2UVO and 2CWG), 
1DBN for the M. amurensis isolectin and 1PUU for viscumin. The structure of the N-
glycan was superimposed in the binding site working with the most populated 
conformation found for the free state (according to a standard NOE/molecular modeling 
approach). The complex structure was then submitted to a short molecular dynamics 
(MD) run, followed by energy minimization with a low gradient convergence threshold 
(0.02) in 5000 steps. In all cases, the OPL2005 force field24 was employed, as integrated 
in the Schroedinger MAESTRO suite of programms25.  
Lectins  
WGA and MAA were purchased from Sigma–Aldrich, VAA was obtained and 
controlled for purity as described26, and WGA-B domain was also obtained as 
previously described14.  
Ligands  
The 6’-SialylLacNAc was purchased from Sigma–Aldrich. The core 
trisaccharide13, Non- and Sialylated-N-Glycan were obtained as previously described27. 
The Glycopeptide was prepared from its corresponding sialylated undecasaccharide–
glycopeptide, obtained from egg yolk in analogy to published procedures28. This 
undecasaccharide–glycopeptide (5.7 mg, 2 μmol) was dissolved in 400 μL of phosphate 
buffer (75 mM; pH 6), and a solution of 0.2 mg (0.6 U) of neuraminidase from 
Clostridium perfringens (Sigma–Aldrich, EC: 3.2.1.18) in 50 μL of phosphate buffer 
(75 mm, pH 6) was added. The mixture was incubated at ambient temperature for 3 
days (TLC: 2-propanol/1 M ammonium acetate 1.5:1) and cleared by centrifugation, 
and the supernatant was purified by gel filtration (Superdex 30 (1.6 cm × 60 cm); flow 
rate, 1 mL/min; eluent, 0.1 m NH4HCO3; detection, 214 nm). The fractions eluting at 77 
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min were collected, lyophilized, and desalted by gel filtration (Sephadex G25 (2.5 cm × 
70 cm); flow rate, 1 mL/min; eluent, 5% ethanol in water; detection 214 nm). The 
fractions eluting at 201 min were lyophilized and yielded 4.05 mg of Non-Sialylated-N-
Glycan glycopeptide (98.2%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
121 
 
3.6 References 
 
1. (a) Haltiwanger, R. S.; Lowe, J. B., Role of glycosylation in development. Annu 
Rev Biochem 2004, 73, 491-537; (b) Gabius, H., The sugar Code: Fundamentals of 
Glycosciences. Wiley-VCH 2009, 28. 
2. Cummings, R. D., The repertoire of glycan determinants in the human glycome. 
Mol Biosyst 2009, 5 (10), 1087-104. 
3. (a) Kiessling, L. L.; Splain, R. A., Chemical approaches to glycobiology. Annu 
Rev Biochem 2010, 79, 619-53; (b) Gabius, H. J.; Andre, S.; Jimenez-Barbero, J.; 
Romero, A.; Solis, D., From lectin structure to functional glycomics: principles of the 
sugar code. Trends Biochem Sci 2011, 36 (6), 298-313. 
4. (a) Arnold, J. N.; Saldova, R.; Hamid, U. M.; Rudd, P. M., Evaluation of the 
serum N-linked glycome for the diagnosis of cancer and chronic inflammation. 
Proteomics 2008, 8 (16), 3284-93; (b) Drake, P. M.; Cho, W.; Li, B.; Prakobphol, A.; 
Johansen, E.; Anderson, N. L.; Regnier, F. E.; Gibson, B. W.; Fisher, S. J., Sweetening 
the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 2010, 56 
(2), 223-36; (c) Reis, C. A.; Osorio, H.; Silva, L.; Gomes, C.; David, L., Alterations in 
glycosylation as biomarkers for cancer detection. J Clin Pathol 2010, 63 (4), 322-9; (d) 
Gabius, H. J., Glycobiomarkers by glycoproteomics and glycan profiling (glycomics): 
emergence of functionality. Biochem Soc Trans 2011, 39 (1), 399-405; (e) Amano, M.; 
Eriksson, H.; Manning, J. C.; Detjen, K. M.; Andre, S.; Nishimura, S.; Lehtio, J.; 
Gabius, H. J., Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-
glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis 
in tandem in a pancreatic carcinoma model. FEBS J 2012, 279 (21), 4062-80. 
5. (a) Etxebarria, J.; Calvo, J.; Martin-Lomas, M.; Reichardt, N. C., Lectin-array 
blotting: profiling protein glycosylation in complex mixtures. ACS Chem Biol 2012, 7 
(10), 1729-37; (b) Song, X.; Yu, H.; Chen, X.; Lasanajak, Y.; Tappert, M. M.; Air, G. 
M.; Tiwari, V. K.; Cao, H.; Chokhawala, H. A.; Zheng, H.; Cummings, R. D.; Smith, D. 
F., A sialylated glycan microarray reveals novel interactions of modified sialic acids 
with proteins and viruses. J Biol Chem 2011, 286 (36), 31610-22; (c) Padler-Karavani, 
V.; Song, X.; Yu, H.; Hurtado-Ziola, N.; Huang, S.; Muthana, S.; Chokhawala, H. A.; 
Cheng, J.; Verhagen, A.; Langereis, M. A.; Kleene, R.; Schachner, M.; de Groot, R. J.; 
Lasanajak, Y.; Matsuda, H.; Schwab, R.; Chen, X.; Smith, D. F.; Cummings, R. D.; 
Varki, A., Cross-comparison of protein recognition of sialic acid diversity on two novel 
sialoglycan microarrays. J Biol Chem 2012, 287 (27), 22593-608; (d) Blixt, O.; Head, 
S.; Mondala, T.; Scanlan, C.; Huflejt, M. E.; Alvarez, R.; Bryan, M. C.; Fazio, F.; 
Calarese, D.; Stevens, J.; Razi, N.; Stevens, D. J.; Skehel, J. J.; van Die, I.; Burton, D. 
R.; Wilson, I. A.; Cummings, R.; Bovin, N.; Wong, C. H.; Paulson, J. C., Printed 
covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl 
Acad Sci U S A 2004, 101 (49), 17033-8; (e) Song, X.; Xia, B.; Stowell, S. R.; 
Lasanajak, Y.; Smith, D. F.; Cummings, R. D., Novel fluorescent glycan microarray 
strategy reveals ligands for galectins. Chem Biol 2009, 16 (1), 36-47. 
6. (a) Andre, S.; Kozar, T.; Kojima, S.; Unverzagt, C.; Gabius, H. J., From 
structural to functional glycomics: core substitutions as molecular switches for shape 
and lectin affinity of N-glycans. Biol Chem 2009, 390 (7), 557-65; (b) Andre, S.; Kozar, 
T.; Schuberth, R.; Unverzagt, C.; Kojima, S.; Gabius, H. J., Substitutions in the N-
Chapter 3 
122 
 
glycan core as regulators of biorecognition: the case of core-fucose and bisecting 
GlcNAc moieties. Biochemistry 2007, 46 (23), 6984-95. 
7. Schauer, R., Sialic acids as regulators of molecular and cellular interactions. 
Curr Opin Struct Biol 2009, 19 (5), 507-14. 
8. Goldstein, I. J.; Poretz, R. D., The Lectins: Properties, Functions and 
Applications in Biology and Medicine. Academic Press: San Diego, CA 1986, 33-247. 
9. Jimenez-Barbero, J.; Javier Canada, F.; Asensio, J. L.; Aboitiz, N.; Vidal, P.; 
Canales, A.; Groves, P.; Gabius, H. J.; Siebert, H. C., Hevein domains: an attractive 
model to study carbohydrate-protein interactions at atomic resolution. Adv Carbohydr 
Chem Biochem 2006, 60, 303-54. 
10. (a) Asensio, J. L.; Canada, F. J.; Bruix, M.; Rodriguez-Romero, A.; Jimenez-
Barbero, J., The interaction of hevein with N-acetylglucosamine-containing 
oligosaccharides. Solution structure of hevein complexed to chitobiose. Eur J Biochem 
1995, 230 (2), 621-33; (b) Asensio, J. L.; Canada, F. J.; Siebert, H. C.; Laynez, J.; 
Poveda, A.; Nieto, P. M.; Soedjanaamadja, U. M.; Gabius, H. J.; Jimenez-Barbero, J., 
Structural basis for chitin recognition by defense proteins: GlcNAc residues are bound 
in a multivalent fashion by extended binding sites in hevein domains. Chem Biol 2000, 
7 (7), 529-43. 
11. (a) Andre, S.; Unverzagt, C.; Kojima, S.; Dong, X.; Fink, C.; Kayser, K.; 
Gabius, H. J., Neoglycoproteins with the synthetic complex biantennary nonasaccharide 
or its alpha 2,3/alpha 2,6-sialylated derivatives: their preparation, assessment of their 
ligand properties for purified lectins, for tumor cells in vitro, and in tissue sections, and 
their biodistribution in tumor-bearing mice. Bioconjug Chem 1997, 8 (6), 845-55; (b) 
Galanina, O. E.; Kaltner, H.; Khraltsova, L. S.; Bovin, N. V.; Gabius, H. J., Further 
refinement of the description of the ligand-binding characteristics for the galactoside-
binding mistletoe lectin, a plant agglutinin with immunomodulatory potency. J Mol 
Recognit 1997, 10 (3), 139-47; (c) Unverzagt, C.; Andre, S.; Seifert, J.; Kojima, S.; 
Fink, C.; Srikrishna, G.; Freeze, H.; Kayser, K.; Gabius, H. J., Structure-activity profiles 
of complex biantennary glycans with core fucosylation and with/without additional 
alpha 2,3/alpha 2,6 sialylation: synthesis of neoglycoproteins and their properties in 
lectin assays, cell binding, and organ uptake. J Med Chem 2002, 45 (2), 478-91. 
12. (a) Geisler, C.; Jarvis, D. L., Effective glycoanalysis with Maackia amurensis 
lectins requires a clear understanding of their binding specificities. Glycobiology 2011, 
21 (8), 988-93; (b) Knibbs, R. N.; Goldstein, I. J.; Ratcliffe, R. M.; Shibuya, N., 
Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin 
from Maackia amurensis. Comparison with other sialic acid-specific lectins. J Biol 
Chem 1991, 266 (1), 83-8; (c) Kawaguchi, T.; Matsumoto, I.; Osawa, T., Studies on 
hemagglutinins from Maackia amurensis seeds. J Biol Chem 1974, 249 (9), 2786-92. 
13. Hernandez-Gay, J. J.; Arda, A.; Eller, S.; Mezzato, S.; Leeflang, B. R.; 
Unverzagt, C.; Canada, F. J.; Jimenez-Barbero, J., Insights into the dynamics and 
molecular recognition features of glycopeptides by protein receptors: the 3D solution 
structure of hevein bound to the trisaccharide core of N-glycoproteins. Chemistry 2010, 
16 (35), 10715-26. 
14. Espinosa, J. F.; Asensio, J. L.; Garcia, J. L.; Laynez, J.; Bruix, M.; Wright, C.; 
Siebert, H. C.; Gabius, H. J.; Canada, F. J.; Jimenez-Barbero, J., NMR investigations of 
protein-carbohydrate interactions binding studies and refined three-dimensional solution 
structure of the complex between the B domain of wheat germ agglutinin and N,N', N"-
triacetylchitotriose. Eur J Biochem 2000, 267 (13), 3965-78. 
15. (a) Wright, C. S., Structural comparison of the two distinct sugar binding sites in 
wheat germ agglutinin isolectin II. J Mol Biol 1984, 178 (1), 91-104; (b) Wright, C. S., 
Chapter 3 
123 
 
2.2 A resolution structure analysis of two refined N-acetylneuraminyl-lactose--wheat 
germ agglutinin isolectin complexes. J Mol Biol 1990, 215 (4), 635-51; (c) Wright, C. 
S., Crystal structure of a wheat germ agglutinin/glycophorin-sialoglycopeptide receptor 
complex. Structural basis for cooperative lectin-cell binding. J Biol Chem 1992, 267 
(20), 14345-52; (d) Wright, C. S.; Jaeger, J., Crystallographic refinement and structure 
analysis of the complex of wheat germ agglutinin with a bivalent sialoglycopeptide 
from glycophorin A. J Mol Biol 1993, 232 (2), 620-38. 
16. (a) Kronis, K. A.; Carver, J. P., Specificity of isolectins of wheat germ 
agglutinin for sialyloligosaccharides: a 360-MHz proton nuclear magnetic resonance 
binding study. Biochemistry 1982, 21 (13), 3050-7; (b) Kronis, K. A.; Carver, J. P., 
Wheat germ agglutinin dimers bind sialyloligosaccharides at four sites in solution: 
proton nuclear magnetic resonance temperature studies at 360 MHz. Biochemistry 1985, 
24 (4), 826-33; (c) Wang, W. C.; Cummings, R. D., The immobilized leukoagglutinin 
from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-
linked oligosaccharides containing terminal sialic acid-linked alpha-2,3 to penultimate 
galactose residues. J Biol Chem 1988, 263 (10), 4576-85. 
17. Jimenez, M.; Andre, S.; Siebert, H. C.; Gabius, H. J.; Solis, D., AB-type lectin 
(toxin/agglutinin) from mistletoe: differences in affinity of the two galactoside-binding 
Trp/Tyr-sites and regulation of their functionality by monomer/dimer equilibrium. 
Glycobiology 2006, 16 (10), 926-37. 
18. (a) Jimenez, M.; Andre, S.; Barillari, C.; Romero, A.; Rognan, D.; Gabius, H. J.; 
Solis, D., Domain versatility in plant AB-toxins: evidence for a local, pH-dependent 
rearrangement in the 2gamma lectin site of the mistletoe lectin by applying ligand 
derivatives and modelling. FEBS Lett 2008, 582 (15), 2309-12; (b) Mikeska, R.; 
Wacker, R.; Arni, R.; Singh, T. P.; Mikhailov, A.; Gabdoulkhakov, A.; Voelter, W.; 
Betzel, C., Mistletoe lectin I in complex with galactose and lactose reveals distinct 
sugar-binding properties. Acta Crystallogr Sect F Struct Biol Cryst Commun 2005, 61 
(Pt 1), 17-25. 
19. Muthing, J.; Meisen, I.; Bulau, P.; Langer, M.; Witthohn, K.; Lentzen, H.; 
Neumann, U.; Peter-Katalinic, J., Mistletoe lectin I is a sialic acid-specific lectin with 
strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal 
beta 1-4GlcNAc residues. Biochemistry 2004, 43 (11), 2996-3007. 
20. Konami, Y.; Yamamoto, K.; Osawa, T.; Irimura, T., Strong affinity of Maackia 
amurensis hemagglutinin (MAH) for sialic acid-containing Ser/Thr-linked carbohydrate 
chains of N-terminal octapeptides from human glycophorin A. FEBS Lett 1994, 342 (3), 
334-8. 
21. Imberty, A.; Gautier, C.; Lescar, J.; Perez, S.; Wyns, L.; Loris, R., An unusual 
carbohydrate binding site revealed by the structures of two Maackia amurensis lectins 
complexed with sialic acid-containing oligosaccharides. J Biol Chem 2000, 275 (23), 
17541-8. 
22. (a) Andre, S.; Sanchez-Ruderisch, H.; Nakagawa, H.; Buchholz, M.; Kopitz, J.; 
Forberich, P.; Kemmner, W.; Bock, C.; Deguchi, K.; Detjen, K. M.; Wiedenmann, B.; 
von Knebel Doeberitz, M.; Gress, T. M.; Nishimura, S.; Rosewicz, S.; Gabius, H. J., 
Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression 
to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic 
carcinoma cells. FEBS J 2007, 274 (13), 3233-56; (b) Patsos, G.; Andre, S.; Roeckel, 
N.; Gromes, R.; Gebert, J.; Kopitz, J.; Gabius, H. J., Compensation of loss of protein 
function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent 
effect on the cell surface glycan profile. Glycobiology 2009, 19 (7), 726-34; (c) Van de 
Wouwer, M.; Andre, S.; Gabius, H. J.; Villalobo, A., Nitric oxide changes distinct 
Chapter 3 
124 
 
aspects of the glycophenotype of human neuroblastoma NB69 cells. Nitric Oxide 2011, 
24 (2), 91-101; (d) Varki, A.; Gagneux, P., Multifarious roles of sialic acids in 
immunity. Ann N Y Acad Sci 2012, 1253, 16-36. 
23. (a) Martin-Santamaria, S.; Andre, S.; Buzamet, E.; Caraballo, R.; Fernandez-
Cureses, G.; Morando, M.; Ribeiro, J. P.; Ramirez-Gualito, K.; de Pascual-Teresa, B.; 
Canada, F. J.; Menendez, M.; Ramstrom, O.; Jimenez-Barbero, J.; Solis, D.; Gabius, H. 
J., Symmetric dithiodigalactoside: strategic combination of binding studies and 
detection of selectivity between a plant toxin and human lectins. Org Biomol Chem 
2011, 9 (15), 5445-55; (b) Mayer, M.; Meyer, B., Characterization of Ligand Binding 
by Saturation Transfer Difference NMR Spectroscopy. Angew Chem Int Ed Engl 1999, 
38 (12), 1784-1788; (c) Jimenez-Barbero, J.; Dragoni, E.; Venturi, C.; Nannucci, F.; 
Arda, A.; Fontanella, M.; Andre, S.; Canada, F. J.; Gabius, H. J.; Nativi, C., Alpha-O-
linked glycopeptide mimetics: synthesis, conformation analysis, and interactions with 
viscumin, a galactoside-binding model lectin. Chemistry 2009, 15 (40), 10423-31. 
24. Kaminski, G.; Friesner, R. A.; Tirado-Rives, J.; Jorgensen, W. L., Evaluation 
and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with 
Accurate Quantum Chemical Calculations on Peptides. J. Phys. Chem. B 2001, 105, 
6474-6487. 
25. Maestro, A Powerful, All-Purpose Molecular Modeling Environment, Version 
8.5. Schroedinger, LLC 2008, New York. 
26. Gabius, H. J.; Darro, F.; Remmelink, M.; Andre, S.; Kopitz, J.; Danguy, A.; 
Gabius, S.; Salmon, I.; Kiss, R., Evidence for stimulation of tumor proliferation in cell 
lines and histotypic cultures by clinically relevant low doses of the galactoside-binding 
mistletoe lectin, a component of proprietary extracts. Cancer Invest 2001, 19 (2), 114-6. 
27. Kajihara, Y.; Suzuki, Y.; Yamamoto, N.; Sasaki, K.; Sakakibara, T.; Juneja, L. 
R., Prompt chemoenzymatic synthesis of diverse complex-type oligosaccharides and its 
application to the solid-phase synthesis of a glycopeptide with Asn-linked sialyl-
undeca- and asialo-nonasaccharides. Chemistry 2004, 10 (4), 971-85. 
28. Seko, A.; Koketsu, M.; Nishizono, M.; Enoki, Y.; Ibrahim, H. R.; Juneja, L. R.; 
Kim, M.; Yamamoto, T., Occurence of a sialylglycopeptide and free sialylglycans in 
hen's egg yolk. Biochim Biophys Acta 1997, 1335 (1-2), 23-32. 
 
 
Chapter 4 
125 
 
 
 
 
 
 
 
 
 
Chapter 4. The recognition of galacto-
oligosaccharides by specific scFv 
antibody fragments by using STD-NMR 
spectroscopy  
 
 
 
 
 
 
 
 
 
 
 
aaaaaa 
Chapter 4 
126 
 
  
    aaaaaa 
    aaaaaa 
    aaaaaa 
Chapter 4 
127 
 
4.1 Introduction 
The immunological importance of the non-human galactosyl-α-(1→3)-galactose 
(Gal-α-(1→3)-Gal) disaccharide epitope was initially highlighted by its direct 
involvement in the hyperacute rejection (HAR) of porcine organ xenografts1. 
Xenotransplantation has been widely considered as a direct means of overcoming the 
critical shortage of human donor organs. Porcine organs, in particular, were first 
considered as the most suitable replacements2. However, porcine tissue expresses a high 
proportion of the Gal-α-(1→3)-Gal epitope and elicits a vigorous anti-Gal-α-(1→3)-Gal 
antibody response, following transplantation of porcine xenografts into humans3. 
The Galα1→3Gal disaccharide is found at the non reducing terminus of protein- 
and lipid-bound glycans, and the α-linked galactose is a non-charged alternative to sialic 
acid as a chain terminator (Fig. 4.1). Galα(1→3)Gal structures have been detected in a 
varietyof mammalian species. Only cells and tissues derived from humans, apes and 
Old World monkeys do not express the α-gal glycotope4, due to the inactivation of the 
α1→3-Galactosyltransferase (α1→3-GT) biosynthesis route5.Therefore, in these 
organisms the sialylated version is the only one that exists, whereas in the rest of 
species, the galactosylated form still takes place (See Fig 4.1a and 4.1b). 
 
Figure 4.1 View of the terminal structures of glycoprotein and glycolipidglycans1. (a) A diantennary N-
glycan terminated by sialic acid and α1,3-linked galactose. (b) The ceramide-pentahexoside.  
However, the α-gal glycotope is found in tissue cultures both on mammalian 
tissues and cells. In fact, in the mouse, G. simplicifolia I-B4 (GSI-B4) lectin staining 
has been employed to detect the Galα(1→3)Gal structure in a variety of organs and cell 
types, with the exception of liver6. Specially, high-level expression is found on the 
endothelial cells of all capillaries, arterioles and arteries, the first point of contact 
between antibodies and donor organ. 
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Cairns et al.7and Vaughan et al.8 have detected both Galα(1→3)Gal containing 
glycoproteins and glycosphingolipids on pig vascular endothelium. The detailed 
structural analyses of the xeno-epitope was carried out by Samuelsson etal9, who 
showed that the major α(1→3)-galactosylated glycosphingolipid in the porcine 
endothelium is the ceramide pentasaccharide [Galα(1→3)Galβ(1→4)GlcNAcβ(1→3)-
Galβ(1→4)Glc-ceramide, Fig. 4.1b). The protein-linked glycans contains the 
Galα(1→3)Galβ1→4GlcNAc trisaccharide at their non-reducing terminus (Fig. 4.1).  
 Other relevant studies, on the characterization of anti-Gal antibodies using thin 
layer chromatography (TLC) demonstrated that anti-Gal recognizes glycosphingolipids 
with non-reducing terminal Galα1→3Galβ1→4GlcNAc-R structures isolated from 
rabbit red blood cells, whereas it does not bind to a range of closely related 
glycosphingolipids (as glycosphingolipids with the Galα1→4Galβ1→4GlcNAc-R 
structures). This fact establishes that anti-Gal is able to distinguish between structures 
that have the same carbohydrate sequence and anomeric configuration, but which differ 
in the linkage positions of the terminal Gal residues10. 
Undesirable immune responses to this Galα1→3Galβ1→4GlcNAc-R epitope are 
also thought to be involved in the suboptimal clinical outcomes after implantation of 
acellular tissue matrices11. Naturally occurring human antibodies directed against the 
Gal-α-(1→3)-Gal epitope are widespread in humans10, comprising up to 3% of 
immunoglobulin (Ig) in human sera (mainly the IgG2 subclass)3b, c. Furthermore, the 
possibility of exploiting the Gal-α-(1,3)-Gal epitope/natural human antibody recognition 
system to improve the efficacy of autologous vaccines is recently gaining increased 
attention 12. 
 
4.2 Objectives  
Herein we describe the analysis of the recognition features of selected ligands by 
specific scFv G12, A4 and A11 antibody fragments. STD NMR methods have been 
employed to access residue-specific binding information. The STD analysis were 
applied to monitor the interactions ofα-3-O-Galactobiose (or Glycotope), the linear-B-
trisaccharide, 3α-4β-D-Galactotriose and 3α-4β-3α-D-Galactotetraose with the above 
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mentioned specific antibodies to study the different involvement of each residue in the 
molecular recognition process.  
 
4.3  The bound state; STD experiments 
 
4.3.1 The recognition of α-3-O-Galactobiose (Glycotope) 
 
STD-NMR experiments were performed to obtain structural information about 
the epitope of the α-3-O-Galactobiose recognized by the scFv G12, A4 and A11 specific 
antibody fragments. As shown in Figure 4.2, the STD experiments demonstrated the 
interaction of scFv G12 with the ligand. Interestingly, STD signals for Gal A’ protons 
(See 1A’, 2A’, 3A’ and 4A’ proton signals in Fig. 4.2a) were clearly more intense than 
those for residues A or B in the presence of scFv G12 (See 4A and 5A proton signals in 
Figure 4.2a). The deduced average STD values per residue indicated that Gal A’ was 
closer to the binding site.  
 
Figure 4.2 The interaction of α-3-O-Galactobiose with the scFv G12 antibody as deduced from the STD 
experiments for a 90:1 molar ratio. (a) Reference (top) and STD spectra (bottom) with the relevant proton 
signals highlighted. (b) Schematic view of the 3D structure of α-3-O-Galactobiose with the measured 
values of the relative STD intensities detected for each proton. 
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In the presence of scFv A4, again the STD signals of H1-H4 protons of GalA’ 
(Fig. 4.3a) were significantly stronger than those of the other residues. Thus, the 
analysis of the STD intensities permitted to suggest that the A’ residue is the major 
epitope for scFv A4.  
In the presence of scFv A11, the measured STDs were significantly weaker, 
strongly suggesting the presence of a weaker interaction. Nevertheless, the inspection of 
the STD values demonstrated again the preferred involvement of GalA’ residue in the 
binding event (See Figure 4.4b).   
 
 
Figure 4.3 The interaction of α-3-O-Galactobiose with the scFv A4 antibody, as deduced from the STD 
experiments for a 90:1molar ratio. (a) Reference (top) and STD spectra (bottom), with the relevant proton 
signals highlighted. (b) Schematic view of the 3D structure of α-3-O-Galactobiose with the values of the 
relative STD intensities detected for each proton. 
 
 
67%
51%
84%
100%
56%
A’
B
αD Galp‐(1‐3)‐αD Galp
αD Galp‐(1‐3)‐βD Galp
A
80%80%
74‐50%
100‐75%
<50%
Reference
STD
X0.7
1B
1A
1A’
4A’
4A
5A
5A’
4B
2A
2A’
3A’
3A
6A’
6A
6B
3B
5B
67%
80%
84%
100%
80%
67%
51%
84%
100%
60%
60% 60%
a.
b.
Chapter 4 
131 
 
 
 
 
Figure 4.4 The interaction of α-3-O-Galactobiose with scFv A11 antibody, as deduced from the STD 
experiments for a 90:1molar ratio. (a) Reference (top) and STD spectra (bottom), with the relevant proton 
signals highlighted. (b) Schematic view of the 3D structure of α-3-O-Galactobiose with the values of the 
relative STD intensities detected for each proton. 
 
Therefore, the superimposition of the STD spectra of the α-3-O-Galactobiose 
ligand in the presence of either scFv A11, A4 and G12 antibody fragments showed the 
existence of a similar STD effect pattern, thus indicating that the ligand epitope 
recognized by the three specific antibodies is fairly analogous (See protons in red, 
Figure 4.5).   
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Figure 4.5 Superimposition of the STD spectra obtained for α-3-O-Galactobiose in the presence of both 
scFv A11 (green), scFv A4 (red) and scFv G12 (blue). The proton signals with the strongest STD effects 
are shown in red. The reference spectrum is shown in violet.  
4.3.2 The relevance of different substitutions: GlcNAc-, Gal- and α-3-O-
Galactobiose-containing decorations at the galactobiose scaffold 
 
As a second step, we paid attention to the relevance and the implication of 
different substitutions at the Galα(1-3)Gal disaccharide scaffold (or glycotope) for the 
recognition by specific scFv antibody fragments. Thus, STD experiments were then 
performed with elongated trisaccharides (with a β(1-4)GlcNAc moiety, a B-
trisaccharide moiety, and a β(1-4)Gal substitution at the reducing-end, respectively). 
The corresponding tetrasaccharide (3α-4β-3α-D-Galactoteraose), containing twice the 
glycotope motif, was also studied. 
In fact, the STD analysis of the B-trisaccharide in the presence of G12, A4 and 
A11 clearly revealed the existence of binding. Inspection of Figures 4.6, 4.7 and 4.8 
permitted to assess that the strongest STD effect arose from the Gal A’ protons (see 
H2A’, H3A’ and H4A’ protons in Fig. 4.6-4.8) in the presence of the three scFv 
antibody fragments. The STD effect decreased for the Gal B’ and especially for the 
GlcNAcA residues (see the STD relative intensities for 4B’, 4B and NHAcA/B proton 
signals in Figs 4.6-4.8). Consequently, these residues are less implicated in the binding 
event, with the GlcNAc moiety point probably towards the solvent. 
Reference
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Figure 4.6 The interaction of the B-trisaccharide with the scFv G12 antibody, as deduced from STD 
experiments for a 90:1 molar ratio. (a) Reference (top) and STD spectra (bottom) with relevant proton 
signals highlighted. (b) Schematic view of the 3D structure of the B-trisaccharide with the values of the 
relative STD intensities detected for each proton. 
 
Figure 4.7 The interaction of the B-trisaccharide with scFv A4 antibody, as deduced from STD 
experiments for a 90:1 molar ratio. (a) Reference (top) and STD spectra (bottom) with relevant proton 
signals highlighted. (b) Schematic view of the 3D structure of the B-trisaccharide with the values of the 
relative STD intensities detected for each proton. 
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Figure 4.8 The interaction of B-trisaccharide with scFv A11 antibody, as deduced from STD experiments 
for a 90:1 molar ratio.(a) Reference (top) and STD spectra (bottom) with relevant proton signals 
highlighted. (b) Schematic view of the 3D structure of the B-trisaccharide with the values of the relative 
STD intensities detected for each proton. 
 
As described above for the glycotope, the superimposition of the STD spectra of 
the B-trisaccharide ligand in the presence of either scFv A11, A4 and G12 antibody 
fragments showed the existence of a similar STD effect pattern, thus indicating that the 
ligand epitope recognized by the three specific antibodies is fairly similar (See protons 
in red, Figure 4.9). 
STD-NMR experiments were also performed to obtain further information about 
the presence of a second βGal residue at the reducing end (3α-4β-D-Galactotriose). The 
STD –based analysis definitely demonstrated its recognition by the three scFv G12, A4 
and A11 specific antibody fragments. The detailed STD intensity analysis of the signals 
showed once again the importance of residue Gal A’ for binding (see the A’ proton 
signals in Figs 4.10-4.12 and 4.14).  
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Figure 4.9 Superimposition of the STD spectra obtained for the B-trisaccharide in the presence of either 
scFv A11 (green), scFv A4 (red) and scFv G12 (blue).The proton signals with strongest STD effects are 
shown in red. The reference spectrum is shown in violet.  
 
Figure 4.10 The interaction of 3α-4β-D-Galactotriose with scFv G12 antibody, as deduced from STD 
experiments for a 90:1 molar ratio. (a) Reference (top) and STD spectra (bottom) with relevant proton 
signals highlighted. (b) Schematic view of the 3D structure of 3α-4β-D-Galactotriose with the values of 
the relative STD intensities detected for each proton. 
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Figure 4.11 The interaction of 3α-4β-D-Galactotriose with scFv A4 antibody, as deduced from STD 
experiments for a 90:1 molar ratio. (a) Reference (top) and STD spectra (bottom) with relevant proton 
signals highlighted. (b) Schematic view of the 3D structure of 3α-4β-D-Galactotriose with the values of 
the relative STD intensities detected for each proton. 
 
Figure 4.12 The interaction of 3α-4β-D-Galactotriose with scFv A11 antibody, as deduced from STD 
experiments for a 90:1 molar ratio. (a) Reference (top) and STD spectra (bottom) with relevant proton 
signals highlighted. (b) Schematic view of the 3D structure of 3α-4β-D-Galactotriose with the values of 
the relative STD intensities detected for each proton. 
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To verify the key involvement of this residue for the recognition process, we 
also carried out a similar STD study, but now employing the reducing end disaccharide 
moiety (4β-D-Galactobiose, that is, devoid of the α-D-Gal residue at the non-reducing 
end) in the presence of scFv A11 antibody fragment using the same conditions for the 
experiment. Fittingly (Figure 4.13), no STD effect was observed at all, thus 
demonstrating the essential involvement of the Gal A’ residue in the molecular 
recognition process. 
 
Figure 4.13 STD experiments of 4β-D-Galactobiosein the presence of scFv A11 antibody with a molar 
ratio 90:1. Reference (top) and STD spectra (bottom). No STD effect was observed. 
 
Figure 4.14 Superimposition of the STD spectra obtained for the 3α-4β-D-Galactotriose in the presence 
of either scFv A11 (green), scFv A4 (red) and scFv G12 (blue). The proton signals with strongest STD 
effects are shown in red. The reference spectrum is shown in violet.  
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Finally, a model tetrasaccharide was also employed with two α-3-O-
Galactobiose units joined by a β(1-4) linkage (3α-4β-3α-D-Galactotetraose).Now, it 
was clearly demonstrated that the non-terminal galactose A’’ moiety is that displaying 
the strongest STD effects in the presence of all antibody fragments (Figures 4.15-4.18). 
Interestingly, the inner Gal A’ residue protons also showed relatively high STD 
intensities, suggesting the existence of an extended binding site for this type of linkage 
or the presence of two distinct binding modes in which either Gal A” or Gal A’ are 
interacting with the antibodies.  
 
 
 
Figure 4.15 The interaction of 3α-4β-3α-D-Galactotetraose with the scFv G12 antibody, as deduced from 
STD experiments for a 90:1 molar ratio. (a) Reference (top) and STD spectra (bottom) with relevant 
proton signals highlighted. (b) Schematic view of the 3D structure of 3α-4β-3α-D-Galactotetraose with 
the values of the relative STD intensities detected for each proton. 
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Figure 4.16 The interaction of 3α-4β-3α-D-Galactotetraose with the scFv A4 antibody, as deduced from 
STD experiments for a 90:1 molar ratio. (a) Reference (top) and STD spectra (bottom) with relevant 
proton signals highlighted. (b) Schematic view of the 3D structure of 3α-4β-3α-D-Galactotetraose with 
the values of the relative STD intensities detected for each proton. 
 
Figure 4.17 The interaction of 3α-4β-3α-D-Galactotetraose with the scFv A11 antibody, as deduced from 
STD experiments for a 90:1 molar ratio. (a) Reference (top) and STD spectra (bottom) with relevant 
proton signals highlighted. (b) Schematic view of the 3D structure of 3α-4β-3α-D-Galactotetraose with 
the values of the relative STD intensities detected for each proton. 
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Figure 4.18 Superimposition of the STD spectra obtained for the 3α-4β-3α-D-Galactotetraose in the 
presence of eithers cFv A11 (green), scFv A4 (red) and scFv G12 (blue). The proton signals with 
strongest STD effects are shown in red. The reference spectrum is shown in violet.  
 
4.4 Conclusions 
Four oligosaccharides related to the glycotope antigen have been shown to 
interact with different scFv glycotope-binding antibody fragments. Using STD 
experiments, we have shown that the presence of 3-O-α-DGalactose A’ moiety is a 
decisive feature for the binding process to take place. In contrast, the other residues at 
the “reducing end” merely display transient interactions with the carbohydrate binding 
site. 
 
4.5 Materials and Methods 
 
Methods 
Sample preparation and NMR studies 
The NMR study of 3α-D-Galactobiose (Carbosynth Product Code: OG06491), 4β-D-
Galactobiose (Carbosynth Product Code: OG15071), 3α-4β-D-Galactotriose (Carbosynth 
Product Code: OG00715), Linear-B-trisaccharide (Carbosynth Product Code: OL06495), and 
3α-4β-3α-D-Galactotetraose (Carbosynth Product Code: OG05062) oligosaccharides in the free 
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state was performed using 1mM samples in D2O. Standard 2D-methods, such as TOCSY (with 
mixing times of 30 and 80ms), ROESY (300 ms), NOESY (600 ms), and HSQC experiments 
were employed, using Bruker Avance 500 and 600 MHz (equipped with a triple channel 
cryoprobe) NMR spectrometers. The target scFv antibody fragments G12, A4 and A11 were 
prepared at The National University of Ireland (NUI Galway). Samples were dialyzed with 
phosphate-buffered saline in deuterated water (PBS, pH= 7.3, uncorrected) for the ligand 
binding experiments. 
Saturation transfer difference (STD)13 experiments were performed on both 500 MHz 
and 600 MHz NMR spectrometers, at 298K or 310K. The experiments were performed using 
samples with a scFv antibody fragment/ligand molar ratio of 1/90. The employed concentrations 
were 25uM/2.25mM for experiments with scFv G12, A4 and A11 antibody fragments. Different 
experiments (8000 scans each) were performed in which the saturation time of the protein was 
2s. Selective “on-resonance” irradiation of antibody resonances was performed at δ0.8ppm, 
while the “off-resonance” frequency was always set at 100ppm. STD experiments on free 
ligands at 1mM in D2O were also acquired in order to obtain “blank” experiments. 
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Chapter 5. Molecular Recognition of 
functionalized glycodendrimers by plant 
lectins: Lectin from Viscum album 
(Viscumin) 
 
 
 
 
 
 
 
 
 
 
 
 
1 
Chapter 5 
146 
 
  
1 
1 
Chapter 5 
147 
 
5.1 Introduction 
As a general term, we can say that the “valency” of a particle (namely a small 
molecule, oligosaccharide, protein, nucleic acid, lipid or aggregate of these molecules, a 
virus, bacterium, or cell) is defined as the number of separated structural units of the 
same kind that can interact with other particles through ligand–receptor 
interactions1.Thus, we can consider that a molecule having a large amount of multiple, 
tethered and identical copies of binding components (ligands or epitopes) can be 
classified as a multivalent entity2. These multivalent structures (or dendrimers) can be 
present on a molecular construct (See Figure 5.1) or biological surface that binds in a 
cooperative way to multiple receptors expressed on a complementary entity. 
 
 
Figure 5.1 (A-E) Examples of different dendrimer scaffold constructions decorated with different 
carbohydrate structures (mannose residues in this case)3. 
 
In fact, multivalency in Nature is very often expressed by dendrimeric 
architectures that represent perhaps the most pervasive topologies observed in vegetal 
and animal kingdoms4. The reasons for this are not entirely clear. For example, trees use 
fractal dendrimeric patterns above and beneath the ground in order to enhance the 
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exposure of their leaves to sunlight to harvest light and maximize the photosynthesis 
process, and of their roots to collect water from the soil. The arterial and central nervous 
system networks, together with the kidneys and lung structures also consist of a great 
number of cells growing into dendritic (or dendrimeric) structures in order to gain the 
largest exchange of material or information with the surrounding tissues5. 
Nowadays, chemical or chemoenzymatic synthesis of multivalent carbohydrate 
dendrimers is very relevant because carbohydrate structures play critical roles in 
multiple key cellular events, such as cellular adhesion and recognition, regulation of 
physiological functions, and pathogenic infections2. These carbohydrate-receptor 
interactions are transformed into very potent attractive forces, dramatically and 
naturally reinforced, when multiple ligand copies are presented to similarly clustered 
receptors. This cooperative effect is called “glycocluster or dendritic effect” that may 
offer numerous benefits in terms of affinity and receptor selectivity versus monovalent 
interaction. The presentation of the sugar epitopes as multiple copies on an appropriate 
scaffold (molecular, dendritic, polymeric) creates a multivalent display that can 
efficiently mimic the natural mode of affinity enhancement that arises from multiple 
interactions between the binding proteins and the carbohydrate ligands. The ligand-
binding specificity of these complexes with lectins is determined by glycan 
microarrays6 and validated by a range of binding assays such as ELISA (enzyme-linked 
immunosorbent assay), ITC(isothermal titration calorimetry), SPR (surface plasmon 
resonance), X-ray crystallography, NMR spectroscopy and analogous techniques2. 
Glycodendrimers have a wide variety of known applications. These glyco-
scaffolds are useful tools in drug discovery has made it possible to participate in 
extracellular and intracellular biochemical processes. Their applications in biological 
systems are fully studied; as for example to used them against viral infections7, against 
bacterial and plant toxins8 and bacterium adhesion to human cells8a, 9 (See Figure 5.2), 
and for immune system stimulation and vaccine approach3. 
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Figure 5.2 Example of a multivalent binding event with a bacterium or a bacterial toxin and a 
glycodendrimer. (A) Depiction of a host eukaryotic cell with surface green and purple sugar groups, two 
glycodendrimers with sugar groups in their surface, a bacterial toxin with receptors for the purple sugar 
groups, and a generic bacterium with receptors for the green sugar groups. (B) Representation of the 
binding of the bacterium and the toxin to the glycodendrimer through multivalent interactions to prevent 
infection of the host cell8a. 
 
5.2 Objectives 
The high-resolution features of the recognition process of synthetic lactose- and 
6-sialyllactose glycodendrimers by viscumin, a toxic plant lectin (VAA) have been 
elucidated. The epitope of the ligand has been dissected as well as the possible 
multivalent capability of the different glycodendrimers to interact with more than one 
unit of the lectin. In principle, this fact should increase the binding affinity as well as 
establish the possibility to generate larger networked complexes.   
 
5.3 The bound state 
5.3.1 The recognition of lactose-functionalized glycodendrimers by 
Viscumin; A combined STD-docking approach 
 
STD experiments 
Figure 5.3 shows the STD analysis for ligand DA2 in the presence of VAA, 
together with the assignment of the key signals. Clear STD signals were observed, as 
depicted in the Figure. The strongest STD effect was detected for the sugar protons for 
the Gal residue (with a STD absolute intensity average of approximately 9%; see Figure 
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5.3B), strongly suggesting that this region of the ligand is in closer contact with the 
protein. The protons belonging to the Glc residue displayed less intense STD signals, 
around 4%, as identified in Fig. 5.3B.  
 
Figure 5.3 (A) STD spectra (bottom) and off-resonance or reference spectra (top) of the sample that 
contains DA2 glycodendrimer in the presence of viscumin, with a 50:1 molar ratio. The absolute STD 
percentages are given for the corresponding proton signals. (B) Schematic structure of DA2 along with 
the average values of the absolute STD intensities. 
 
Figure 5.4 shows the STD results for DA3 ligand in the presence of VAA, 
together with the assignment of the key chemical shifts. Clear STD signals were 
observed, and the strongest STD effect arose again from the sugar protons for the Gal 
residue with a STD absolute intensity average of approximately 8% (see Figure 5.4B). 
In fact, the rest of protons from the dendrimer displayed significantly weaker STDs, 
around 3%, as depicted in Fig. 5.4B.  
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Figure 5.4 (A) STD spectra (bottom) and off-resonance or reference spectra (top) of the sample that 
contains DA3 in the presence of viscumin, with a 50:1 molar ratio. The absolute STD percentages are 
given for the corresponding proton signals. (B) Schematic structure of DA3 along with the average values 
of the absolute STD intensities. 
 
Figure 5.5 displays the STD analysis for DA4 ligand, using the same protocol. 
Similar to the observations for DA2 and DA3 glycodendrimers, again the strongest STD 
effect arose from the Gal moiety with STD absolute intensity averages of approximately 
5% (Figure 5.5B). Again, the Glc residue and the aromatic linker protons showed STD, 
although in lesser extent than for the Gal residue (STD absolute intensity average of 
approximately 3 and 4% respectively; see Figure 5.5B).  
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Figure 5.5 (A) STD spectra (bottom) and off-resonance or reference spectra (top) of the sample that 
contains DA4 in the presence of viscumin with a molar ratio50:1. The absolute STD percentages are 
given for the corresponding proton signals. (B) Schematic structure of DA4 along with the average values 
of the absolute STD intensities. 
 
Docking model 
These experimental observations were validated using a three-dimensional 
model of the complex, which was built using the method described in the experimental 
section. The well known VAA binding site (the TYR binding site10) was employed for 
the docking protocol. DA2, DA3 and DA4 ligands basically produced similar results in 
the presence of viscumin. Figure 5.6 displays the aminoacids that are implicated in the 
recognition of the glycodendrimer. Most of the key interactions involve the Gal moiety, 
as deduced from the STD NMR analysis. It should be pointed out the existence of a 
bidentate hydrogen bond between ASP235 with OH3 and OH4 of the Gal residue, as 
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well as a second hydrogen bond between ASN256 and the OH3 of the Gal moiety. 
Additionally, a clear CH-π stacking interaction between TYR249 and the Gal residue 
takes place. Interestingly, GLN238 establishes a hydrogen bond with OH3 of Glc 
residue. 
 
Figure 5.6 Docking model of the region (lactose) of the glycodendrimer DA2 that binds to the viscumin 
TYR binding site. The aminoacids providing better contacts with the ligand (GLN238, ASN256, ASP235, 
TYR249) are highlighted. 
The possibility of simultaneous binding of two, three, or four VAA moieties to 
the ligand was also explored using the docking protocol. The results are given in 
Figures 5.7, 5.8 and 5.9 respectively. The built model suggests the possibility of 
simultaneous binding of two and three VAA units in the case of DA2 and DA3 
glycodendrimers respectively (see Figure 5.7 and 5.8).However, only of a maximum of 
three VAA units can be bound to DA4 ligand. Indeed, four simultaneous units would 
rise to important steric conflicts (See Image B, Figure 5.9), thus precluding the 
existence of larger multivalent complexes. Nevertheless, under the experimental 
conditions employed for the NMR experiments, with excess of ligand over the lectin 
entity, it is evident that the possibility of formation of high-order complexes is highly 
unexpected. Very probably, the NMR data reflect the presence of 1:1 complexes in fast 
dissociation in the relaxation time scale (as required for the presence of STD). 
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Figure 5.7 Docking model of the glycodendrimer DA2bound to two units of viscumin.  
 
Figure 5.8 Docking model of the glycodendrimer DA3 bound to three units of viscumin.  
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Figure 5.9 (A) Docking model of the glycodendrimer DA4 bound to four units of viscumin. (B) Different 
view of the docking model of the glycodendrimer DA4 bound to four units of viscumin.  
 
5.3.2 The recognition of 6’sialyllactose-functionalized glycodendrimers by 
Viscumin; A combined STD-docking approach 
 
STD experiments 
Figure 5.10 shows the STD results in the case of ligand DA3-2,6-Ac in the 
presence of Viscumin (VAA), together with the assignment of the key chemical shifts. 
Clear STD signals were again observed, and the strongest STD effect was detected for 
the sugar protons for Gal residue followed by Glc and sialic acid residues (with a STD 
absolute intensity average of approximately 3%; see Figure 5.10C), strongly suggesting 
that this region of the ligand is in closer contact with the protein. However, also several 
protons from the glucose and sialic acid residues displayed very clear STDs, around 2%, 
as identified in Fig. 5.10C. The aromatic linker also received saturation of the protein, 
less than 2%. 
A
A‐chain
B‐chain
A‐chain
A‐chain
B‐chain
B‐chain
A‐chain
B‐chain
1 2
34
B
A‐chain
B‐chain
A‐chain
A‐chain
B‐chain
B‐chain
A‐chain
B‐chain
1
2
34
90°
Chapter 5 
156 
 
 
 
Figure 5.10 (A) STD spectra (bottom) and off-resonance or reference spectra (top) of the sample that 
contains DA3-2,6-Ac in the presence of viscumin with a molar ratio 100:1. The absolute STD percentages 
are given for the corresponding proton signals. (B) Extension of the proton sugar region with the 
corresponding STD absolute values. (C) Schematic structure of DA3-2,6-Ac along with the average 
values of the absolute STD intensities. 
Figure 5.11 shows the STD results for ligand DA4-2,6-Ac in the presence of 
VAA, together with the assignment of the key signals. Clear STD signals were 
observed, which are also depicted in the Figure. The strongest STD effect was detected 
for the sugar protons for both Glc and Gal residues (with a STD absolute intensity 
average of approximately 5%; see Figure 5.11C), strongly suggesting that this region of 
Reference x 1.8
STD
Reference x 1.8
STD
2%
2%2%
H1Gal H1Glc
2%
H3Sial
H4
Gal
2.5%
H2Glc
H3Glc
H5Sial
2%
H6Sial
2%
H2Gal
3%
2%
H4Glc
3%
H3Gal
H2ax SialH2eq Sial
NHAc Sial
H1Gal H1Glc
2%2%
2%
2%
3%
A
B
C
~2%
<2%
~2%
~2% ~3% ~2%
~2%
~3%
~3%
~2%
DA3‐2‐6‐Ac
Chapter 5 
157 
 
the ligand is in closer contact with the protein. However, also several protons from the 
sialic acid residue displayed very clear STDs, around 3%, as identified in Fig. 5.11C. 
The aromatic linker also received saturation of the protein. 
 
 
Figure 5.11 (A) STD spectra (bottom) and off-resonance or reference spectra (top) of the sample that 
contains DA4-2,6-Ac in the presence of viscumin with a molar ratio 100:1. The absolute STD percentages 
are given for the corresponding proton signals. (B) Extension of the proton sugar region with the 
corresponding STD absolute values. (C) Schematic structure of DA4-2,6-Ac along with the average 
values of the absolute STD intensities. 
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Figure 5.12 displays the STD analysis for ligand DA4-2,6-Gc, using the same 
protocol. Similar to the observations for DA4-2,6-Ac, the strongest STD effect arose 
from the sialyllactose moiety with Glc, Gal and Sial STD absolute intensity averages of 
approximately 3, 3 and 4% respectively (Figure 5.12C). Again, the aromatic linker 
protons showed STD, although in lesser extent than for the DA4-2,6-Ac analogue.  
 
 
Figure 5.12. (A) STD spectra (bottom) and off-resonance or reference spectra (top) of the sample that 
contains DA4-2,6-Gc in the presence of viscumin with a molar ratio 100:1. The absolute STD percentages 
are given for the corresponding proton signals. (B) Extension of the proton sugar region with the 
corresponding STD absolute values. (C) Schematic structure of DA4-2,6-Gc along with the average 
values of the absolute STD intensities. 
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Docking model 
These experimental observations were also validated using a three-dimensional 
model of the complex, which was built using the method described above. The different 
ligands basically produced similar results in the presence of viscumin. Figure 5.13 
displays the aminoacids that are implicated in the recognition of the glycodendrimer. 
Interestingly, SER200 and GLN238 establish hydrogen bonds with OH3 and the 
carboxylic acid of the sialic acid residue, respectively. It should be pointed out the 
existence of a bidentate hydrogen bond between ASP235 with OH3 and OH4 of the Gal 
residue, as well as a second hydrogen bond between ASN256 and the OH3 of the Gal 
moiety. Additionally, a clear CH-π stacking interaction between TYR249 and the Gal 
residue takes place. 
 
 
Figure 5.13 Docking model of the region (sialyllactose) of the glycodendrimer DA4-2,6-Ac that binds to 
the viscumin TYR binding site. The aminoacids providing better contacts with the ligand (GLN238, 
ASN256, ASP235, TYR249, SER200) are highlighted. 
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The possibility of simultaneous binding of two, three, or four VAA moieties to 
the ligand was also explored using the docking protocol. The results are given in 
Figures 5.14 and 5.15. The built model suggests the possibility of simultaneous binding 
of three VAA units in DA3-2,6-Ac, but only of a maximum of two VAA units in the 
case of DA4 ligands. Only with DA4 glycodendrimers, the simultaneous binding of 
three lectins would give rise to important steric conflicts, thus precluding the existence 
of larger multivalent complexes. 
 
Figure 5.14 Docking model of the glycodendrimer DA3-2,6-Ac bound to four units of viscumin (Top) 
and the docking models of the corresponding non precluded complexes (Down).  
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Figure 5.15 Docking model of the glycodendrimer DA4-2,6-Ac bound to four units of viscumin (Top) 
and the docking models of the corresponding non precluded complexes (Down).  
 
On the other hand, no experimental evidences of simultaneous binding could be 
extracted from the NMR experiments in a non-ambiguous manner, using different 
VAA/ligand molar ratios in DOSY experiments (see Figure 5.16). Observation of the 
diffusion coefficient of the NMR signals of DA4-2,6-Ac ligand in the presence of 
different amounts of VAA showed a significant increase in their corresponding 
diffusion coefficient. However, given the excess of the ligand and the linear averaging 
of the diffusion coefficient, these observations could be due to the presence of either 1:1 
or 1:2 complexes between the ligand and VAA. 
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Figure 5.16 (Top) DOSY experiments of glycodendrimer DA4-2,6-Ac in the presence of Viscumin (DA4-
2,6-Ac:VAA ratios 1:8, 1:4 and 1:2). (Down) 1H-NMR spectra of samples described on top. 
 
5.4 Conclusions 
Therefore, the reported lactose- and 6’sialyllactose-functionalized 
glycodendrimers can be easily accommodated by this lectin, providing enhanced 
binding. NMR experiments assisted by molecular modeling permitted the identification 
of the key sugar-lectin binding features, while the modeling protocol suggested a model 
for the possibility of multivalent interactions of these ligands with this lectin.  
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5.5 Materials and Methods 
 
Methods 
NMR experiments 
The NMR study of compounds DA2, DA3, and DA4in water solution was performed 
using 1mM samples in D2O. Standard 2D-methods, such as TOCSY (with mixing times of 30 
and 80ms), ROESY (300 ms), NOESY (400 and 600 ms), and HSQC experiments were 
employed to assign the NMR chemical shifts, using Bruker Avance 500 and 600 MHz 
(equipped with a triple channel cryoprobe) NMR spectrometers. 
Viscumin (Viscum Album Agglutinin, VAA) samples for saturation-transfer difference 
(STD) experiments were prepared in phosphate-buffered saline in deuterated water 
(NaH2PO410mM, NaCl137mM andKCl2.7mM; pH7.3 for Viscumin, uncorrected) using 
ligand/lectin ratios of 50:1. The temperature was 298 K. Data from one-dimensional (1D) STD 
experiments were acquired at 600 and 500 MHz using a Gaussian pulse (49 ms) cascade 
separated by 1 ms delays. In all cases, the on-resonance frequency was set at the aliphatic region 
(-0.2ppm), and the experiments were recorded with a saturation time of 2 s. The off-resonance 
frequency was always set at 100 ppm. 
The NMR study of DA3-2,6-Ac, DA4-2,6-Ac and DA4-2,6-Gc samples in water 
solution was performed using 1mM samples in D2O. Standard 2D-methods, such as TOCSY 
(with mixing times of 30 and 80ms), ROESY (300 ms), NOESY (400 and 600 ms), and HSQC 
experiments were employed to assign the NMR chemical shifts, using Bruker Avance 500 and 
600 MHz (equipped with a triple channel cryoprobe) NMR spectrometers. 
Viscumin (Viscum Album Agglutinin, VAA) samples for saturation-transfer difference 
(STD) experiments were prepared in deuterated water (NaH2PO4 10mM, NaCl137mM 
andKCl2.7mM; pH7.3 for Viscumin, uncorrected) using ligand/lectin ratios of 100:1. The 
temperature was 298 K. Data from one-dimensional (1D) STD experiments were acquired at 
600 and 500 MHz using a Gaussian pulse (49 ms) cascade separated by 1 ms delays. In all 
cases, the on-resonance frequency was set at the aliphatic regions (0.5 ppm), and the 
experiments were recorded with a saturation time of 2 s. The off-resonance frequency was 
always set at 100 ppm. 
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Molecular Modelling 
The templates for the modeling procedures were built based on the reported X-ray 
structure of Viscumin complexed with lactose (pdb code: 1PUU). The structures of the 
glycodendrimers were superimposed in the TYR249 binding site,using the most populated 
conformation found for the free state (according to a standard NOE/molecular modeling 
approach). The complex structure was then submitted to a short molecular dynamics (MD) run, 
followed by energy minimization with a low gradient convergence threshold (0.05) in 5000 
steps. In all cases, the OPL2005 force field11 was employed, as integrated in the Schroedinger 
MAESTRO suite of programms12.The protocol has been already described12. 
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1. We have demonstrated that the combination of STD and trNOESY NMR and 
MD simulations provide important information about the molecular recognition 
of synthetic oligosaccharides towards two specific IgG C7-37 and IgM G19-2 
antibodies. Our study has provided experimental evidences on the individual 
importance of the different residues, depending on its position at the 
oligosaccharide sequence, also for longer oligosaccharides, and their relevance 
for the molecular recognition process. The information derived from STD-NMR 
experiments clearly showed evidences of the direct involvement of residue C 
followed by its neighbor residues (RhapB-RhapC-GlcNAcpD) in every 
synthetic oligosaccharide in the presence of both mAbs. 
 
2. trNOESY-NMR experiments provided structural information about the major 
Φ/Ψ values of each glycosidic linkage and therefore, the existing conformational 
equilibrium in the bound state, which was compared to that existing in the free 
state. The data indicate that the molecular recognition events involve 
conformational selection processes. 
 
3. The analysis of the computed molecular surfaces showed that the major polar 
zones correspond to the non-interacting region of the ligand. Analysis of 
molecular surfaces showed that the major non-polar areas of the ligand are close 
to the antibody surface.  
 
4. The preparation of N-glycans facilitates definition of the docking sites of lectins 
on complex glycans. The nature of the target epitope strictly depends on the 
nature of the tested lectin, which can select distinct determinants of the complex-
type saccharide chain with exquisite specificity, depending on the relative 
presentation of the different residues and the architecture of the binding site. 
 
5. We have underscored the importance of the coexistence of binding sites from 
different lectin domains for achieving glycan binding by comparing a single 
hevein domain and WGA, a tetramer. The monomeric unit does not recognize 
the large glycan, with the branching at the βMan residue being the key structural 
element for precluding the interaction. In contrast, the multidomain lectin WGA 
binds the terminal reducing end of either non- or sialylated-N-glycan owing to 
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the possibility of achieving additional inter-site stabilizing interactions from one 
of the neighboring hevein domains. Thus, in naturally occurring N-
glycopeptides, binding occurs via the N-glycan–Asn stem region. As 
demonstrated, on the level of small glycans, WGA can accommodate sialic acid 
residues. Indeed, using α2,6-sialyllactose, we clearly demonstrate that this small 
trisaccharide is recognized by WGA, but the situation is different at the level of 
N-glycans.  
 
6. Work with VAA has yielded insights into how α2,6-sialylation can be 
accommodated by this lectin, providing enhanced binding in natural N-glycans 
when compared to the non-sialylated LacNAc-terminated analogue. Our 
methodology has permitted identification of the direct involvement of the sialic 
acid, as well as a network of interactions. 
 
7. Conversely, the results for the MAL–MAH mixture have permitted definition of 
the role of the α2,6-linked sialic acid residue in blocking binding of the 
corresponding sialylated-N-glycan. The binding to the LacNAc terminus of the 
non-sialylated-N-glycan is detectable, providing the control reference for 
positive binding. 
 
8. Four oligosaccharides related to the glycotope antigen have been shown to 
interact with different scFv glycotope-binding antibody fragments. Using STD 
experiments, we have shown that the presence of 3-O-α-DGal A’ moiety is a 
decisive feature for the binding process to take place. In contrast, the other 
residues at the “reducing end” merely display transient interactions with the 
carbohydrate binding site. 
 
9. The reported lactose- and 6’sialyllactose-functionalized glycodendrimers can be 
easily accommodated by Viscumin, providing enhanced binding. NMR 
experiments assisted by molecular modeling permitted the identification of the 
key sugar-lectin binding features, while the modeling protocol suggested a 
model for the possibility of multivalent interactions of these ligands with this 
lectin. 
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